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 Abstract 
 
 
Procyanidins (PCs) are phenolic compounds that belong to the class of flavonoids and are 
oligomers of monomeric (epi)catechin units. These monomeric units can be linked to each 
other by a single C4-C8 or C4-C6 linkage, which is referred to as B-type. Besides these 
single linkages an additional ether bond can be present, C2-O-C7 or C2-O-C5, which is 
referred to as A-type. PCs are highly abundant in our diet. Well known PC food sources are 
cocoa, apple, grape seeds, wine and nuts. After the intake of PC-rich sources health 
beneficial effects have been detected, which are mainly related to the prevention of 
cardiovascular diseases such as lowering of blood pressure.  
The aims of this thesis were to study the bioavailability, bioconversion and 
bioactivity of purified PCs. Therefore, we first developed techniques for the efficient 
purification of both A- and B-type PCs from peanut skins and grape seeds, respectively. 
Furthermore, tools were set-up to analyze and characterize individual PCs in complex 
mixtures.  
We showed that A-type PC dimers were absorbed from the small intestine of rats 
and that they were better absorbed than B-type PC dimers. The PC dimers were not 
conjugated or methylated upon absorption in contrast to their monomeric units 
(epi)catechin. Furthermore, the presence of A-type PC tetramers enhanced the absorption of 
B-type PC dimers.  
The microbial conversion of B-type PC dimers was studied by exposing them to 
human microbiota. The main microbial metabolites were 2-(3,4-dihydroxyphenylacetic acid 
and 5-(3,4-dihydroxyphenyl)-γ-valerolactone. Based on these and other metabolites that 
were detected, a tentative microbial degradation route was proposed for B-type PC dimers, 
in which the interflavanic bond does not need to be cleaved upon degradation.  
Subsequently, the vasorelaxing potential of purified PCs and their microbial 
metabolites was analyzed by measuring their effect on the NO production of endothelial 
cells. Both A- and B-type PCs showed a tendency (insignificant) to increase NO production  
with increasing degree of polymerization and several of their human microbial metabolites 
that were tested were inactive. Besides enhancing NO production, several other 
mechanisms could be targets of PCs and were also discussed.  
This thesis increased our knowledge on the absorption, biotransformation and 
bioactivity of A- and B-type PCs. A possible interaction between oligomers with a high and 
low degree of polymerization, influencing absorption processes has been discussed, which 
suggests that until now the biofunctional potential of PAs has been underestimated. 
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Proanthocyanidins in relation to cardiovascular health 
 
 
The modern sedentary life together with a high-calorie diet has a large impact on health. As 
a consequence, lifestyle-related obesity is rapidly growing (1-3). Obesity is an important 
characteristic feature of the metabolic syndrome, which reflects the increase in risk factors 
for type 2 diabetes and cardiovascular diseases (CVD) (4, 5). 
Mortality due to CVD, as one of the life-style related diseases, accounts currently 
for more than 30% of the deaths in the Netherlands (6). The number of hospitalizations for 
people with CVD was over 300.000 in 2004 (7), in a population of 16 million people. 
Smoking, hypertension and hyperlipidaemia are the prevalent risk factors related to the 
development of CVD, while obesity and diabetes mellitus have become more important   
(5, 8).  
Efforts are made to unravel relations between our diet and the occurrence or, more 
important, the prevention of CVD. As an example, French people exhibited a lower 
incidence of cardiovascular mortality than expected based on their relatively high intake of 
saturated fat (“the French paradox”). The consumption of red wine was considered to be an 
important factor and an inverse relation between red wine consumption and mortality from 
CVD was found (9). Besides, evidence has been collected on beneficial effects of cocoa 
(chocolate) on CVD. Several studies reported that both after frequent intake and after a 
single dose of cocoa blood pressure was reduced (10-13).  
One group of phenolic compounds, the proanthocyanidins, highly abundant in 
both product groups, gained considerable attention. This introduction will give background 
information on the occurrence of proanthocyanidins in dietary sources and the current 
knowledge on their bioavailability and bioactive properties. 
 
 
Nature and occurrence of proanthocyanidins 
 
 
Classification of proanthocyanidins 
Proanthocyanidins belong to the class of flavonoids, which have a characteristic C6-C3-C6 
diphenylpropane skeleton. Biosynthesis of proanthocyanidins follows the phenylpropanoid 
pathway and as a final step condensation of flavan-3-ols and flavan-3,4-diols into 
oligomers, the proanthocyanidins, occurs (14, 15). The actual mechanism of condensation 
and the proportion flavan-3-ols and flavan-3,4-diols involved is not known (16). In the 
older literature, often the name leucoanthocyanidins or condensed tannins were used for 
proanthocyanidins (17). Later this was redefined and leucoanthocyanidins represented the 
class of monomeric flavan-3,4-diols, while proanthocyanidins were defined as oligomers of 
General introduction 
 
 3 
monomeric flavan-3-ols. Both leucoanthocyanidins and proanthocyanidins bear the name of 
anthocyanidin. Leucoanthocyanidins refers to their biosynthetic conversion into 
anthocyanidins by the enzyme anthocyanidin synthase (leucoanthocyanidin dioxygenase) 
(18). The translation of leuco is white/colorless and a leuco compound is defined as a 
colorless compound, which can be converted to a dye by oxidation. The name of 
proanthocyanidins does not relate to their biosynthetic origin, but rather to their chemical 
behavior. Proanthocyanidins are converted into anthocyanidins when they are incubated in 
hot mineral acid. Leucoanthocyanidins also possess this feature. Hence the difficulties to 
distinguish the presence of both groups using a colorimetric method based on the formation 
anthocyanidins.  
 
Subgroups of proanthocyanidins 
As mentioned before, proanthocyanidins derive their name from the fact that they can be 
converted into the colored anthocyanidins when incubated in hot mineral acid (19). This 
phenomenon is still used as a rapid method to determine their presence in extracts (20). 
Proanthocyanidins can be subdivided into at least fifteen subgroups based on their 
hydroxylation patterns (21) on the A and the B-ring of the monomeric flavan-3-ol. The 
subgroups procyanidins, prodelphinidins and propelargonidins (Figure 1) are of prime 
importance in terms of human intake. The other 12 subgroups have been detected mainly in 
non-food sources (21).  
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PA subgroup monomeric unit R1 R2 food source 
procyanidin (epi)catechin OH H apple, grape seeds, sorghum 
prodelphinidin (epi)gallocatechin OH OH nuts, grapes, black currants 
propelargonidin (epi)afzelechin H H berries, beans, cinnamon 
Figure 1. Common proanthocyanidin subgroups and selected food sources in which they are 
present (22). 
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Figure 2. Depolymerization of a procyanidin (4 x epicatechin) (A) and an arbitrarily chosen 
prodelphinidin (2 x epicatechin and 2 x epigallocatechin) (B) tetramer when incubated with 
mineral acid. 
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The specific anthocyanidins that are formed upon heating in mineral acid (23) 
determine the name of the subgroup. Procyanidin is the most abundant subgroup present in 
foods and is a homogeneous group exclusively consisting of (epi)catechin units (Figure 1). 
When procyanidins are incubated in hot mineral acid, the extension units will be converted 
into cyanidins and the terminal unit will be released as the flavan-3-ol (epi)catechin. An 
example of the conversion of a procyanidin tetramer is given in      Figure 2A. A second 
subgroup is prodelphinidin, a heterogeneous group, consisting of at least one 
(epi)gallocatechin unit besides (epi)catechin units. An example of acid-induced 
depolymerization of a prodelphinidin tetramer is given in Figure 2B. This tetramer is 
composed of two epigallocatechin units and two epicatechin units. The terminal unit will be 
released as flavan-3-ol, in this particular case epigallocatechin. The extension units, one 
epigallocatechin and two epicatechins, will be released as delphinidin and cyanidins, 
respectively. The third subgroup present in foods is propelargonidin.  
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Figure 3. Representative structures of proanthocyanidins. The monomeric units can be linked 
through a single carbon-carbon bond (C4-C8 (1) or C4-C6 (2)) or with an additional ether bond 
(C4-C6, C2-O-C7 (3) or C4-C8, C2-O-C7 (4)). Galloyl substituents can also be present (1). 
Chapter 1
 
 6 
Similarly as prodelphinidins, it is a heterogeneous group, consisting of at least one 
(epi)afzelechin unit besides (epi)catechin units. Therefore, depending on the position of the 
monomeric units, acid depolymerization can result in the anthocyanidins pelargonidin 
and/or cyanidin (from the extension units) and the flavan-3-ols (epi)afzelechin or 
(epi)catechin (from the terminal unit).  
The monomeric units can be linked through a single carbon-carbon bond: a C4-C8 
or a C4-C6 linkage (Figure 3, structures 1 and 2, respectively). Proanthocyanidins that 
exclusively contain one of these C-C bonds are referred to as B-type proanthocyanidins. An 
additional bond, an ether bond, can be present between the monomeric units, usually a C2-
O-C7 (Figure 3, structures 3 and 4) or a C2-O-C5 ether bond. Proanthocyanidins that 
contain both a C-C and an ether bond (C-O-C) between the monomeric units are called A-
type proanthocyanidins. Furthermore, galloyl substituents at the C3 position (Figure 3, 
structure 1) have been detected, which are highly abundant in grape seed (24, 25). 
The size of proanthocyanidins is indicated by their degree of polymerization (DP), 
which implies the number of monomeric units that are attached to each other. In certain 
cider apple varieties, the degree of polymerization ranged from 2 up to 190 (26). The DP 
can vary between different sources (Figure 4). Sources like barley, peanuts and raspberry 
mainly contain low DP oligomers, while the opposite applies to cranberry and pecan nuts  
(22). 
0 20 40 60 80 100
grape seeds (dry)
raspberry
apple (golden delicious)
plum
apricot
barley
cranberry
pecan nuts
roasted peanuts 
baking chocolate
cinnamon
So
ur
ce
% (w/w) of total amount of proanthocyanidins
1 2 3 4 tot 6 7-10 >10DP: 
 
Figure 4. Abundance of proanthocyanidins of various degrees of polymerizations in different 
dietary sources expressed as proportion (% w/w) of the total amount of proanthocyanidins 
present (22). 
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Variations in the number and position of the bonds between the monomeric units, 
the structure of the monomeric units, additional substituents, and the DP, results in an 
enormous structural variety of naturally occurring proanthocyanidins. 
 
Nomenclature 
Initially, proanthocyanidins were named on the basis of an alphanumeric system (27). 
Dimers with an A-type interflavanic linkage were named A with an additional number as 
new structures were discovered, for example A1 and A2 (Figure 5) present in peanut skins 
(28). Dimers containing a single linkage (B-type) were annotated as B followed by 
numbers, for example B1 and B2 (Figure 5), which are often detected as the main dimers 
in major proanthocyanidin sources like apple (29), cocoa (30) and wine (31). This was 
continued with the notation C for trimers containing single linkages. However, this 
nomenclature was not informative about the monomeric composition. Furthermore, the 
interflavanic linkages were only indicated for dimers (A= double and B= single linkage) 
and not for higher oligomers, as C represents trimers without indicating if it contains single 
or double linkages. Nowadays, most authors use the nomenclature of proanthocyanidins 
that was first suggested by Hemmingway and coworkers (32), which has similarities with 
polysaccharide nomenclature. Translating this nomenclature to proanthocyanidins, the 
monomeric units are defined and the configuration of the interflavanic linkage (α or β) is 
given between brackets. Besides the hydroxylation pattern, the nomenclature of the 
monomeric units depends on the configuration at C2 and C3. This configuration determines 
whether the prefixes epi (epimer) or ent (enantiomer) should be used. For example the 
configuration 2R:3S represent catechin ((+)-catechin) and 2R:3R represents epicatechin    
((-)-epicatechin). The configuration at C2 is almost always R, but when this is S the prefix 
ent should be used. For example 2S:3R represents ent-catechin ((-)-catechin) and 2S:3S 
represents ent-epicatechin ((+)-epicatechin). 
Using this nomenclature, B1 becomes epicatechin-(4β-8)-catechin or abbreviated 
as EC-(4β-8)-C and A1 becomes epicatechin-(2β-O-7, 4β-8)-catechin. The disadvantage of 
this notation is that it becomes quite extensive for higher oligomers. Often both 
nomenclatures are used together. 
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Figure 5. Structures and nomenclature of procyanidin dimers A1, A2, B1 and B2. 
 
 
Dietary sources of proanthocyanidins 
 
 
Proanthocyanidins are present in a wide variety of plant derived foods and beverages, like 
chocolate, apple, grapes, legumes, berries, peanuts, wine and several spices (22, 33). They 
are the second most abundant phenolic compound in our diet after lignin (22). In the US, 
the estimated intake of proanthocyanidins over the period 1981-1991 was 53.6 mg/day (22). 
More recently, Mink and coworkers (34) assessed the intake of proanthocyanidins in the 
Iowa Women’s Health Study, a cohort of 35.000 postmenopausal women, to determine the 
relation to CVD mortality. Subjects were divided in five different groups on the basis of 
their intake. The group with the lowest and highest intake had a median intake of 62 (range 
of 0-90) and 524 (range of 343-3226) mg/day, respectively. Averaging the median intake 
over the five different groups that were used in this cohort, an average intake of 228 mg/day 
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can be estimated. The intake of 53.6 mg/day reported by Gu and coworkers (22) is similar 
to group with the lowest intake reported by Mink and coworkers (34). Both used the rather 
extended USDA database to determine the intake. It seems that 53.6 mg/day would 
underestimate the intake for a large part of the population, and 228 mg/day might be a more 
reliable estimate of the US intake.  
For the Dutch population the proanthocyanidin intake has not been reported. The 
intake of monomeric flavan-3-ols in the Dutch population was estimated to be 50 mg/day 
(35) explained by the intake of tea (± 50%) and sources like chocolate, apple and wine. The 
concentrations (% w/w) of proanthocyanidins in chocolate apple and wine are higher 
compared to those of monomeric flavan-3-ols (Figure 4). For example, apple contains ~10-
20 times, and chocolate ~8 times more proanthocyanidins than monomeric flavan-3-ols. 
(22, 36). Therefore, the intake of proanthocyanidins in the Dutch population might be 
comparable with the US data of Mink and coworkers (34). 
 
 
Absorption of proanthocyanidins 
 
 
Bioavailability of proanthocyanidins 
Proanthocyanidins are known to be present in our diet, but their fate after ingestion is not 
fully understood. First, they should survive the acidic environment of the stomach. 
Procyanidin dimers that were incubated in simulated gastric juice (pH 2.0) for 3.5 h (37) 
were not stable and their concentration decreased with 30%. Simultaneously, epicatechin 
concentrations increased. Nothing was reported on the release of anthocyanidins. In the 
same study, higher oligomers were completely depolymerized, releasing dimers and 
epicatechin. In contrast, an in vivo study with six human volunteers showed that after 
ingestion of a cocoa beverage, containing proanthocyanidins, depolymerization did not 
occur during 1 h (38). After ingestion of the cocoa beverage the pH increased from 2.0 to 
5.4, which is beneficial for proanthocyanidin stability. Furthermore, the food matrix might 
have contained protective substances that prevented proanthocyanidin degradation, but this 
was not reported. A study performed with ileostomy patients who ingested apple juice, 
confirmed that procyanidins will pass the stomach and reach the colon intact (39).  
Several in vivo studies have been performed, which showed that procyanidins can 
be absorbed and subsequently appear in plasma (Table 1). These studies focused on the 
absorption of products/extracts containing B-type procyanidins like cocoa (40), apple (41) 
and grape seeds (42-45), or purified B-type procyanidins (42, 46). The majority of these in 
vivo studies suggested that only procyanidin dimers can be absorbed, but trimers have also 
been detected in urine and plasma of rats (41, 44, 45). 
 
Table 1. Overview on the in vivo absorption of proanthocyanidins reported in literature. 
PC source species dose 1 metabolites 2,3,4,5 reference 
cocoa beverage human (n=5) 375 mg/kg (3.6 mg dimers/kg) B2 (41 ± 4 nM, t= 2h) (40) 
grape seed extract human (n=4) 2 g (18 mg dimers) B1 (10.6 nM, t= 2h) (43) 
apple extract rat (n=6) 1000 mg/kg (1412 mg dimers/kg) B1 (170 nM, t=2h) (41) 
   B2 (400 nM, t=2h)  
   C1 (140 nM, t=2h)  
B2 rat (n=5) 50 mg/kg B2 (500 nM, t= 0.5h) (46) 
   EC (210 nM, t= 0.5h)  
   3-OMeEC (110 nM, t=0.5h)  
B3 rat (n=15) 2% (w/w) in diet for 2 weeks < 20 nM (42) 
grape seed extract rat (n=15) 20-40% (w/w) in diet for 2 weeks < 20 nM  
grape seed extract rat (n=3) 1 g/kg (28.4 mg/kg dimers) n.d. (44) 
   urine: B1-B4 (2.2% (w/w) of intake)  
             C2 (4.3% (w/w) of intake)  
grape seed extract rat (n=8) 300 mg/kg, twice a day for 3 days dimers and trimers, not quantified (45) 
   urine: dimers and trimers, not quantified  
1 the dose was expressed as mg/kg body weight if possible. If applicable, the exposure time is indicated. 
2 plasma metabolites are given unless another matrix is given. 
3 EC= epicatechin, 3-OMeEC = 3’-O-methyl-epicatechin, B1= EC-(4β-8)-C, B2= EC-(4β-8)-EC, B3= C-(4β-8)-C, B4= C-(4β-8)-EC, 
C1= EC-(4β-8)-EC-(4β-8)-EC. 
4 EC and 3-OMeEC are not given when the source contained EC  
5 n.d. = not detected. 
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In vitro, dimer B3 (catechin-(4α-8)-catechin) and trimer C2 (catechin-(4α-8)-
catechin-(4α-8)-catechin) were both absorbed by epithelial Caco-2 cells (47) in the same 
order of magnitude as mannitol, a marker for paracellular transport. Higher oligomers 
(average DP 6) were not absorbed. In vivo, trimers did not seem to be absorbed as easy as 
suggested by the in vitro assay (47). Nothing has been reported on the bioavailability of   
A-type procyanidins. This will be explored in this thesis.  
A higher absorption of dimers compared to higher DP oligomers, resulted in an 
increased interest for procyanidin sources rich in low DP oligomers, especially dimers. 
Research efforts have aimed at developing processing methods to convert the naturally-
occurring, more abundant high DP oligomers (Figure 4) to monomers and low DP 
oligomers. For example, the processing of cocoa might be adjusted (unfermented, blanched 
and without roasting) to obtain cocoa powder with higher amounts of monomers and dimers 
(48). Chocolate products enriched in monomers and low DP oligomers have recently been 
launched on the market (CocoaVia®, Mars). Another way to obtain low DP oligomers is to 
depolymerize the proanthocyanidins in mineral acid as indicated in Figure 2. The 
formation of anthocyanidins is prevented by the addition of a nucleophile, like catechin or 
epicatechin, to create low DP oligomers (49, 50). Also cysteine has been used as 
nucleophile, resulting in the commercially available extract Oligonol (Amino Up Chemical 
Company, Sapporo, Japan), which is rich in low DP oligomers (51).  
 
Methylation and conjugation of proanthocyanidins 
Already upon absorption, phenolic compounds can be conjugated by glucuronidation and/or 
sulfation and additionally, methylation can take place (52). The extent of conjugated 
metabolites can be determined by analyzing samples with and without β-glucuronidase/ 
sulfatase treatment. Conjugation and methylation are important processes, occurring upon 
absorption of epicatechin in humans (48, 53) and rats (54-56). Therefore, it might be 
hypothesized that conjugation and methylation are also important reactions for 
procyanidins.  
Knowledge on the conjugation of proanthocyanidins is limited. Most studies 
dealing with absorption of procyanidins (Table 1) either analyzed the total amount of 
procyanidins (40, 42, 43, 46) or the unmodified amount of procyanidins (44). Only Shoji 
and coworkers (41) determined the difference between total and unmodified PCs, and 
showed that 10% of the absorbed procyanidins was conjugated. 
The enzyme catechol-O-methyl-transferase has been reported to methylate 
phenolic compounds (52). In vitro, also procyanidin dimers were shown to be a substrate 
for this enzyme (57). Methylation of procyanidin dimers upon absorption has been reported 
occasionally. Small amounts of monomethylated procyanidin dimers have been detected 
twice based on MS data (41, 57). Besides monomethylated dimers, recently a 
tetramethylated procyanidin dimer was tentatively identified after administration of a grape 
Chapter 1
 
 12 
seed extract to rats (45). Also administration of specific wine-derived dimers (58), 
composed of two epicatechin units linked by an ethyl bridge, resulted in tetramethylated 
dimers, but in contrast to the other studies, in this study they were the only metabolites 
present in rat plasma (59). Standards of methylated and/or glucuronidated procyanidins are 
still lacking, which limits the development of accurate, rapid, quantitative and sensitive 
methods to measure them. 
Unlike procyanidins, data on the bioavailability and metabolism of B-type 
dimers/oligomers of the other two subgroups; prodelphinidins and propelargonidins is 
lacking. Information on A-type proanthocyanidins is completely lacking. In this thesis, 
absorption and metabolism of A-type and B-type procyanidin dimers will be compared. 
 
Cleavage of the interflavanic linkage of poanthocyanidins upon 
absorption 
No consensus has been reached on the question whether (epi)catechin is a metabolite of 
procyanidins. This is partly due to the fact that most procyanidin sources that have been 
used in in vivo studies (Table 1) also contained (epi)catechin. Therefore, the origin of 
(epi)catechin and its methylated and/or conjugated metabolites detected in plasma could not 
be determined. Two studies that have used purified B-type dimers reported (epi)catechin as 
a procyanidin metabolite. Epicatechin was the major metabolite of B2 (epicatechin-(4β-8)-
epicatechin) and B5 (epicatechin-(4β-6)-epicatechin), which was studied ex vivo by 
perfusion of the rat small intestine (57) and (methylated)epicatechin was present in rat 
plasma after the intake of B2 (46).  
Detection of epicatechin or its metabolites raises the question whether 
procyanidins are actively converted into epicatechin upon absorption, or whether hydrolysis 
of procyanidins into epicatechin is caused by the experimental conditions. Therefore, in this 
thesis, purified procyanidin dimer, trimer, and tetramer fractions, free of monomers, will be 
used for bioavailability studies. 
 
 
Microbial metabolism of proanthocyanidins 
 
The majority of proanthocyanidins will reach the colon after passage through the small 
intestine, where only small amounts are absorbed (39). Metabolites formed by the 
microbiota in the colon might add to the beneficial health effects of procyanidins. It is 
known that the monomeric units of procyanidins, (epi)catechin, are degraded into 
phenylvaleric acids, phenylpropionic acids, phenylacetic acids, benzoic acids and hippuric 
acids (60-63). In addition, 5-(3,4-dihydroxyphenyl)-γ-valerolactone and 5-(3-
hydroxyphenyl)-γ-valerolactone have been identified in various species, including man (60, 
64-69).  
General introduction 
 
 13 
Table 2 summarizes a total of twenty-eight different microbial metabolites that 
have been reported to originate from procyanidins. Fifteen of these have only been detected 
once. Phenylpropionic and phenylacetic acids (mainly meta hydroxylated) were the main 
microbial metabolites that have been detected, both in vitro and in vivo. Additional 
metabolites like benzoic and hippuric acids have been detected only in vivo. From these 
studies the metabolites derived from procyanidins seem similar to those reported for 
(epi)catechin, their free monomeric units (see above). However, four out of the six in vivo 
studies (62, 63, 70-73) used procyanidin sources that also contained monomers. Therefore, 
metabolites detected in those studies might also have originated from the monomers.  
Three in vitro fermentations (74-76) with procyanidins have been performed. Two 
of these studies used a mixture of procyanidin oligomers (DP 2-71, and average DP 7)     
(74, 75) that were fermented with human microbiota. A drawback of using high DP 
oligomers is their antimicrobial properties (77, 78), which might be related to their 
interaction with proteins (79, 80). Only one of these studies used a low DP oligomer, i.e. 
purified B2 (81), but fermentation was performed with microbiota of rats instead of 
humans.  
Fermentations performed with catechin and epicatechin, showed differences in 
bioconversion between animal and human microbiota (66, 82). In this thesis, we study the 
human microbial conversion of purified B-type dimers. Care was taken to exclude 
monomers during the isolation of the dimers.  
 
 
Potential health effects of proanthocyanidins 
 
 
Bioacitivity of proanthocyanidins (in vitro and animal studies) 
A range of health related properties are reported for proanthocyanidins: Antiviral activity 
(83, 84), insulin-like activity (85), anti-tumor activity (86, 87), anti-inflammatory activity 
(88, 89), and antioxidant activity (90). Only few studies have used pure proanthocyanidins 
or proanthocyanidin fractions with a defined degree of polymerization. An increase in 
antioxidant activity with increasing DP has been reported, which was based on molarities 
(91). In contrast, another study reported that a B-type trimer (C1) showed higher 
antioxidant activity compared to higher oligomers (83). Compared to resveratrol and 
ascorbic acid, an A-type propelargonidin dimer and trimer had similar or better radical 
scavenging abilities, tested in different systems on a molar basis (92). Thus, both A- and B-
type procyanidins have been reported to exert antioxidative capacities. 
Only few studies showed the vasorelaxing properties of proanthocyanidins. These 
studies mostly tested the ability of procyanidins to relax animal aorta rings. Two studies 
reported vasorelaxing activity of procyanidins from cocoa (93) and grape seeds (94).  
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Table 2. Overview of in vivo (urine) and in vitro microbial metabolites of proanthocyanidins 
reported in literature. 
reference 74 A 75 76 62 C 
procyanidin 
source/composition apple extract willow tree extract B3 
B3, C2 and 
polymer fraction 
  14C-labelled   
 Av DP 2-71 Av DP=7  no DP 1-3  
Av DP=7 
no DP 1-3 
fermentation conditions in vitro human (n=4) 
in vitro  
human (n=1) 
in vitro 
rat (n= -) 
in vivo 
rats (n=5) 
concentration/dose 0.2-7.9 mM B 5 mM 1.7 mM 1 g/kg diet 5 days 
metabolites     
phenylpropionic acid x x x  
3-hydroxy x x  x 
4-hydroxy  x x  
3,4-dihydroxy x   x 
phenylacetic acid   x  
3-hydroxy x x  x 
4-hydroxy  x x  
3,4-dihydroxy x   x 
3-methoxy-4-hydroxy     
benzoic acid x    
3-hydroxy    x 
4-hydroxy    x 
3,4-dihydroxy     
3-methoxy-4-hydroxy    x 
4-O-methyl-gallic acid     
hippuric acid     
3-hydroxy    x 
4-hydroxy    x 
ferulic acid     
m-coumaric acid    x 
protocatechuic acid    x 
phenylvaleric acid     
3-hydroxy  x  x 
phenyl--valerolactone     
3,4-dihydroxy     
3-hydroxy   x  
3-methoxy-4-hydroxy     
ethylcatechol     
3,4-diHPP-2-ol H   x  
A metabolites that showed a distinctive increase compared to the control  
B includes flavan-3-ols, procyanidins and chlorogenic acid 
C metabolites significantly increased (P < 0.05) after the B3 diet compared to a control diet 
D metabolites significantly increased (P < 0.05) from 0-48 h 
E only the dominating metabolites are given, serum metabolites are indicated with xE 
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71 63 D 72 E 70 F 73 G 
pine bark extract chocolate sorghum bran extract 
grape seed 
extract grape vine extract 
     
DP 2-4 DP 1-10 DP 1-polymers + DP 1 + DP 1 
in vivo 
human (n=1) 
in vivo 
human (n=11) 
in vivo 
rat (n=5-7) 
in vivo 
human (n=69) 
in vivo  
rat (n=5) 
in vitro (n= -) 
960 mg 80 g 0-400 g/kg diet, 50 days 
1000 mg/day  
6 weeks 
in vivo  
15-75 mg/kg 
     
     
 x x x x G 1-2 
     
     
     
 x x x x G 1-2 
  xE   
 x    
  x  x 
    x G 1-2 
 x   x 
     
  xE   
  xE  x G 1 
   x  
    x 
    x 
     
 x    
     
     
 x    
     
     
x    x G 1-2 
     
x     
    x G 1 
     
F metabolites significantly increased (P < 0.002)  
G the main metabolites detected in urine are given. It was indicated when similar metabolites were detected in the faces 
(xG1) or after in vitro fermentation (xG2) 
H 3,4-diHPP-2-ol=1-(3-hydroxyphenyl)-3-(2,4,6-trihydroxyphenyl)propan-2-ol 
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The activity of the cocoa B-type procyanidins depends on their DP, i.e. only 
oligomers with a DP of 5 and higher were active (93). 
Only one study tested the relaxation properties of A-type dimers and trimers (95). In that 
study it was found that trimers were more active than dimers. Several mechanisms might 
underlie the relaxation of arteries, one of which might be the stimulation of NO production 
by endothelial cells. Therefore, in this thesis we will test different A- and B-type 
procyanidin fractions for their NO-stimulating potential. 
 
Bioacitivity of microbial metabolites of proanthocyanidins (in vitro 
and animal studies) 
A higher activity for high DP oligomers might not be relevant, because high DP oligomers 
have a low bioavailability. Besides proanthocyanidins, the activity of microbial metabolites 
might also be of interest. Data on the bioactivity of such metabolites (phenylpropionic, 
phenylacetic acids, etc.) are very limited. One of the metabolites of procyanidins (Table 2), 
5-(3’,4’-dihydroxyphenyl)-γ-valerolactone, has been reported to have an antioxidative 
activity in between that of epicatechin and ascorbic acid (65). Furthermore, 3,4-
dihydroxyphenylacetic acid showed anti-proliferative activity (96). Some of the microbial 
metabolites enhanced the expression of endothelial nitric oxide synthase (eNOS), the 
enzyme responsible for the NO production of endothelial cells, but the main metabolites 
(phenylpropionic and phenylacetic acids) were not included in that study (97). Therefore, in 
this thesis, we performed a study on the potential of several phenolic metabolites to 
enhance NO production of endothelial cells. 
 
Human intervention studies 
Williamson and Manach (98) reviewed 21 human intervention studies with 
proanthocyanidin-rich sources like cocoa (including chocolate), pine bark (Pycnogenol) and 
grape (including wine, grape juice and grape seed extracts) (Table 3). The biomarkers 
affected included a decreased LDL cholesterol level, decreased platelet aggregation, and 
increased antioxidant status, which are all related to the functioning of the vascular system. 
Intervention studies that reported increased plasma antioxidant status have 
promoted the development of many commercial proanthocyanidin extracts (Oligonol®, 
Vitaflavan®, Oligopin®, Pycnogenol®, MegaNaturalTM etc.) that have a health claim on 
this antioxidant activity. Evidence on the health potential of cocoa and grape/wine is 
focused on blood pressure (13, 99, 100), endothelial-dependent relaxation (101), and LDL 
concentration/oxidation (102, 103). The improved flow-mediated dilation after a cocoa 
drink rich in flavan-3-ols coincided with an increase of nitric oxide, a vasorelaxing 
mediator, in plasma (104). Recently, a meta-analysis of randomized placebo controlled 
trials (105) confirmed that chocolate intake increased flow-mediated-dilation and reduced 
blood pressure. 
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Table 3. Summary of human intervention studies with procyanidin rich sources in which 
biomarkers were significantly affected.  
biomarkers significantly affected sources nr. studies references 
increased plasma anti-oxidant status cocoa/chocolate, cranberry 
juice, pomegranate juice 
5 (98) 
decreased lipid peroxide/thiobarbituric 
acid reactive species 
cocoa/chocolate, red wine, 
grape extract 
3 (98) 
endothelial-dependant dilatation cocoa 2 (98, 101) 
increased flow-mediated dilatation grape juice, cocoa 3 (98-100) 
decreased blood pressure cocoa, Pycnogenol 4 (13, 98-100)  
decreased susceptibility of LDL to 
oxidation 
cocoa, grape juice, grape 
extract, pomegranate juice 
7 (98,102, 103) 
decreased platelet aggregation cocoa, Pycnogenol, grape 
juice 
4 (98) 
decreased LDL plasma concentration cocoa, Pycnogenol 3 (98, 100, 103) 
 
A drawback of all intervention studies mentioned is that none of them has been 
performed with pure procyanidins. Some used procyanidin-rich extracts, but also wine and 
juices have been used. Besides proanthocyanidins, these products contain a multitude of 
other compounds. Therefore, it is uncertain whether the potential health effects observed 
can be ascribed only to proanthocyanidins (106). 
 
 
Thesis Outline 
 
 
Proanthocyanidins are an important group of phenolic compounds in our diet and evidence 
on their beneficial health effects is increasing. However, many aspects on their occurrence 
in the diet, their bioavailability, metabolism, and bioactivity are still unknown, especially 
with respect to A-type procyanidins. Therefore, the aims of this thesis were: i) to determine 
the bioavailability and metabolism of A-type in comparison to B-type procyanidins, ii) to 
determine the human microbial metabolites of B-type procyanidins, and iii) to determine 
the potential of A- and B-type procyanidins or their microbial metabolites to improve 
vascular function by influencing NO-release of endothelial cells.  
To achieve these aims it is important to isolate A- and B-type dimers and other 
oligomers, and concomitantly to develop of appropriate analytical tools for their 
characterization. 
Peanut skins are a by-product from the peanut butter industry and a cheap, rich 
source of A-type procyanidins. Considering the reported health beneficial effects of 
proanthocyanidins, peanut skins might be an interesting source of proanthocyanidins for the 
use in food supplements. To determine the biofunctional potential of this source, the 
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proanthocyanidin composition is needed. Therefore, we characterized the molecular 
diversity of A-type proanthocyanidin dimers to heptamers present in peanut skin    
(Chapter 2). Often monomers are present in the extracts that are used to analyze the 
bioavailability or bioactivity of proanthocyanidins, which might interfere with the outcomes 
of these studies. To prevent this for our studies on bioavailability and metabolism, we 
isolated and purified several A- and B-type procyanidin dimers from peanut skin and grape 
seeds (Chapter 3). Care was taken to specifically exclude monomers from these isolates. 
Subsequently, the absorption and metabolism of these purified dimers, and fractions 
containing trimers and tetramers was studied by an in situ perfusion rat model (Chapter 4). 
A major fraction of the procyanidins ingested will reach the colon where they become 
substrates for microbiota. The microbial metabolites formed might (partly) explain the 
health effects found for proanthocyanidins. Therefore, an in vitro fermentation model with 
human microbiota was used to identify metabolites of B-type dimers (Chapter 5). Because 
intervention studies showed that proanthocyanidin intake seems to favorably affect 
endothelial function, the potential of various proanthocyanidins and their microbial 
metabolites to increase nitric oxide production of endothelial cells was studied (Chapter 6). 
Finally, the results from this thesis are discussed in a broader sense (Chapter 7).  
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Abstract 
 
 
Peanut skins, a by-product of the food industry, are a rich source of proanthocyanidins, 
which might be used in food supplements. Data on the molecular diversity of 
proanthocyanidins in peanut skins is limited and conflicting with respect to the ratio of 
double (A-type) versus single linked (B-type) flavan-3-ol units. 
We combined NP and RP-LC-MS to analyze the molecular diversity of proanthocyanidins 
in a 20% (v/v) MeOH extract of peanut skins. Monomeric to pentameric fractions were pre-
purified using NP-HPLC and further separated by RP-HPLC-MS. With this method, 83 
different proanthocyanidin molecular species were characterized and quantified. A-type PC 
oligomers were predominant and represented 97.6 % (w/w) of the extract. In addition, the 
position of the A-linkages in 16 trimers and 27 tetramers was determined and appeared to 
occur at all possible positions. The majority of trimers and tetramers with one or more A-
linkage(s), always had an A-linkage at the terminal unit.  
 
 
Key words: peanut skins, proanthocyanidins, A-type, quantification, molecular diversity, 
NP-HPLC, RP-HPLC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations used: DP, degree of polymerization; E, extension unit; HRF, heterocyclic ring 
fission; PA, proanthocyanidin; PC, procyanidin; PD, prodelphinidin; PP, propelargonidin; QM, 
quinine methide fission; RDA, retro-Diels-Alder fission; T, terminal unit 
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Introduction 
 
 
Proanthocyanidins (PAs), present in a wide variety of food products and beverages, are the 
second most abundant class of phenolic compounds in our diet (1). Intervention studies 
with PA-rich extracts and products like cocoa and wine suggest protective effects of PAs 
against cardiovascular diseases (2, 3). Peanut skins, a by-product from the peanut butter 
industry, might be an excellent source for the production of PA-rich extracts for use in food 
supplements, like the ones already available from grape seed (Vitaflavan, DRT 
Nutraceutics, France) and pine bark (Pycnogenol, Horphag Research, Switzerland). To 
explore the full potential of peanut skins as a food supplement, it is important to know the 
molecular diversity of the PAs present.  
PAs can be divided into several groups. The most common PAs, occurring in food 
sources such as peanut skins, are the procyanidins (PCs) (1), exclusively consisting of 
(epi)catechin units. Besides PCs, prodelphinidins (PDs), a heterogeneous group consisting 
of at least one (epi)gallocatechin unit and additional (epi)catechin units, and 
propelargonidins (PPs), a heterogeneous group consisting of at least one (epi)afzelechin 
unit and additional (epi)catechin units, occur in food sources.  
The monomeric units of PAs are linked through a C4-C8 or C4-C6 bond (B-type), 
which can coexist with an additional C2-O-C7 linkage (A-type). Each proanthocyanidin 
oligomer contains one terminal unit of which the C-ring is not connected to another 
monomeric unit. All other units are called extension units. The most well-known sources of 
A-type PAs, mainly PCs, are peanuts, plums, cranberries and cinnamon (1, 4), but data 
about the molecular diversity of PCs are limited. The position of A-linkages in several 
tetramers and pentamers from plums and cinnamon has been identified by mass 
spectrometric (MS) analysis on the basis of their product ions (5). The position of the A-
linkage can be source dependent. In plums, it was located at the terminal unit, while in 
cinnamon it was located between the extension units. Similarly, the monomeric 
composition within prodelphinidins and propelargonidins, ((epi)catechin, (epi)gallocatechin 
and (epi)afzelechin), and positions of the monomers in the molecule has been determined 
with MS analysis (5-7).  
Peanut skins have a high PA content (17% (w/w)) (8). The degree of 
polymerization (DP) of PAs in peanut skins has been reported to range from 2 to 8, while 
only low amounts of monomers are present (9, 10). In the skins, both C4-C8 and C4-C6 
linked A and B-type PCs have been identified (8, 11, 12). Reports concerning the ratio of 
double (A-linkage) / single (B-linkage) linked flavan-3-ol units in peanut oligomers are 
contradictory. Lazarus and coworkers (10) analyzed a peanut PC extract, containing 
monomers up to octamers, with NP-HPLC-UV-MS to determine the abundance of A-linked 
oligomers. They found that the ions, detected with MS, corresponding to A-linked 
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oligomers predominated over the ions corresponding to B-linked oligomers, but the 
positions of the A-linkages were not determined. Furthermore, their analytical technique 
(NP-HPLC) underestimated the molecular diversity, because it poorly separates oligomers 
of the same DP. In contrast to Lazarus and coworkers (10), NMR data of Karchesy and 
Hemingway (8) showed that the A-linkages were rare in a polymer fraction of peanut skins 
(linkage ratio of A:B was 1:15). The position of the A-linkages in peanut skins has only 
been identified in one trimer and one tetramer (12). 
In the present study, we combined NP and RP-LC-MS to be able to analyze 
molecular PA species that are present in peanut skins. NP-HPLC has been used before to 
separate and characterize peanut PCs (10), but we used it as a first step to obtain fractions 
of monomers to pentamers. Subsequently, each fraction was further separated by RP-LC-
MS, which enabled us to determine molecular diversity of peanut skins PCs, which 
appeared to be much larger than reported before. Additionally, the most abundant 
molecular species were determined and the positions of A-linkages in a large number of 
trimers and tetramers were established. 
 
 
Materials and Methods 
 
 
Materials 
Peanut skins were kindly provided by Imko-The Nut Company BV (Doetinchem, The 
Netherlands). Organic solvents used for extractions were of analytical grade. Organic 
solvents used for HPLC analysis were all of HPLC grade. Hexane, dichloromethane, 
acetonitrile and acetone were purchased from Sigma-Aldrich (Steinheim, Germany), 
methanol from Mallinckrodt Baker B.V. (Deventer, The Netherlands) and ethyl acetate, 
sulfuric acid, hydrochloric acid and glacial acetic acid from Merck (Darmstadt, Germany). 
Other chemicals were of analytical grade and purchased from Merck (Darmstadt, 
Germany). Milli-Q water from a Millipore system was used. 
 
Extraction  
Peanut skins (75 g) were defatted with hexane using soxhlet extraction. The residue was air 
dried. The defatted skins (59.6 g) were extracted successively three times with 1L of 20% 
(v/v) aqueous MeOH, three times with 1L of 70% (v/v) aqueous MeOH, and three times 
with 1L of 70% (v/v) aqueous acetone. After each extraction the suspension was filtered 
over a 595 ½ filter (Schleicher & Schuell, Dassel, Germany) after which the retentate was 
subjected to the next extraction. The three 20% (v/v) MeOH fractions were combined, as 
well as the three 70% (v/v) MeOH and the three 70% (v/v) acetone fractions. Subsequently, 
they were concentrated with a rotary evaporator and lyophilized, resulting in three extracts 
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referred to as 20MeOH, 70MeOH and 70Acetone. During the extractions and evaporation, 
light was excluded as much as possible by the use of marquees and tinfoil. The three 
extracts were subjected to solvent partitioning for further purification. The 20MeOH extract 
was put in a separation funnel to which 500 mL water and 500 mL ethyl acetate was added, 
and placed in an ultrasonic bath for 10-15 min at room temperature. After vigorous mixing, 
the water phase and ethyl acetate phase were collected separately. The water phase was re-
extracted twice following the same solvent partitioning procedure, resulting in three ethyl 
acetate phases and one water phase. The ethyl acetate phases were combined and 
subsequently extracted with water (1:1, v/v) twice. At the end of the partitioning procedure, 
one ethyl acetate phase and three water phases were obtained. For the 70MeOH and the 
70Acetone extracts the same procedure was followed. The ethyl acetate was evaporated 
with a rotary evaporator, and the material was dissolved in water and lyophilized, resulting 
in three final extracts referred to as: 20MeOH-EA, 70MeOH-EA and 70acetone-EA. The 
water phases of each extract were analyzed for their total neutral saccharide contents. 
 
Analysis of the total neutral saccharide content 
The total neutral saccharide content was determined according to the Dubois method (13) 
with some alterations. A stock solution of 150 µg glucose/mL water was used to make a 
standard curve: 0, 50, 100 and 200 µL of the glucose stock was filled up to 1000 µL with a 
2.5% (w/v) phenol (Fluka Chemie GmbH, Buchs, Switzerland) solution in water (R2= 
0.9965). From the water phases, obtained after extraction, 100-200 µL was taken and filled 
up to 1000 µL with the 2.5% (w/v) phenol solution. After addition of 2.5 mL sulfuric acid 
(96% w/w) and cooling down, the absorbance was measured at 490 nm in an UV 1601 
spectrophotometer (Shimadzu Benelux B.V, ‘s Hertogenbosch, The Netherlands).  
 
Determination of PA oligomer composition by NP-HPLC-UV-MS 
The presence of PA oligomers in the 20MeOH-EA, 70MeOH-EA and 70acetone-EA 
extract was determined by NP-HPLC-UV-MS (14). A Thermo Spectra system was used 
containing a P 4000 pump, an AS 300 autosampler and an UV 3000 detector (Thermo 
Separation products, Fremont, CA, USA). Analysis was performed on a Luna Silica (2) 
column (4.6 mm ID x 250 mm, 5 µm particle size, Phenomenex, Torrance, CA) operated at 
room temperature. Samples were dissolved in methanol. The mobile phase consisted of (A) 
dichloromethane, (B) methanol and (C) acetic acid/H2O (50% v/v). The flow rate was 1 
mL/min and detection was performed at 280 nm. The elution profile was as follows; C was 
kept constant at 4% throughout the elution; 0-20 min, B: linearly 14%-23.5%; 20-50 min, 
B: linearly 23.5%-35% followed by a washing step at 96% B for 10 min and reconditioning 
of the column. 
 An LCQ Classic equipped with an ESI source was coupled to the HPLC system by 
means of a splitter (Accurate, LC Packings, Amsterdam, The Netherlands), which reduced 
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the flow rate 20 times. The MS detector was controlled by Xcalibur software (Thermo 
Finnigan, San Jose, CA). Measurements were performed in the negative mode with an ion 
spray voltage of 4.5 kV, a capillary voltage of -5.0 V and a capillary temperature of 270 °C. 
The scan range was set from m/z 100-2000. The MS2 function was performed in the data 
dependent mode. The collision energy value was 27%.  
 
Preparative isolation of monomers to pentamers by NP-HPLC  
Fractionation by DP was performed on a normal phase column, Inertsil PREP-SIL 30 mm 
ID x 250 mm with a 10 m particle size (GL sciences Inc., Tokyo, Japan). A Waters system 
equipped with a 2767 sample manager, a 2525 binary gradient module, a 2996 photodiode 
array detector (PDA) and an UV fraction manager was used (Waters Inc., Etten-Leur, The 
Netherlands). The binary mobile phase consisted of (A) hexane and (B) acetone. The 
elution profile was as follows: 0-30 min, B linearly 40%-60%; 30-50 min, B isocratic on 
60%; 50-70 min, B linearly 60%-75% followed by a washing step at 98% B for 3 min and 
reconditioning of the column for 10 min. The flow rate was 27.2 mL/min and PDA spectra 
from 210-300 nm were recorded. Each run, 10 mL (~ 50 mg/mL acetone/hexane/ethanol 
(7:3:2) 20MeOH-EA extract, in total 5 runs: 2654 mg) was applied. Fractions (18 mL) were 
collected during 90 min and pooled into 9 fractions: F1 (13.6-22.3 min: 55 mg), F2 (22.3-
28.2 min: 16 mg), F3 (28.2-38.1 min: 447 mg), F4 (38.1-46.8 min: 82 mg), F5 (46.8-62.0 
min: 346 mg), F6 (62.0-64.0 min: 59 mg), F7 (64.0-71.2 min: 304 mg), F8 (71.2-77.2: 257 
mg) and F9 (77.2-90.0: 651 mg). These fractions (total of 2217 mg = 84% (w/w) recovery) 
were rotary evaporated, lyophilized and weighted prior to further analysis. 
 
Characterization of PA oligomers by RP-UPLC-UV-MS 
 
Fractions F1 to F4  
These fractions were separated on an XterraRP dC18, 4.6 mm ID x 150 mm column with a 
3.5 µm particle size (Waters) (14). A Thermo Spectra system was used containing a P 4000 
pump, an AS 300 autosampler and an UV 3000 detector (Thermo Separation products, 
Fremont, CA, USA). Samples were dissolved in methanol. The mobile phase was 
composed of (A) H2O + 0.1% (v/v) acetic acid and (B) acetonitrile + 0.1% (v/v) acetic acid. 
The flow rate was 0.7 mL/min and detection was performed at 280 nm. The elution profile 
was as follows; the first 5 min isocratic on 10% B; 5-35 min, B: linearly 10%-30%; 35-40 
min, B: linearly 30%-90% and reconditioning of the column. MS analysis was similar as 
with NP-HPLC-UV-MS. 
 
Fractions F5 to F9  
These fractions were analyzed by RP-UPLC-UV-MS on an Accela system equipped with 
an Accela pump, column oven (50 °C), autosampler and PDA detector (Thermo Scientific), 
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and controlled by Xcalibur software (Waters). Analysis was performed on an Acquity 
UPLC-BEHC18 Shield, 2.1 mm i.d. x 150 mm column with 1.7 µm particle size (Waters). 
The different oligomeric fractions were dissolved (1 mg/mL) in 0.1% (v/v) aqueous acetic 
acid and 5 µL was injected. The mobile phase was composed of (A) H2O + 0.1% (v/v) 
acetic acid and (B) acetonitrile + 0.1% (v/v) acetic acid. The flow rate was 0.6 mL/min and 
the column oven temperature was set on 50 °C. Detection was performed at 280 nm. The 
elution profile was as follows: The first 0.25 min isocratic on 9% B; 0.25-18 min, B: 
linearly 9%-32.5%; 18-19 min, B: linearly 32.5%-90%; 19-23 min, B: isocratic on 90% 
followed by reconditioning of the column for 3 min.  
The UPLC was connected to an MS detector by means of a splitter (Analytical 
Scientific Instruments (ASI), El Sobrante, CA), which reduced the flow rate to 0.3 mL/min. 
An LTQ XL equipped with an ESI Source was used and controlled by Xcalibur software 
(Thermo Scientific, Waltham, MA). Measurements were performed in the negative mode 
with an ion spray voltage of 4.5 kV, a capillary voltage of 5.0 V and a capillary temperature 
of 200 °C. Optimal collision energy values (CID) were obtained by infusion of the different 
oligomeric mixtures and were: m/z 575, CID 40%; m/z 863, CID 35%; m/z 1149, 1151, 
1439 and 1437, CID 40% and m/z 1435, CID 45%. For each oligomeric fraction, a full scan 
was made within the range of m/z 150-2000 and MS2 scans were recorded for further 
characterization and to determine the position of the A-linkage.  
 
 
Results 
 
 
Oligomeric composition of the extracts  
Successive extraction of defatted peanut skins with 20% MeOH, 70% MeOH and 70% 
acetone yielded 15.8, 6.2 and 5.1 g of dry material, respectively. Additionally, ethyl acetate 
partitioning resulted in a final yield of 2.8 g 20MeOH-EA and 0.9 g 70MeOH-EA extract. 
The ethyl acetate partitioning of these two fractions removed 82-86% (w/w) dry material, 
including 34-49% (w/w) glucose equivalents. For the 70Acetone-EA extract 27% (w/w) 
glucose equivalents were removed by ethyl acetate partitioning, and a final yield of less 
than 0.1 g was obtained.  
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Figure 1. Normal phase chromatograms of the extracts 20MeOH-EA, 70MeOH-EA and 
70Acetone-EA. The numbers 1 to 6 represent the DP, determined by MS analysis, and p 
represents polymeric material. 
 
The oligomeric composition of each extract was determined by NP-HPLC-UV-
MS. NP-HPLC enables separation by DP (15) (Figure 1). The DP, depicted as numbers in 
Figure 1, was assigned based on the m/z values. As an example, Figure 2 shows the 
precursor ions present in the 20MeOH-EA extract, which contained a range of monomers 
(m/z 289) to hexamers (m/z 1725). On the basis of NP-HPLC-MS, only precursor ions of A-
linked PCs were present (m/z 575, 861, 863, 1151, 1149, 1437 and 1725), which can be 
distinguished from B-linked oligomers (e.g. m/z 577, 865, 1153, 1441, and 1729) by the 2 
Da difference for each A-linkage present. The 20MeOH-EA extract was richer in small 
oligomers than the other extracts (Figure 1). The acetone extract contained mainly 
polymeric material, eluting at the end as one unresolved peak. The high yield of the 
20MeOH-EA extract and its large variety in PCs with different DPs made it a good source 
to determine the molecular diversity of A-type oligomers present in peanut skins. Nine 
fractions, F1 up to F9 (Figure 3), were obtained by separation using preparative NP-HPLC. 
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Figure 2. Precursor ions that were detected in the 20MeOH-EA extract, analyzed by NP-HPLC-
UV-MS, using identical conditions as in Figure 1. DP represents the degree of polymerization. 
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Figure 3. Separation of the 20MeOH-EA extract with preparative normal-phase HPLC. Nine 
fractions were collected: F1-F9.  
 
Molecular diversity of procyanidins in peanut skins 
 
Monomers and dimers 
Fractions F1 to F4 were characterized with RP-HPLC-UV-MS (Figure 4). By comparison 
with standards it could be shown that fraction F1 exclusively contained catechin (1) and 
epicatechin (2) in a molar ratio of 5:1. Only A-type dimers were detected in fraction F2. 
The composition of each peak, which was determined by their precursor ions ([M-H]-) and 
product ions, is given in Table 1. Peaks 3-6 in F2 represented A-type PCs (m/z 575). 
Furthermore, peak 7 (m/z 589) might represent an A-type methylated PC dimer, but no MS2 
data were obtained to confirm this finding. Besides PC dimers, fraction F2 also contained 
an A-type propelargonidin dimer, consisting of one (epi)afzelechin and one (epi)catechin 
unit (8) (m/z 559). 
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Figure 4. RP-HPLC profiles of fractions F1-F4 (Figure 3). Compositional information on the 
peaks is given in Tables 1 and 2. 
 
 
 
Table 1. Compositional information of the peaks observed in Figures 4 and 7 based on MS 
analysis. 
DP nr of 
A-
bonds 
compositiona  [M-H]- product ions peak numbers % (w/w) of 
20 MeOH-
EA 
1 0 (epi)cat 289 245 1 2.5 
2 0 (epi)cat 577 451, 425, 407, 289, 287 9, 14-17 2.4 
2 1 (epi)afz-A-(epi)cat 559 433, 407, 289, 269 8 < 0.1 
2 1 (epi)cat 575 449, 423, 407, 289, 285 3-6, 10-13 19.9 
2 1 (epi)cat + CH3 589 7 < 0.1 
3 0 (epi)cat 865 739, 713, 577, 575 57 < 0.1 
3 1 (epi)cat 863 737, 711, 693, 575, 451, 411 18-20, 25-37, 39-47, 56, 60 17.0 
3 2 (epi)cat 861 735, 709, 575, 571 21-23, 38, 55 1.6 
3 2 (epi)cat + (epi)afz 845 719, 693, 677, 575, 555, 289 24 0.5 
4 1 (epi)cat 1151 1025, 999, 863, 575 59, 65, 71-75, 77, 79, 80, 82, 89 4.3 
4 2 (epi)cat 1149 863, 861, 859, 575, 573 48-51, 53, 58, 61-64, 66-69, 76, 78, 83, 85, 90 18.8 
4 3 (epi)cat 1147 54, 70 0.1 
4 2 (epi)cat + (epi)afz 1133 52 < 0.1 
5 2 (epi)cat 1437 1311, 1285, 1149, 863, 861, 573 81, 84, 86-94, 97, 99-103, 105-108, 110 26.0 
5 3 (epi)cat 1435 95, 96 0.4 
6 1 (epi)cat 1727 98, 104 2.2 
6 3 (epi)cat 1723 110-114 3.5 
7 3 (epi)cat 2011 109 0.8 
a The A represents a double (A-type) bond, (epi)cat = (epi)catechin, (epi)afz= (epi)afzelechin, 
CH3 = an additional methyl group 
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A tentative structure of this dimer, with (epi)afzelechin as the extension unit (E) 
and (epi)catechin as the terminal unit (T), was drawn based on the product ions detected 
(Figure 5). Three characteristic fragmentation routes have been described for PAs: 
Quinone methide fission (QM), retro-Diels-Alder fission (RDA) and heterocyclic ring 
fission (HRF) (5, 16). The product ions resulting from QM cleavage of the terminal (T) and 
extension (E) unit, [MT - H]- and [ME - 5H]- for A-type dimers, provided information about 
the monomeric sequence within propelargonidins and prodelphinidins (5, 17). The QM 
product ions of the dimer (m/z 559) were m/z 289 [MT - H]- and m/z 269 [ME - 5H]-   
(Figure 5), representing an (epi)catechin [290 Da - H = 289]- and (epi)afzelechin unit [274 
Da - 5H= 269]-, respectively. 
RDA fragmentation for A-type dimers has been reported to occur mainly at the 
terminal unit (5). The RDA product ion of m/z 407 indicated a loss of 152 Da, confirming 
that the terminal unit is an (epi)catechin unit. Also the RDA m/z 391 (407 - 16 Da) was 
present, which has been reported for A-type dimers (18). Based on both the QM and RDA 
product ions, we concluded that (epi)catechin was the terminal unit, and (epi)afzelechin the 
extension unit. Product ions derived from RDA, QM and HRF fragmentation could only be 
used to determine the position of (epi)afzelechin and (epi)catechin units, but not to 
distinguish between the epimers. 
The dimers in fraction F3 have been identified as described in detail elsewhere 
(14). In brief, F3 contained four A-type PC dimers (10-13), of which A1 (10) and A2 (12) 
were most abundant, and two B-type PC dimers (9 and 14). Fraction F4 contained some B-
type PC dimers (15-17). 
 
Trimers to heptamers 
Besides B-type PC dimers, fraction F4 also contained A-type PC trimers with one (18-20) 
or two (21-23) A-type linkages. Additionally to the PC trimers present, an A-type 
propelargonidin trimer was detected (peak 24, m/z 845). In a similar way as described for 
the propelargonidin dimer (peak 8, Figure 5), a tentative structure on the positions of the 
monomeric units is given in Figure 6 based on the product ions detected. The RDA product 
ion of m/z 693 indicated a loss of 152 Da. Therefore, the terminal unit was annotated as 
(epi)catechin. Also the RDA product ion m/z 677 (693 -16 Da) was present. The identified 
QM product ions had m/z values of 575, 289 [MT - H]- and m/z 555 [ME - 5H]- (Figure 6). 
Based on these QM and RDA product ions, the trimer was characterized as (epi)afzelechin-
A-(epi)catechin-A-(epi)catechin, in which A represents an A-linkage.  
To improve resolution of the complex, multi-component chromatograms, fractions 
F5 to F9 were analyzed with RP-UPLC-UV-MS (Figure 7). Fraction F5 exclusively 
contained A-type PC trimers. Fractions F6 and F7 also contained A-type PC trimers, and 
one B-type PC trimer (m/z 865) (57) was detected.  
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Figure 5. Fragmentation pattern of peak 8 (m/z 559; Figure 4), consistent with a structure 
composed of (epi)afzelechin (extension unit) and epi)catechin (terminal unit).  
 
A-type PC tetramers with one (m/z 1151), two (m/z 1149) or three (m/z 1147) A-
linkages were detected in fractions F6 to F8. B-type PC tetramers (m/z 1153) did not occur 
in any fraction. One peak (m/z 1133) (52) was tentatively identified as a propelargonidin 
tetramer, consisting of one (epi)afzelechin unit, three (epi)catechin units and two A-
linkages. No MS2 data could be obtained to confirm this finding. PC pentamers, hexamers 
and one heptamer (109), containing up to three A-linkages, were detected in fractions F8 
and F9.  
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Figure 6. Fragmentation pattern of peak 24 (m/z 845; Figure 4), consistent with a structure 
composed of one (epi)afzelechin and two (epi)catechin units. 
 
Position of the A-linkages in trimers and tetramers from peanut 
skins 
The position of the A-linkages of several trimers and tetramers (Table 2) could be 
determined via the product ions derived from QM fission (Figure 8). The position of the A-
linkage within trimers was detected at both possible positions; between the internal and 
terminal unit and between the two extension units. When tetramers contained one A-linkage 
(m/z 1151), this linkage was not located between the two internal units. When tetramers 
contained two A-linkages (m/z 1149), these linkages were present at all possible positions. 
The position of the A-linkages within higher DP oligomers could not be determined, 
because insufficient amounts of product ions were obtained to draw conclusions.  
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Figure 7. RP-UPLC profiles of fractions F5-F9 (Figure 3). Compositional information on the 
peaks is given in Tables 1 and 2. 
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Table 2. Position of A-linkages in trimers and tetramers separated by RP-UPLC (Figure 7) 
based on MS analysis. A denotes the position of the A-linkage. 
connection sequencea  [M-H]- product ionsb peak numbers % (w/w) of 20 
MeOH-EA 
(epi)cat-A-(epi)cat-(epi)cat 863 573, 289 26, 27, 34, 35, 40, 41, 46, 47 1.9 
(epi)cat-(epi)cat-A-(epi)cat 863 575, 287 25, 28-33, 36, 37, 39, 42-45 13.6 
(epi)cat-A-(epi)cat-A-(epi)cat 861 575, 571, 289, 285 38, 55 1.1 
(epi)cat-A-(epi)cat-(epi)cat-(epi)cat 1151 861, 577, 573 73, 75 0.3 
(epi)cat-(epi)cat-A-(epi)cat-(epi)cat 1151 863, 861 - - 
(epi)cat-(epi)cat-(epi)cat-A-(epi)cat 1151 863, 575 59, 65, 77, 80, 82, 89 3.4 
(epi)cat-A-(epi)cat-A-(epi)cat-(epi)cat 1149 859 78 0.2 
(epi)cat-(epi)cat-A-(epi)cat-A-(epi)cat 1149 861 58, 61, 63, 69, 83 1.7 
(epi)cat-A-(epi)cat-(epi)cat-A-(epi)cat 1149 575, 573 48-50, 53, 62, 64, 66-69, 76, 83, 85, 90 17.3 
(epi)cat-A-(epi)cat-A-(epi)cat-A-(epi)cat 1147 54, 70 0.1 
a the monomeric unit on the right side represents the terminal unit 
b product ions derived from quinine methide fission 
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Figure 8. A schematic representation of QM fragmentation (m/z values) of trimers and 
tetramers to determine the position of the A-linkage. E represents the extension units and T the 
terminal unit of the oligomer. 
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Quantification of PC oligomers 
Similar molar extinction coefficients (at 280 nm) have been reported for epicatechin (ε 
3750 M-1cm-1) and catechin (ε 4050 M-1cm-1) (19). Because mainly PCs were present 
(96.7% (w/w) of the 20MeOH-EA extract), it was assumed that the oligomers present 
within one fraction, which are of similar DP, also had a similar molar extinction coefficient. 
For each peak, its relative contribution to the total peak area of that fraction was 
determined. For example, F1 (Figure 4) contained peak 1 and 2, representing 83.1 and 
16.9% of the total area, respectively. Subsequently, the relative mass contribution of each 
peak to the 20MeOH-EA extract was determined. For example, 55 mg of F1 was obtained 
after preparative NP-HPLC, which represents 2.5% (w/w) of the total amount of 20MeOH-
EA extract (2217 mg). Therefore, peak 1 was calculated to represent (2.5 * 0.831) 2.1% 
(w/w) of the 20MeOH-EA extract. Similar calculations were performed for each peak in 
fractions F2-F9 (Tables 1 and 2). If a peak represented e.g. two different structures, based 
on MS data, the area was divided by two. Based on these calculations the A-type oligomers 
represented 95.0% (w/w) of the 20MeOH-EA extract (Table 1). Only 2.4% (w/w) B-type 
PC dimers and < 0.1% (w/w) B-type PC trimers were present. The tentatively identified A-
type properlargonidins (8, 24, and 52) represented < 0.7% (w/w) of the total amount of A-
type oligomers (95.0% (w/w)).  
PC trimers with one A-linkage (m/z 863) represented 17.0% (w/w) while PC 
trimers with two A-linkages (m/z 861) represented only 1.6% (w/w) (Table 1). The position 
of the A-linkage in the majority of the PC trimers with one A-linkage (13.6% (w/w) with 
30, 32 and 33 as main peaks of a total of 17.0% (w/w)) was between the internal and 
terminal unit (Table 2). Of all the tetramers (23.3% (w/w) of the 20MeOH-EA extract), 
those with two A-linkages (m/z 1149) were the most abundant and accounted for 18.8% 
(w/w) of the 20MeOH-EA extract (Table 1). The main peaks were detected in fractions F6 
(49 and 50), F7 (61, 62, 66 and 67) and F8 (76). Similarly as with the trimers, tetramers that 
contained at least one A-linkage between the internal and terminal unit predominated and 
represented 22.5% (w/w) of the 20MeOH-EA extract from a total of 23.0% (w/w) of A-
type tetramers in which the A-linkage position was determined (Table 2). Most of the 
pentamers, hexamers and heptamers contained two or more A-linkages (Table 1). 
 
 
Discussion 
 
 
Diversity of PAs in peanut skins 
PCs were the main group of PAs present in a 20% MeOH extract of peanut skins. This is in 
line with data reported for acetone and water extracts of peanut skins (8, 10-12). Catechin 
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and epicatechin, in a molar ratio of 5:1, were the exclusive free monomers present, which is 
in line with the ratio of 9:1 reported previously (8).  
Novel findings were the presence of propelargonidins (8, 24 and 52), containing 
one (epi)afzelechin unit as an extension unit, and the possible presence of a methylated 
dimer (7). However, these molecular species were a minority and represented only < 0.8% 
(w/w) of the 20MeOH-EA extract. Methylated dimers are not commonly present in food, 
although methylated A-type PAs have been detected in Cassipourea gummiflua (20).  
We could separate 114 different peaks. However, peaks with the same m/z values 
and retention times that were detected in successive fractions might represent the same 
proanthocyanidin molecule. For example, peak 9 (fraction F3) and 17 (fraction F4) both 
had an m/z value of 577 and similar retention times. Therefore, these two peaks were 
considered to represent the same B-type PC dimer. In the same way, all peaks with similar 
m/z values and retentions times in successive fractions have been compared. In addition, the 
positions of the A-linkages were accounted for. For example, the A-linkage of the PC 
trimers in peak 36 (fraction F5) and peak 47 (fraction F6), having the same m/z value (863) 
and retention time, occurred at different positions. Thus, peak 36 and 47 represent different 
molecules. Based on these considerations, the 114 peaks appeared to account for 83 
different PA molecular species, which were characterized with respect to number and 
composition of subunits, as well as to number and position of A-linkages. 
 
Peanut skins contain predominantly A-type PCs 
Depending on the extraction solvent a different oligomeric composition was obtained, as 
expected (21). We continued with the 20MeOH-EA extract, which yielded most PAs. 
Previous studies dealing with the identification of peanut skins PAs were performed with 
70% acetone extracts (8, 10, 11). Our results showed that the 20MeOH-EA extract was rich 
in lower DP oligomers; oligomers of DP >7 were not present.  
Conflicting results have been obtained on the abundance of A- and B-type PAs in 
peanut skins. Lazarus and coworkers (10) reported that A-type PCs dominated over B-type 
PCs. In contrast, Karchesy and Hemingway (8) reported a ratio of 1:15 of A- versus B-
linkages. These latter observations were based on mass spectrometric data only, without 
separation of oligomers, which limits both accurate qualification and quantification of the 
molecular diversity. The combination of NP and RP-HPLC enabled us to estimate the 
contribution of each peak to the total extract, based on their UV responses. Our data support 
the finding of Lazarus and coworkers (10). We predominantly identified A-type PCs 
(95.0% (w/w) of the 20MeOH-EA extract); only few B-type PC dimers (2.4% (w/w) of the 
20MeOH-EA extract) and one B-type PC trimer (< 0.1% (w/w) of the 20MeOH-EA 
extract) was present. No B-type tetramers to heptamers were detected.  
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The main trimers and tetramers in peanut skins contained a 
terminally located A-linkage  
Different positions of the A-linkages for several trimers to pentamers have been reported 
for plum and cinnamon PCs (5). Theoretically, a precursor ion corresponding to a PC trimer 
with one A-linkage (m/z 863) could represent many different structures, but the molecular 
diversity was not addressed in that study. 
The positions of the A-linkages in peanut PCs were only reported for a purified 
trimer and tetramer (12). Using the same considerations for preventing overestimation of 
the number of compounds as described for the determination of molecular diversity, we 
were able to determine the position of A-linkages in 16 trimers and 27 tetramers. Our data 
showed that they were present at all positions possible: At the extension, internal and 
terminal units. Separation by RP-LC prior to MS analysis enabled quantification of the 
main peaks. These results showed that the majority of trimers and tetramers with one or 
more A-linkage(s) (13.6% (w/w) and 22.5% (w/w) of the 20MeOH-EA extract, 
respectively) always had an A-linkage at the terminal unit. In plums, the A-linkage within 
tetramers is also located at the terminal unit (5, 22). On the other hand, in cinnamon the A-
linkage was detected between the extension units, but not at the terminal unit (5, 23). 
Therefore, our data provide further support for the concept that the location of the A-
linkages seems to be source-dependent.  
 
In conclusion, by combining NP and RP-HPLC, we were able to demonstrate the 
presence of a large molecular diversity of proanthocyanidins present in a 20% MeOH 
extract of peanut skins. Furthermore, this method enables estimation of the most abundant 
molecular proanthocyanidin species that were present. These data may contribute to the 
evaluation of the health potential of peanut skins based supplements.  
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Abstract 
 
 
In order to fully explore the biofunctional potential of proanthocyanidins (PA), isolated and 
well-characterized PA dimers are of great importance. Current methods to obtain pure A- 
and B-type dimers are laborious, because they comprise multiple chromatographic steps, 
often yielding only one or two specific dimers. In the current study, an efficient isolation 
procedure is described, to isolate a large variety of A-type dimers from peanut skins and B-
type dimers from grape seeds. Yields increased 20-400 times for A-type dimers and about 
10 times for B-type dimers compared to other methods with a lesser number of 
chromatographic steps. Dimers isolated from peanut skins were identified as; epicatechin-
(2-O-7, 4-8)-catechin (A1), epicatechin-(2-O-7, 4-8)-epicatechin (A2), epicatechin-(2-O-7, 
4-6)-catechin, epicatechin-(2-O-7, 4-8)-entcatechin, isolated from peanut skins for the first 
time, and epicatechin-(4-6)-catechin (B7). Dimers from grape seeds were identified as; 
epicatechin-(4-8)-catechin (B1), epicatechin-(4-8)-epicatechin (B2), catechin-(4-8)-catechin 
(B3) and catechin-(4-8)-epicatechin (B4).  
 
 
Key words: grape seeds, peanut skins, isolation, procyanidin dimers, reversed-phase HPLC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations used: CV, column volume; 1D, one dimensional; 2D, two dimensional; DP, 
degree of polymerization; HRF, heterocyclic ring fission; HSCCC, high speed counter current 
chromatography; IFL, interflavanic linkage; NP, normal phase; PA, proanthocyanidin; PC, 
procyanidin; QM, quinine methide fission; RDA, retro-Diels-Alder fission; SPE, solid phase 
extraction 
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Introduction 
 
 
Proanthocyanidins (PAs), also referred to as condensed tannins, are present in a wide 
variety of food products. PAs can be divided into several subclasses, of which the 
procyanidin (PC), exclusively consisting of (epi)catechin units and their galloyl derivatives, 
is the most abundant. The monomeric units of PCs are linked through a C4-C8 or C4-C6 
bond (B-type), which can coexist with an additional C2-O-C7 or the less abundant C2-O-
C5 bond (A-type) (Figure 1). 
The biofunctional potential of PAs, including PCs, has been established through 
human intervention studies (1), animal studies and in vitro assays (2). However, the effects 
found cannot be solely ascribed to PAs, because in these studies mostly foods or crude 
extracts have been used that also contained monomers ((epi)catechin) or other phenolic and 
bioactive compounds. Therefore, bioactivity studies performed with pure PAs are 
important, especially with dimers, as these are believed to be reasonably well bioavailable. 
Furthermore, A- and B-type PA dimers should be compared much more extensively with 
respect to their bioactivity and bioavailability. 
Several studies reported anti-oxidative properties for both A- and B-type dimers. For 
example, B-type dimers were reported to inhibit LDL oxidation (3, 4) and were more potent 
than ascorbic acid and trolox (5). Furthermore, an A-type dimer from Geranium niveum 
showed a higher scavenging ability for ABTS, O2-, OH- and HOCl on a molar basis, 
compared to resveratrol and/or ascorbic acid (6). Because these studies used different test 
systems, it can not be concluded which type of dimer is the better antioxidant. Other studies 
reported that A-type dimers stimulated endothelial dependent relaxation (7) and suppressed 
allergic responses against ovalbumin (8), but no B-type dimers were included in those 
studies. Only few studies directly compared the bioactivity of A- and B-type dimers. The 
antiviral activity and inhibitory activity against microsomal lipid peroxidation was similar 
for A- and B-type dimes (9), but A-type dimers were better protectants of a lipid bilayer 
against disruption by Triton-X compared to B-type dimers (10). Thus, several activities 
have been tested but the information is insufficient to conclude which of the dimers, A- or 
B-type, have more bioactive potential. 
To bring about a biological effect, sufficient amounts of dimers should reach the 
target tissues. Although intact oligomers with a degree of polymerization (DP) >2 are 
believed to be unabsorbable, data on the absorption of dimers are not consistent (11-14). 
Furthermore, A-type PAs have not been included in these bioavailability studies. In order to 
fully explore the biofunctional potential of PAs, research should focus on the relation 
between their structure, bioavailability and bioactivity. Isolated and well-characterized PA 
dimers are, therefore, of great importance. 
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Figure 1. The structures of A-type and B-type dimers present in grape seeds and peanut 
skins, respectively. EC=epicatechin, C= catechin and ent = enantiomer.  
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Efficient isolation of different types of PA dimers requires sources containing high 
amounts and a large diversity of dimers. Commonly used sources for the isolation of B-type 
PCs are apple and cocoa, which primarily consist of epicatechin units (15, 16) that are 
mainly 4-8 linked (16, 17). Grape seeds are also rich in B-type PCs (18) with relatively 
more catechin units (19) compared to apple and cocoa. Additionally, 4-6 linkages and 
galloylated derivatives are present (16, 20, 21). Therefore, grape seed is a promising source 
to isolate a large diversity of B-type dimers. A-type PCs can be found in peanuts, plums, 
cranberries and cinnamon (18). Peanut skins contains up to 17% (w/w) PCs (22) and both 
C4-C8 and C4-C6 linked A- (with an additional C2-O-C7 linkage) and B-types have been 
identified (22, 23).  
The methods reported to obtain pure A- and B-type dimers are laborious as they 
include multiple chromatographic steps. The first step in isolation usually consists of a 
separation based on DP. Previously, size exclusion materials like Sephadex LH-20 (17, 24) 
and Toyopearl (20, 25) were used for this purpose. A combination of five different 
columns, including four size exclusion columns, was required to isolate several A-type 
dimers from peanut skins (23). The high diversity of B-type PC dimers in grape seeds 
makes it a good but also challenging source for the current chromatographic methods to 
isolate the dimers. Recently, a high speed counter current chromatographic (HSCCC) 
technique was used to isolate PC dimers from grape seeds (26). However, an elution of 
many hours was needed and additional Reversed-phase (RP) HPLC was a prerequisite to 
obtain pure dimer fractions. Nowadays, more specific silica-based stationary phases are 
used (16, 27-30) and separations of PAs from several sources up to DP 10 have been 
described (27). Additionally, fractions up to DP 8 have been purified from apple (31). 
Nevertheless, when pure dimer fractions are to be isolated, often size exclusion 
chromatography, instead of normal phase (NP) HPLC, in combination with RP-HPLC has 
been used. Advantages to use NP-HPLC followed by RP-HPLC are: 1) only one HPLC 
system is required instead of the multiple systems needed for HSCCC, 2) peak shape on NP 
and thereby purity of the different DP fractions is better than that on size exclusion or 
HSCCC, 3) a baseline separation of dimers on NP-HPLC facilitates isolation of a fraction 
containing only all dimers while size exclusion or HSCCC often results in inefficient 
isolation of dimers to prevent contamination with monomers or trimers due to overlap of 
peaks. 
The combination of NP- and RP-HPLC to obtain pure dimers has rarely been used 
and little is known about the behavior of A-type PCs on such columns. In this study an 
efficient method for the isolation of both A- and B-type dimers is described by combining 
NP- and RP-HPLC chromatography, yielding sufficient amounts of material for 
bioavailability studies. 
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Materials and Methods 
 
 
Materials 
Sources to isolate PCs were peanut skins, kindly provided by Imko-The Nut Company BV 
(Doetinchem, The Netherlands) and a commercially available procyanidin extract from 
grape seeds (Vitaflavan, DRT, Levita Chemical International NV, Antwerpen, Belgium). 
PC dimer standards B1, B2, B3 and B4 were obtained at Apin Chemicals (Abingdon, UK). 
Organic solvents used for HPLC analysis were all HPLC-grade. Milli-Q water from a 
Millipore system was used. 
  
Extraction of peanut skins 
Peanut skins (~75 g) were defatted with hexane using soxhlet extraction. The residue was 
air dried. The defatted skins (~60 g) were extracted three times with 1L of 20% (v/v) 
aqueous methanol. After each extraction the suspension was filtered over a 595 ½ filter 
(Schleicher & Schuell, Dassel, Germany), after which the pellet was subjected to the next 
extraction. The three 20% (v/v) methanol fractions were combined, concentrated by 
evaporation under vacuum and lyophilized. During the extractions and evaporation, light 
was excluded as much as possible by the use of marquees and tinfoil. Solvent partitioning 
was used for further purification. The lyophilized extract was put into a separation funnel to 
which 500 mL H2O and 500 mL ethyl acetate was added. This was placed in an ultrasonic 
bath for 10-15 min at room temperature. After vigorous mixing, the H2O phase and ethyl 
acetate phase were collected separately. The H2O phase was put back into the funnel and 
the solvent partitioning procedure was repeated twice resulting in three ethyl acetate phases 
and one H2O phase. The ethyl acetate phases were combined and subsequently extracted 
with H2O (1:1, v/v) twice. The ethyl acetate phase was vacuum evaporated, dissolved in 
H2O and lyophilized, resulting in the final extract referred to as: peanut skin extract.  
 
Removal of gallic acid from grape seed procyanidins  
To enable preparative HPLC isolation of PC dimers, gallic acid substituents were 
enzymatically removed. Vitaflavan was dissolved (2 g/L) in a sodium acetate buffer (0.1 M, 
pH 5.0), after which tannase (Gamma Chemie, Darmstadt, Germany) was added (80 mg/L). 
The mixture was incubated at 30 °C for 24 h after which freshly prepared tannase was 
added. After another 24 h of incubation, free gallic acid was removed by SPE. The C18 
cartridge (Sep-Pak Vac 200 cc, 5g, Waters, Millford, MA) was conditioned following the 
supplier's instructions. The sample was loaded and washed with 2 column volumes (CV) 
H2O. Subsequently, PCs were eluted with methanol (2 CV). The methanol was evaporated 
under vacuum. The sample was dissolved in H2O, frozen, and lyophilized. 
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Preparative isolation of A- and B-type dimers  
 
Normal phase HPLC 
Fractionation by DP was performed on an Inertsil PREP-SIL 30 mm ID x 250 mm column 
with a 10 µm particle size (GL sciences Inc., Tokyo, Japan). A Waters system equipped 
with a 2767 sample manager, a 2525 binary gradient module, a 2996 photodiode array 
detector (PDA) and an UV fraction manager was used. The binary mobile phase consisted 
of (A) hexane and (B) acetone. The elution profile was as follows: 0-30 min, 40%-60% B; 
30-50 min, isocratic at 60% B; 50-70 min, 60%-75% B, followed by a washing step at 98% 
B for 3 min, and reconditioning of the column. The flow rate was 27.22 mL/min and PDA 
spectra from 210-300 nm were recorded. In a run, 10 mL (~70 mg/mL in 
acetone/hexane/ethanol (7:3:2)) peanut skin extract or the tannase-treated grape seed extract 
was applied. The fraction containing dimers was collected from 22.3-28.2 min for the 
peanut skin extract and from 28.2 - 38.1 min for the grape seed extract. The fractions were 
evaporated under vacuum and lyophilized. 
 
Reversed phase HPLC 
An XterraRP 50 mm ID x 100 mm column with a 5 µm particle size (Waters) was used 
with a flow rate of 82.7 mL/min. The fractions containing dimers (~70 mg), which were 
obtained with preparative NP-HPLC, were dissolved in methanol using ultrasonic treatment 
if needed and filtered over a Spartan ® 0.45 m filter (Schleicher & Schuell, Dassel, 
Germany) before injection. The binary mobile phase consisted of (A) H2O + 0.1% (v/v) 
acetic acid and (B) acetonitrile + 0.1% (v/v) acetic acid. The elution profile for the 
separation and isolation of the individual peanut skin dimers was as follows: the first 3 min 
isocratic on 0% B; 3-23 min, B: linearly 0%-22%; 23-28 min, B: linearly 22%-89% 
followed by reconditioning of the column. The elution profile for the grape seed dimers was 
as follows: the first 10 min isocratic on 10% B; 10-23 min, B: linearly 10%-50%; 23-27 
min, B: linearly 50%-95% followed by reconditioning of the column. PDA spectra were 
recorded from 210-300 nm. The fractions that were collected after injecting peanut skin 
dimers were; IP (15.7-16.6 min), IIP (17.6-18.7 min), IIIP (18.7-19.6 min), IVP (19.6-20.5 
min), VP (21.2-22.0 min) and VIP (22.0-22.8 min). The fractions that were collected after 
injecting grape seed dimers were; IG (10.0-12.2 min), IIG (13.0-13.7 min), IIIG (13.9-14.2 
min), IVG (14.8-15.5 min), VG (15.7-15.9 min), VIG (16.1-16.3 min), VIIG (16.5-17.0 min) 
and VIIIG (17.4-17.8 min). Subsequently, the fractions were evaporated under vacuum and 
either lyophilized or solubilized in methanol prior to further analysis. Fraction IVG 
consisted of two PC dimers, which were further purified on an Atlantis dC18 (19 mm ID x 
100 mm, 5 µm particle size; Waters). The fraction (~16 mg) was dissolved in 10 mL 50% 
(v/v) aqueous methanol, filtered over a Spartan ® 0.45 m filter and injected. The flow rate 
was 17.1 mL/min. The binary mobile phase consisted of (A) H2O + 0.1% (v/v) acetic acid 
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and (B) methanol + 0.1% (v/v) acetic acid combined in the following elution profile: 0-16.7 
min, B: linearly 5%-45%; 16.7-20 min, B: linearly 45%-60%; 20-23.3 min, isocratic at 60% 
B, followed by reconditioning of the column. Fractions were collected from 9.5-10.5 min 
(IVG1) and from 10.8-12.0 min (IVG2).  
 
Analytical HPLC 
 
Normal phase HPLC 
A Thermo Spectra system was used containing a P 4000 pump, an AS 300 autosampler and 
an UV 3000 detector (Thermo Separation products, Fremont, CA, USA). Analysis was 
performed on a Luna Silica (2) 4.6 mm ID x 250 mm column with a 5 µm particle size 
(Phenomenex, Torrance, CA) operated at room temperature. Samples were dissolved in 
methanol. The mobile phase consisted of (A) dichloromethane, (B) methanol and (C) acetic 
acid/H2O (50% v/v). The flow rate was 1 mL/min and detection was performed at 280 nm. 
The elution profile was as follows; C was kept constant at 4% throughout the elution; 0-20 
min, B: linearly 14%-23.5%; 20-50 min, B: linearly 23.5%-35% followed by a washing 
step at 96% B for 10 min and reconditioning of the column.  
 
Reversed phase HPLC 
The same Thermo Spectra system was used and analysis was performed on an XterraRP 
dC18, 4.6 mm ID x 150 mm column with a 3.5 µm particle size (Waters). Samples were 
dissolved in methanol. The mobile phase was composed of (A) H2O + 0.1% (v/v) acetic 
acid and (B) acetonitrile + 0.1% (v/v) acetic acid. The flow rate was 0.7 mL/min and 
detection was performed at 280 nm. The elution profile for peanut skin dimers was as 
follows; the first 5 min isocratic on 10% B; 5-35 min, B: linearly 10%-30%; 35-40 min, B: 
linearly 30%-90% and reconditioning of the column. The elution profile for grape seed 
dimers was as follows; the first 15 min isocratic on 10% B; 15-35 min, B: linearly 10%-
50%; 35-40 min, B: linearly 50%-95% followed  by reconditioning of the column. Samples 
were compared to retention times of B-type dimer standards B1, B2, B3 and B4. 
 
Characterization of B-type dimers by phloroglucinolysis 
Fractions IP and VIP, obtained after preparative HPLC, were analyzed on RP-HPLC before 
and after acid-catalyzed degradation as described by Fournand and coworkers (32). Briefly, 
intact dimers were analyzed on RP-HPLC-UV. After acid-catalyzed degradation of the 
dimers in the presence of excess phloroglucinol, released terminal units and extension unit-
phloroglucinol adducts were analyzed by RP-HPLC-UV. Dimers were identified based on 
the retention time of the intact dimers and the retention time of (epi)catechin and their 
phloroglucinol adducts, released after acid-catalyzed degradation.  
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Spectroscopic analysis 
 
ESI-MS detection 
An LCQ Classic equipped with an ESI source was used and controlled by the software 
Xcalibur (Thermo Finnigan, San Jose, CA). The detector was coupled to an HPLC system 
by means of a splitter (Acurate, LC Packings, Amsterdam, The Netherlands), which 
reduced the flow rate 20 times. Measurements were performed in the negative mode with 
an ion spray voltage of 4.5 kV, a capillary voltage of -5.0 V and a capillary temperature of 
270 °C. The scan range was set from m/z 100-2000. The MS/MS function was performed in 
the data dependant mode. The collision energy value was 27%. 
 
Maldi-TOF-MS 
Samples were analyzed on an Ultraflex instrument equipped with a nitrogen laser of 337 
nm and controlled by the software Flexanalysis (Bruker Daltonics B.V., Wormer, The 
Netherlands). A laser intensity of 29% was applied and data were collected within a mass 
range of 400-2000 Da. The apparatus was operated in both the positive and the negative 
mode with a delayed extraction time of 100 ns and an acceleration voltage of 20 kV. 
Samples were mixed with the matrix 2,5-dihydroxybenzoic acid (Bruker Daltonics) (10 
mg/mL H2O) (1:1) and 2 µL was put on a stainless steel metal plate, crystallized under a 
blow drier and analyzed.   
 
NMR spectroscopy 
NMR experiments were performed on a Varian UNITY INOVA 500 MHz spectrometer 
(Varian NMR instruments, Palo Alto, CA, USA) equipped with a 3 mm indirect detection 
probe operating at 500 MHz for 1H and 125.7 MHz for 13C. One-dimensional (1D) 1H, two 
dimensional (2D) 1H TOCSY and ROESY, and 2D (1H-13C) HSQC and HMBC spectra of 
samples dissolved in methanol-d4 (fractions IP, IIP and IVP) or dimethyl sulfoxide-d6 
(fractions IIIP, VP and VIP) were recorded at 298 °K. Chemical shifts (δ) are given in ppm 
and coupling constant (J) values are given in Hz. Spectra signals were referenced to the 
solvent signals, either DMSO (1H signal at 2.5 ppm and 13C signal at 39.5 ppm) or 
methanol (1H signal at 3.3 ppm and 13C signal at 49.0 ppm). Spectra were processed and 
analyzed with VNMR software (Varian, CA, USA).  
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Results and discussion 
 
 
Preparative isolation of A- and B-type dimers  
 
Use of NP-HPLC for the isolation of a dimeric fraction 
To be able to isolate the grape seed dimers, gallic acid substituents were enzymatically 
(tannase) removed, which improved the resolution especially between the dimers and 
trimers, as described previously (16). The dimers from the tannase-treated grape seed 
extract, as well as those from the peanut skin extract, were isolated with preparative NP-
HPLC (Figure 2), which separates by DP.  
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Figure 2. Isolation of A-type dimers from peanut skins (panel A) and B-type dimers from grape 
seeds (Panel B) by preparative NP-HPLC. The fractions containing the A- or B-type dimers were 
collected, evaporated under vacuum and lyophilized.  
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The total recovery of all material after NP-HPLC was 85% (w/w) (n=1) for the peanut skin 
extract and 78% (w/w) ± 4.8 (n=4) for the grape seed extract. This is comparable to 
recoveries obtained for apple extracts obtained with the same method (31). The dimers 
represented 16.8% (w/w) (n=1) of the peanut skin extract and 21.2% (w/w) ± 2.1 (n=5) of 
the grape seed extract, similar to previously reported amounts in grape seeds (33). Both 
dimer fractions were free of monomers and trimers as their masses, m/z 289 [M-H]- and m/z 
865, 863 (1 A-interflavanic linkage (IFL)), and 861 [M-H]- (2 A-IFL), respectively, were 
not detected by NP-HPLC-UV-MS. The A- and B-type dimers could be distinguished by 
their parent ions (m/z 575 [M-H]- and m/z 577 [M-H]- respectively) and accompanying 
MS/MS spectra. PCs have three characteristic fragmentation routes, which have been 
described as: Quinone methide (QM), retro-diels-alder (RDA) and heterocyclic ring fission 
(HRF) cleavage (34). A lower retention of the peanut skin dimers compared to grape seeds 
dimers on the silica stationary phase (Figure 2) could hint at the presence of A-type dimers, 
which are less polar than the B-type dimers due to the additional bond.  
This was confirmed by the MS/MS spectra, which showed parent ions of m/z 575 
for the peanut skin dimers with m/z 289 + 285 (QM), m/z 423 + 407 (RDA) and m/z 449 
(HRF) as fragment ions. The grape seed dimers had parent ions of m/z 577, and m/z 289 + 
287 (QM), m/z 425 + 407 (RDA) and m/z 451 (HRF) as fragment ions. The observation that 
the fragmentation of A-type dimers, just like the B-type, yields a fragment ion of 407 rather 
than 405 has been reported earlier (35).  
 
Use of RP-HPLC for purification of individual dimers 
The fractions containing the dimers were further separated on an XterraRP dC18 column. 
The total recovery of all material after RP-HPLC was 65.1% (w/w) (n=1) for the peanut 
skin dimers and 68.7% (w/w) ± 5.3 (n=3) for the grape seed dimers. 
 
 
Figure 3. Isolation of dimers from peanut skins (A) and grape seeds (B) on a preparative 
XterraRP C18 column. Fractions were collected as indicated by I through VIII. The origin is 
indicated by P (peanut skins) and G (grape seeds). 
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The peanut skin dimers contained 6 peaks in total indicated by IP  till VIP (Figure 3A). 
Separation of the grape seed dimers resulted in 8 peaks, IG till VIIIG (Figure 3B). Peak IVG 
consisted of 2 components based on reinjection on an Atlantis dC18 column. Preparative 
separation on this column resulted in two pure fractions: IVG1 and IVG2 (Figure 4). The 
total recovery was 66.4% (w/w) (n=1). 
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Figure 4. Isolation of dimers B2 (IVG2) and B3 (IVG1) on a preparative Atlantis dC18 column 
from fraction IVG, previously isolated on XterraRP (Figure 3B). 
 
Structure elucidation of isolated A-type dimers  
Four peaks (IIP to VP) were characterized as A-type dimers based on their parent ions (m/z 
575 [M-H]-) and MS/MS fragments. Because no commercial standards were available for 
A-type dimers, NMR spectroscopy was performed for structural identification (Tables 1 
and 2)  
 
Determination of interflavanic linkage (IFL)  
The NMR spectra of the fractions IIP, IIIP, IVP and VP were very similar and typical for A-
type dimers as described previously (23). In short, an isolated AB system in the 
heterocyclic proton region (δ 4.0-4.5 ppm, J=2.8-3.5 Hz) was attributed to protons at 
carbon 3 and 4 of the C-ring (C3-C and C4-C). Two meta-coupled doublets and a singlet in 
the aromatic region (δ ± 6 ppm) were assigned to the protons of the A-ring and the residual 
proton of the D-ring, respectively. Two AMX systems in the aromatic downfield region (δ 
6.5-7.5) were detected as B- and E-ring protons. The other signals were unambiguously 
attributed to the F-ring protons. Therefore, the A-IFL involved both the C4 and C2 of the  
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Table 1. 1H NMR chemical shifts (δ in ppm) and multiplicity (J in Hz) of compound of fractions IP 
to VP in either MeOH-d4 (fractions IP, IIP and IVP) or DMSO-d6 (fractions IIIP and VP) at 298 °K. 
Ring proton IP IIP IIIP IVP VP 
C 2 4.91* - - - - 
 3 4.01 (bs) 4.06 (d, 3.5) 3.94 (d, 3.0) 4.06 (d, 3.4) 3.97 (d, 2.8) 
 4 4.55 (bs) 4.23 (d, 3.5) 4.19 (d, 3.0) 4.40 (d, 3.4) 4.12 (d, 2.8) 
A 6 5.99 5.95 (d, 2.3) 5.85a (m)* 6.07 (d, 2.3) 5.90 (d, 1.6) 
 8 6.04 (bs) 6.06 (d, 2.3) 5.86a (m)* 6.00 (d, 2.3) 5.83 (d, 1.6) 
B 2 6.88 (bs) 7.13 (d, 2.2) 6.98 (d, 1.9) 7.14* 7.03 (d, 1.9) 
 5 6.71 (m)* 6.80 (m)* 6.73 (m)* 6.85* 6.74 (d, 8.3) 
 6 6.68 (m)* 7.01 (dd, 8.4, 2.2) 6.83 (m)* 7.02 (dd, 8.3, 2.2) 6.89 (dd, 8.3, 1.9) 
F 2 4.57 (d, 7.7) 4.73 (d, 7.9) 4.61 (d, 6.8) 4.92 (bs) 4.50 (d, 6.8) 
 3 3.97 (m) 4.14 (m) 3.88 (m) 4.23 (bs) 3.84 (m) 
 4 2.46 (m)* 2.57 (dd, 16.3, 8.4) 2.41 (dd, 17.2, 8.4) 2.76 (dd, 17.3, 2.2) 2.44 (dd, 16.4, 7.4) 
 4 2.75 (m)* 2.93 (dd, 16.3, 5.7) 2.78 (dd, 17.2, 4.9) 2.94 (dd, 17.3, 4.9) 2.66 (dd, 16.4, 5.3) 
D 6 - 6.09 (s) 5.98 (s) 6.09 (s) - 
 8 5.99* - - - 5.78 (s) 
E 2 6.83 (bs) 6.91 (bs) 6.85 (m)* 7.15* 6.69* 
 5 6.76 (m)* 6.82 (m)* 6.73 (m)* 6.81* 6.67* 
 6 6.71 (m)* 6.82 (m)* 6.72 (m)* 6.98 (dd, 8.2, 1.9) 6.56 (dd, 8.1, 2.1) 
a in the same column assignments may be interchanged. 
* multiplicity undetermined due to overlaps 
 
Table 2. 13C NMR chemical shifts (δ in ppm) of compound of fractions IP to VP in either MeOH-d4 
(fractions IP, IIP and IVP) or DMSO-d6 (fractions IIIP and VP) at 298 °K. 
ring carbon IP IIP IIIP IVP VP 
C 2 77.0 99.6 98.6 99.5 99.0 
 3 72.5 67.4 65.6 67.4 65.3 
 4 37.3 28.9 27.7 28.5 28.3 
A 5 157.8 156.1a 155.6a 156.3a 155.8a 
 6 96.6 97.9b 96.2b 95.9 96.1 
 7 159.2 157.4 156.3 157.5 156.3 
 8 95.9 96.2b 94.3b 97.6 93.6 
 4a 102.4 103.3 102.4 103.7 103.7 
 8a 159.2 153.5a 152.6a 153.6a 152.5a 
B 1 132.1 131.5 130.4 131.2 130.4 
 2 114.7 115.4 114.6 114.5 114.7 
 3 145.8 144.9 144.1c 144.9 144.2 
 4 145.4 146.1 145.4c 146.2 145.3 
 5 115.4 115.4 114.8 114.9 114.5 
 6 119.0 119.4 117.6 118.7 117.8 
F 2 82.4 84.0 81.5 81.1 80.7 
 3 68.6 67.8 65.8 66.2 66.1 
 4 28.6 28.6 28.4 29.2 27.7 
D 5 155.6 155.5 154.2 156.0 153.2 
 6 108.0 96.2 94.3 95.6 107.7 
 7 159.2 151.4 150.4 151.7 150.0 
 8 96.6 106.1 104.9 106.6 92.8 
 4a 102.4 102.4 101.2 101.8 102.3 
 8a 154.7 150.8 149.8 151.5 153.2 
E 1 131.9 129.8 129.9 130.5 130.4 
 2 115.1 115.4 114.6 115.2 114.1 
 3 145.9 146.0 145.0 145.9 144.7 
 4 145.8 146.0 145.0 145.7 144.7 
 5 115.4 115.9 114.8 115.3 114.9 
 6 119.9 120.3 118.3 119.7 117.9 
a, b, c in the same column assignments may be interchanged. 
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upper unit. The junctions at the lower unit were determined through the analysis of both 1H-
13C long-range HMBC and 1H through space ROESY correlations. 
The bond positions of fractions IIP, IIIP and IVP were determined in a similar way 
as illustrated in Figure 5A. First, C8a-D was attributed through its correlation with the 
proton at C2-F, whereas C5-D was identified through its correlations with both protons at 
C4-F. The residual proton of the D-ring showed correlations with two deshielded carbons (δ 
> 150 ppm). One could easily be determined to be the C5-D, while the other one was 
deduced to be C7-D, since its chemical shift was different from that of C8a-D. Therefore, 
the residual proton was determined to be at C6-D. Consequently, the IFL implied 
attachment to C8 of the D-ring. Also the long range correlation between the proton at C4-C 
and C8a-D and ROESY spectra, which showed correlations between the proton at C4-C 
and E-ring protons, were in agreement with a C4-C8 linkage. 
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Figure 5. Main HMBC (          ) and ROESY (          ) correlations allowing linkage positions to be 
established, in either (C2-O-C7, C4-C8) A) or (C2-O-C7, C4-C6) B) dimers. 
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The ether bond was deduced to be C2-O-C7, as it is the only possibility in case of a C4-C8 
linkage. Therefore, the components of fractions IIP, IIIP and IVP were identified to be (C2-
O-C7, C4-C8) double linked dimers. 
In the case of fraction VP, no conclusive evidences of the IFL positions could be 
found based on long range HMBC correlations. The residual D-ring proton could not be 
determined, because C8a-D and C5-D overlapped. However, ROESY correlations between 
the proton at C4-C and protons of E-ring were clearly lacking, which indicated a C4-C6 
linkage (23) (Figure 5B). In this case, the ether linkage can be either C2-O-C7 or C2-O-C5. 
Since a weak, but clear, correlation occurred between the proton at C8-D and the proton at 
C2-F, as well as one between the proton at C8-D and protons at C2 and C6 of the B-ring, 
the linkage can be deduced to be C2-O-C7. The C2-O-C7 linkage was also in accordance 
with the 13C chemical shift of C7-D, which was upfield (δ 150) compared to free 
hydroxylated C7-A (δ 156.3). Based on all the data the component of fraction VP was 
identified as a (C2-O-C7, C4-C6) double linked dimer. 
NMR spectra of fraction VIP were not conclusive because of its low purity. The 
major compound, which, based on NMR signals, represented about 35% of fraction VIP, 
exhibited some typical NMR signals (an ABC-ring system) of an A-type dimer. However, 
structural identification was difficult due to numerous overlaps and poor signal intensities. 
Phloroglucinolysis of fraction VIP did not result in depolymerization, which supported the 
hypothesis of the presence of an A-type dimer in this fraction. 
 
Monomeric composition 
In the case of fractions IIP, IIIP, and VP, the large values observed for the J23 F-ring coupling 
constants (J ~7Hz) were characteristic for catechin. In contrast, for fraction IVP this value 
was relatively low (~1Hz), which is characteristic for an epicatechin unit. The upper units 
of fractions IIP-VP were supposed to be epicatechin, as Lou and coworkers (23) found that 
A-type dimers from peanut skins always contained epicatechin as upper units. Therefore, 
the two major peaks, IIP and IVP, were identified as epicatechin-(2-O-7, 4-8)-catechin (1), 
also referred to as A1, and epicatechin-(2-O-7, 4-8)-epicatechin (2), referred to as A2. 
Fraction IIIP showed similar NMR spectra compared to fraction IIP (A1). Dimer A1 has 
been identified in peanut skins before and seems to be abundantly present (22, 23). 
Therefore, the major fraction IIP was annotated to be A1, while the less abundant fraction 
IIIP, containing a similar NMR spectrum, was tentatively identified as the enantiomer of A1 
(3). The presence of enantiomers in peanut skins was also found by Lou and co-workers 
(23), who identified the enantiomer of dimer A2. However, the enantiomer of A1 has not 
been identified in peanut skins before. Fraction VP was characterized as epicatechin-(2-O-7, 
4-6)-catechin (5). 
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Structure elucidation of isolated B-type dimers 
The fractions obtained from grape seeds all represent B-type dimers (m/z 577 [M-H]-) based 
on RP-HPLC-UV-MS and their fragment products with MS/MS. Comparison with 
standards resulted in the identification of IG as B1 (9), IIG as B4 (12) and IVG, which 
consisted of both B2 (10) and B3 (11). The remaining peaks could not be identified further. 
Peak IVG was further separated on an Atlantis dC18 column, resulting in pure fractions of 
B2 (10) (IVG2) and B3 (11) (IVG1) (Figure 4).  
One peak isolated from peanut skins (IP, Figure 3A) was identified as a B-type 
dimer, which was B7 (epicatechin-(4-6)-catechin) (13) based on its retention time before 
phloroglucinolysis and its products after phloroglucinolysis. This was confirmed with NMR 
(Tables 1 and 2). Both 1D and 2D homonuclear 1H and 2D heteronuclear 1H-13C 
experiments were performed. The main difference compared to the spectra of an A-type 
dimer is the presence of a proton at C2-C. The structure of this dimer was determined as 
follows: C8a-D (δ 154.7) was first identified through its long range correlation with the 
proton at C2-F. The bond location was determined from the long range correlations of the 
proton at C4-C. This proton had no correlation with C8a-D at δ 154.7 but exhibited 
correlations with several deshielded carbons at δ 155.6, 159.2, 159.2 and 157.8, which were 
attributed to C5-D, C7-D, C8a-A and C5-A. A long range correlation of the proton at C4-C 
with C5-D and the lack of a correlation with C8a-D indicated that C4-C is linked to C6-D 
(36). The J23 F-ring coupling constant values allowed to discriminate between epicatechin 
(J ~1Hz) and catechin (J ~7Hz) (2,3 cis or trans) configuration of the lower unit (37) and 
was determined to be catechin since the J23 coupling constant value was 7.7 Hz.  
 
 
Conclusion 
 
 
The main A-type dimers, A1 (1) and A2 (2), were efficiently isolated. In comparison to a 
previously published method (23), the required chromatographic methods were reduced 
from five to two, while simultaneously the yields of A1 and A2 increased 20-400 times. To 
compare both methods, the yields of A1 and A2 were expressed as weight percentage of the 
total amount of peanut skins that was used. Lou and coworkers (23) used skins of 279 kg 
peanuts. The amount of skins they used was calculated to be 11 kg, assuming that the 
skins represent 4% (w/w) of the total peanut (38). Differences in extraction procedure and 
the origin of peanut skins might also have contributed to the pronounced yield differences 
found. Next to A1 and A2, four other peanut skin dimers were isolated including the 
tentatively identified enantiomer of A1 (3), not previously detected in peanut skins, 
epicatechin-(2-O-7, 4-6)-catechin (5), B7 (13) and one unidentified dimer.  
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Although grape seeds have been used before as a source to isolate PC dimers, data 
on the efficiency of those isolations are not well documented. Dimers isolated with NP-
HPLC resulted in about 21% (w/w) of the PC extract, which is in accordance with 
compositional LC-MS analysis of PC dimers in grape seed extracts performed by others 
(21, 33). The yield for B1-4 from the grape seed extract using NP/RP-HPLC was about 10 
times higher compared to a recently published HSCCC method (26). Recoveries for the 
additional RP-HPLC that was performed after HSCCC were not given, but would likely 
lower their total yield. Furthermore, pre-purification steps like precipitation or SPE to 
remove polymers and improve resolution, prior to HSCCC, were not needed. 
The combination of NP/RP-HPLC is suitable to efficiently isolate a large variety 
of both A- and B-type dimers with a limited number of chromatographic steps. Table 3 
summarizes the purity, yield and structure of each peak that was isolated. Sufficient 
amounts of material were obtained to study the bioavailability of both A- and B-type 
dimers, which is subject of further research in our laboratory. 
 
Table 3. Characteristics of the isolated A- and B-type dimers obtained after successive 
preparative normal and reversed phase HPLC 
source fractiona composition/structureb purityc % (w/w)d
peanut skin extract IP EC-(4-6)-C (13) 93 0.2
IIP EC-(2-O-7, 4-8)-C (1) 99 6.9
IIIP EC-(2-O -7, 4-8)-ent C (3) 81 0.3
IVP EC-(2-O -7, 4-8)-EC (2) 98 2.1
VP EC-(2-O -7, 4-6)-C (5) 99 0.3
VIP - < 75 0.2
grape seed extract IG EC-(4-8)-C (9) 95 3.2
IIG C-(4-8)-EC (12) 81 1.2
IIIG - <75 0.2
IVG1 C-(4-8)-C (11) 88 1.5
IVG2 EC-(4-8)-EC (10) 99 7.1
VG - 80 0.1
VIG - 65 0.2
VIIG - 93 1.2
VIIIG - 96 0.9  
a the fractions represent the peaks as shown in Figures 4 and 5. 
b the numbers represent the structures in Figure 1. 
c based on the peak area (280 nm), assuming equal molar response factors, 
analyzed on analytical RP-HPLC 
d calculated as % (w/w) of the peanut skin extract and grape seed extract. 
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Abstract 
 
 
Intervention studies with procyanidin-rich extracts and products like cocoa and wine 
suggest protective effects of procyanidins against cardiovascular diseases. However, there 
is no consensus on the absorption and metabolism of procyanidin dimers. Interestingly, 
nothing is known about the absorption of A-type procyanidins. In the current study, the 
absorption and metabolism of purified procyanidin dimers A1 (epicatechin-(2-O-7, 4-8)-
catechin), A2 (epicatechin-(2-O-7, 4-8)-epicatechin), and B2 (epicatechin-(4-8)-
epicatechin), A-type trimers, and monomeric epicatechin were compared by in situ 
perfusion of the rat small intestine. Potential enhancement of the absorption of dimers by 
oligomers with a higher degree of polymerization was also tested. Unmodified and 
methylated metabolites were distinguished from their conjugates by analyzing the 
difference in the amount of unmodified and methylated compounds in samples before and 
after treatment with β-glucuronidase. Our results showed for the first time that A1 and A2 
dimers are absorbed from the small intestine of rats, and that they are better absorbed than 
dimer B2. Absorption of the A-type dimers was only 5-10% of that of monomeric 
epicatechin. None of the dimers were conjugated or methylated in contrast to epicatechin, 
which was partly methylated and 100% conjugated. A-type trimers were not absorbed. 
Furthermore, we confirmed that the presence of tetrameric procyanidins enhanced the 
absorption of B2. On the contrary, the tetramers did not affect the absorption of A1. 
Epicatechin, methylated epicatechin or their conjugates were no metabolites of any of the 
procyanidins tested. 
 
 
Key words: Bioavailability; A-type procyanidin dimers; rat; intestinal perfusion 
 
 
 
 
 
 
 
 
 
Abbreviations used: DMSO, dimethyl sulfoxide; DP, degree of polymerization; EC, 
epicatechin; ECD, electro-chemical-detection; LOD, limit of detection; 3OMeEC, 3’-O-methyl-
epicatechin; 4OMeEC, 4’-O-methyl-epicatechin; PC, procyanidin; UPLC, Ultra-Performance-
liquid-Chromatography 
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Introduction 
 
 
Proanthocyanidins, also known as condensed tannins, are one of the most abundant 
subclasses of phenolic compounds in our diet (1). Many foods and beverages that are 
regularly consumed contain high amounts of proanthocyanidins, e.g. apples, berries, nuts, 
chocolate, wine and cranberry juice (1). The most common subgroup of proanthocyanidins 
is the procyanidins (PCs). They are oligomers of exclusively (epi)catechin units and their 
galloyl derivatives. PC monomeric units are connected through a single C4-C8 or C4-C6 
linkage. These PCs are referred to as B-type. Besides B-type, also A-type PCs exist, which 
have an additional C2-O-C7 or C2-O-C5 linkage (Figure 1). PC sources always contain the 
B-type. In some sources A-type PCs are additionally present, like in cranberries, peanuts, 
plums and spices like cinnamon (1). 
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Figure 1. Structures of A1, A2, B2, epicatechin, 3’-O-methyl-epicatechin and 4’-O-methyl-
epicatechin, that were tested for their bioavailability or detected as metabolites. 
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Intervention studies with PC-rich extracts and products like cocoa and wine 
suggest protective effects of PCs against cardiovascular diseases (2, 3). In vitro studies 
reported an increased antioxidant (4) and antitumor activity (5, 6) and an inhibitory effect 
on pancreatic lipase (7), with increasing degree of polymerization (DP) on the basis of 
molarities. However, it is unlikely that the high DP PCs will reach the plasma. After 
consumption of cocoa (8) and a grape seed extract (9), from the PCs only dimers B2 
(epicatechin-(4-8)-epicatechin) and B1 (epicatechin-(4-8)-catechin) have been detected in 
human plasma. In humans and rats, besides monomers only PC dimers seem to be absorbed 
intact (8-10), but with a much lower efficiency than the monomers (11). In a study 
performed by Shoji and coworkers (12), also PC trimers were detected in rat plasma, which 
might be explained by the high dose of 1000 mg/kg that was administered. Their data also 
showed that PC oligomers with a DP ≥ 8 increased the absorption of PC dimers and trimers. 
Only few studies used single pure PC dimers to study their absorption (10, 13-15). No 
consensus has been obtained on the absorption and metabolism of B-type PC dimers. Some 
studies report the presence of epicatechin and its methylated and/or conjugated forms as B-
type PC dimer metabolites (10, 13), while others did not detect any absorption at all (14, 
15). All these studies only included B-type dimers. Nothing is known about the absorption 
of A-type PC.  
In the current study, absorption and metabolism of epicatechin and purified PC 
dimers B2, A1 (epicatechin-(2-O-7, 4-8)-catechin) and A2 (epicatechin-(2-O-7, 4-8)-
epicatechin) (Figure 1) are compared. Absorption of A-type PC might be different from 
that of B-type PC due to the presence of an additional linkage that alters its structure. Also 
two mixtures containing only A-type trimers or tetramers were tested. To investigate the 
influence of the presence of higher DP oligomers on the absorption of dimers, perfusion of 
dimers was also performed together with a mixture of A-type tetramers. Absorption was 
measured by in situ perfusion of the rat small intestine, using the protocol of Arts and 
coworkers (16). Already upon absorption, phenolic compounds can be conjugated by 
glucuronidation and/or sulfation and in addition methylation can take place (17). Samples 
were analyzed for the presence of unmodified, methylated and/or conjugated metabolites by 
measuring their unmodified and methylated forms before and after treatment with a β-
glucuronidase/sulfatase.  
 
 
Materials and Methods 
 
 
Chemicals 
Procyanidin dimers B2 (from grape seeds), A1, A2, a mix of A-type trimers (A-type DP3) 
and a mix of A-type tetramers (A-type DP4) (from peanut skin) were purified as described 
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in Chapters 2 and 3. (-)-Epicatechin and β-glucuronidase with sulfatase activity (Helix 
pomatia, G1512) were purchased from Sigma (St Louis, MO, USA). 3’-O-methyl-
epicatechin (3OMeEC) and 4’-O-methyl-epicatechin (4OMeEC) (Figure 1) were 
purchased from Gerbu Biochemicals (Gaiberg, Germany). All other chemicals used were of 
analytical grade. 
 
Animals and diets 
The experimental protocol was approved by the Animal Welfare Committee of 
Wageningen University, Wageningen, The Netherlands. Male Wistar rats (Harlan, Horst, 
The Netherlands; specific pathogen free, n= 49), mean body weight ~ 200 g at arrival, were 
housed in groups of two. The room was temperature controlled (19-22 °C) with 55% 
relative humidity and a 12 h light-dark cycle (lights on at 6 am). After arrival, the rats were 
fed a standard diet for 4 days to acclimatize, followed by 7 days on a commercially 
available radiated flavonoid free diet (adjusted NIH-31 diet, Arie Blok, Woerden, The 
Netherlands, (see Table 1 for composition). Rats had ad libitum access to water and feed. 
In total seven compounds and/or combinations were tested for their bioavailability, namely 
epicatechin, B2, A1, A2, A-type DP3, A-type DP4 and a mixture consisting of A-type DP4, 
B2 and A1 (Table 2). For each compound or mixture the perfusion was performed in six 
rats. There was no significant difference in average weight between the different treatment 
groups (Table 2). 
 
Table 1. Composition of the radiated flavonoid free diet, which was fed to the rats for 7 days 
before perfusion experiments were performed.  
composition percentage (w/w) 
glucose (Cerelose TM) 43.79 
D,L-methionine  0.20 
salt 0.16 
choline 50% 0.25 
KCl 0.49 
KH2PO4 0.67 
MgO  0.04 
CaHPO4.2*H2O  1.10 
CaCO3 0.90 
corn starch 10.00 
cellulose 5.00 
acid casein 22.00 
MgSO4.7*H2O 0.40 
corn oil 14.50 
vitamin premix NIH-31 0.25 
trace element premix NIH-31 0.25 
sum 100 
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Table 2. The average weight and bile flow of the rats that were used for perfusion and the 
recovery of each test compound from the perfusion buffer. 
compound/mixture perfusion buffer concentration ( M ± SE) 
rats (n=6)a 
mean weight (g ± SE) 
bile flow (n=5)a  
mean (mg/min ± SE) 
 t=0 t=30    
epicatechin 100 100 ± 2 273.7 ± 2.3 7.7 ± 1.2 
B2 100 96 ± 3 273.3 ± 3.1 7.9 ± 0.8 
A1 100 108 ± 8 271.4 ± 3.0 7.3 ± 1.0 b 
A2 100 96 ± 5 276.7 ± 3.3 9.3 ± 0.7 
A-type DP3 100 102 ± 2 274.3 ± 2.7 8.4 ± 0.6 
A-type DP4 100 105 ± 7 278.8 ± 4.3 7.3 ± 1.0 b 
mixture        A1 100 96 ± 2 277.7 ± 3.3 8.1 ± 0.7 
B2 100 94 ± 3   
A-type DP4 100 94 ± 2   
a  the average weight and bile flow of the rats were not significantly different (One-way Anova, P 
≤ 0.05) 
b n=6 
 
In situ perfusion of the small intestine 
The perfusion was performed as described by Arts and co-workers (16). In short, rats were 
anaesthetized and the bile duct, portal vein and small intestine (duodenum, jejunum and 
ileum) were cannulated and the small intestine gently rinsed with 60 mL saline (0.9% (w/v) 
NaCl) (37 °C). Each test substance was dissolved in dimethyl sulfoxide (DMSO) and 
diluted to a final concentration of 100 µM (0.1% (v/v) DMSO) with potassium phosphate 
buffer (5 mM, pH 6.7) containing 100 mM NaCl, 20 mM KCl, 2 mM CaCl2, 2 mM MgCl2 
and 0.5 mM sodium taurocholate. The saline in the intestine was replaced with 15 mL of 
the test solution. Subsequently, the cannula of the intestine was immediately connected to 
the pump (Meyvis, Minipuls 3, Gilson), after which perfusion started (1 mL/min, 30 min). 
Samples were taken of bile (t=0, 0-15 and 15-30 min) and portal vein blood (t=0, 15 and 30 
min). In addition, samples were taken from the perfusion solution before entering the 
cannulated intestine (t=0 and 30 min) and after passing the cannulated intestine (t=10, 20 
and 30 min). The bile flow was determined by weighing the samples taken (Table 2) and 
was shown not to be significantly different between the treatment groups. 
 
Preparation of samples 
Plasma, bile and perfusion buffer samples were similarly treated as described by Donovan 
and coworkers (14). The amounts of unmodified (not metabolized) epicatechin, A1, A2, B2 
or DP3 and their methylated and/or conjugated (glucuronides and sulfates) forms were 
determined. The amounts of conjugates were determined by the measurement of 
unmodified and methylated forms before and after treatment with a                       
β-glucuronidase/sulfatase, which hydrolyses the conjugates. Bile (20 µL) was mixed with 
β-glucuronidase (10 µL, ~60.000 U/ mL sodium acetate buffer, 0.5 M, pH 5.0 containing 7 
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g/L ascorbic acid) and incubated for 1 h at 37 °C. Subsequently, samples were 
deproteinized with 100 µL methanol containing 200 mM hydrochloric acid and centrifuged 
(12000 g; 10 min; 4 °C). Plasma (80 µL) was incubated with 35 µL β-glucuronidase and 
perfusion buffer samples (50 µL) were incubated with 35 µL β-glucuronidase and 20 µL 
sodium acetate buffer (7 g/L ascorbic acid) to reach a pH of 5.0. Both plasma and perfusion 
buffer samples were incubated similarly, but for 2 h at 37 °C, and subsequently 
deproteinized with 200 µL methanol containing 200 mM hydrochloric acid. The stability of 
each test compound (100 µM) incubated for 2 h at similar conditions as used during the 
enzyme incubation was ≥ 90% in the absence of β-glucuronidase and ≥ 89% in the presence 
of β-glucuronidase except for A-type DP3 (82%). 
 
Verification of β-glucuronidase activity under various test conditions 
To test if the enzyme activity was altered by the presence of bile and plasma, 20 µL of 
plasma, bile or sodium acetate buffer was mixed with 8.5 µL β-glucuronidase (~ 8000 
U/mL sodium acetate buffer, 0.5 M, pH 5.0) and 7 µL phenolphthalein-glucuronide (3 mM 
in demineralized water) and incubated for  2 h at 37 °C. Subsequently, 145 µL sodium 
glycine buffer (200 mM, pH 10.4) was added and the color was measured at 540 nm. 
Samples were incubated in duplicate. A blank, containing inactive β-glucuronidase (the 
enzyme was added after addition of glycine buffer) served as a control. β-Glucuronidase 
activity was not significantly affected by the presence of plasma or bile and was 110% (SD 
12) and 89% (SD 6), respectively, compared to the activity measured in the absence of 
plasma or bile. Each time samples were incubated with β-glucuronidase, a control sample 
with phenolphthalein-glucuronide was analyzed to confirm β-glucuronidase activity. In a 
similar way the effect of 1.5 -170 µM PC dimers on β-glucuronidase activity was tested. No 
significant decrease in activity was detected due to the presence of the dimers. 
 
HPLC-Electro-Chemical-Detection (ECD) 
Quantitative determination of PCs and monomers was performed with HPLC-ECD, as 
described previously (18). The cells of the coularray detector were set on 250, 350, 450 and 
600 mV. The mobile phase was composed of (A) sodium phosphate buffer (100 mM, pH 
3.35) containing 10 mg/L SDS and (B) 60% (v/v) acetonitrile, 10% (v/v) methanol in 
sodium phosphate buffer (30 mM, pH 3.45) containing 15 mg/L SDS. The flow rate was 1 
mL/min. The most optimal column was selected for each analyte and matrix combination. 
Analysis was performed on four different columns. An Inertsil ODS-3, 4.6 mm i.d. x 150 
mm, 5 µm column (GL Sciences) was used for the detection of EC, 3OMeEC, 4OMeEC in 
bile and plasma (before and after β-glucuronidase treatment) and for all compounds in the 
perfusion fluid samples (before and after β-glucuronidase treatment). An XterraRP dC18, 
4.6 mm i.d. x 150 mm, 3.5 m column (Waters) was used to analyze A1, A2 and B2 in 
plasma (before and after β-glucuronidase treatment) and bile (before β-glucuronidase 
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treatment). An Atlantis dC18, 4.6 mm i.d. x 150 mm, 3 µm column (Waters) was used for 
the analysis of A-type DP3 in bile (before β-glucuronidase treatment) and A-type DP4 in 
bile and plasma (before β-glucuronidase treatment) and a Symmetry Shield 4.6 mm i.d. x 
150 mm, 5 µm column (Waters) for A-type DP3, A1, A2 and B2 in bile (after β-
glucuronidase treatment) and A-type DP3 in plasma (before and after β-glucuronidase 
treatment). The elution profile was as follows: 0-20 min, B: linearly 20%-75%; 20-25 min, 
B: linearly 75%-100%; 25-28 min, isocratic at 100% B; 28-30 min, B: linearly 100%-20%, 
and reconditioning of the column for 3 min. For each sample 50 µL was injected. The limit 
of detection (LOD) for EC, 3OMeEC, 4OMeEC, B2, A1 and A2 was about 20 nM and for 
A-type DP3 60 nM. 
 
UPLC-MS analysis 
UPLC-MS analysis was used to identify methylated and/or glucuronidated dimers and to 
confirm the presence of epicatechin, A1, A2, B2, DP3, 3OMeEC and 4OMeEC. A 
Micromass Quattro Ultima system (Waters), equipped with an ESI source and controlled by 
Masslynx software was coupled to an Acquity Ultra Performance LC system (Waters). 
Analysis was performed on an Acquity UPLC-BEHC18, 2.1 mm i.d. x 100 mm, 1.7 µM 
column (Waters) with a flow rate of 0.4 mL/min, which was reduced to 0.2 mL/min by 
capillaries before it entered the MS. The column oven temperature was 40 °C. The mobile 
phase was composed of (A) 10% (v/v) aqueous acetonitrile adjusted to pH 3.35 with formic 
acid and (B) 60% (v/v) aqueous acetonitrile with 10% (v/v) methanol adjusted to pH 3.45 
with formic acid. The elution profile was as follows: 0-1 min, isocratic on 10% B; 1-5 min, 
B: linearly 10%-50%; 5-8 min, B: linearly 50%-100%; 8-10 min isocratic at 100% B; 10-
10.1 min, B: linearly 100%-10%, and reconditioning of the column for 0.4 min. For each 
sample 15 µL was injected. 
Measurements were performed in the negative ion mode with a capillary voltage 
of 2.0 kV, a cone voltage of 25 V, a capillary temperature of 300 °C and a source 
temperature of 120 °C. The collision energy values were optimized by infusion of 
standards. For each perfused compound/mixture, two plasma samples and two bile samples, 
both before and after β-glucuronidase treatment, were analyzed for the presence of EC, 
3OMeEC, 4OMeEC, B2, A1, A2 and A-type DP3 in the Multiple-Reaction-Monitoring 
(MRM) mode with each 2-3 precursor/product ion pairs as indicated in Table 3. 
Identification was performed on the basis of MS data and retention times of standards. The 
LOD for each compound was about 10 nM. Furthermore, samples were screened for the 
presence of glucuronidated and/or methylated A- and B-type dimers (m/z 589, 591, 751, 
753, 765, 767 [M-H]-) in the Select-Ion-Recording (SIR) mode and by product ion scans 
(Table 3).  
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Table 3. MS detection of the test compounds and their metabolites. 
compound a precursor ion [M-H]- product ion b CE (V) c 
epicatechin 289.1 109.2 20 
  203.2 20 
  245.2 15 
3OMeEC/4OMeEC 303.0 137.1 20 
  244.1 15 
  285.2 15 
A1/A2 575.1 285.1 25 
  289.1 25 
  449.2 25 
B2 577.1 289.1 20 
  407.2 20 
  425.2 15 
DP3 863.1 575.2 20 
  711.2 20 
methylated B2 591.0 - 25 
B2-glucuronide 753.0 - 25 
methylated B2-glucuronide 767.0 - 20 
methylated A1/A2 589.0 - 25 
A1/A2-glucuronide 751.0 - 25 
methylated A1/A2-glucuronide 765.0 - 20 
a 3OMeEC= 3’-O-methyl-epicatechin and 4OMeEC= 4’-O-methyl-epicatechin.  
b the most abundant product ions were determined by infusion with standards. 
c CE= collision energy in Volts 
 
Statistical Analysis 
A Student’s t test was performed to determine significant decreases of each component in 
perfusion buffer or a significant increase in plasma or bile. One-way Anova using SPSS 
software (SPSS for windows, version 15.0, SPSS Inc., Chicago, IL) was used to test for 
statistical differences of weight and bile flow of the rats (Table 2) between treatment 
groups. A probability of ≤ 0.05 was considered significant. Error bars are depicted as mean 
± SE. 
 
 
Results 
 
 
Perfusion fluid 
Perfusion fluid was sampled before it entered the cannulated intestine (t=0 and t=30 min) to 
test the stability of the test compounds in the buffer used. No significant decline was 
Chapter 4 
 
 78 
detected for any of the test compounds during the 30 min of perfusion (Table 2). 
Incubation with β-glucuronidase of the perfusion fluid that had passed the cannulated 
intestine showed that no conjugates were present in any of the treatments. Thus conjugation 
by epithelial cells and subsequent excretion of conjugates back into the lumen did not take 
place.  
 
Plasma  
 
Perfusion with procyanidins 
MS analysis (see Table 3 for precursor and product ions) showed that methylated and/or 
conjugated dimers and unmodified, methylated and/or conjugated epicatechin monomers 
were absent after perfusion with any of the PCs. Perfusion with pure B2 did not result in its 
(< 10 nM) absorption in plasma. After perfusion with dimer A1 or A2, both were detected 
in plasma by LC-MS analysis (no further results shown). Unmodified A1 increased from 
0.05 (SE 0.02) µM after 15 min to an average of 0.11 (SE 0.04) µM after 30 min, quantified 
with ECD (Figure 2A). Dimer A2 could not be quantified due to disturbance of peaks 
derived from the matrix.  
Perfusion with A-type trimers (DP3) did not result in their absorption (< 10 nM) 
and no monomers or dimers were detected. Perfusion of the mixture (containing DP4, B2 
and A1) resulted in the absorption of unmodified A1 and B2, which was confirmed with 
LC-MS (Figures 3A and B). A1 significantly (P ≤ 0.03) increased from 0.02 (SE 0.002) 
µM at 15 min to 0.06 (SE 0.01) µM at 30 min, and 0.05 (SE 0.02) µM B2 was detected 
only after 30 min (Figure 3B). Perfusion with A-type DP4 was performed as a control to 
rule out depolymerization into monomers, dimers or trimers. No monomers, dimers or 
trimers were detected. 
 
Perfusion with epicatechin 
No unmodified or methylated epicatechin was detected in plasma, but only their conjugated 
forms (determined as epicatechin and methylated epicatechin after enzymatic hydrolysis of 
the conjugates) were found. After perfusion with epicatechin for 30 min, the concentration 
of epicatechin conjugates was 0.7 (SE 0.1) µM (Figure 2C). Furthermore, 3’-O-methyl-
epicatechin conjugates were present, which reached a concentration of 0.3 (SE 0.04) µM 
after 30 min. MS analysis confirmed the identity of both epicatechin (m/z 289.1 [M-H]-) 
and 3’-O-methyl-epicatechin (m/z 303.0 [M-H]-) and their retention times were equal to 
those of the standards (Figure 3C). 4’-O-Methyl-epicatechin was not detected. The molar 
ratio between epicatechin and 3’-O-methyl-epicatechin in plasma was 2.3 (after 30 min). 
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Figure 2. Plasma concentrations of A1 (■), B2 (  ), epicatechin conjugates (■) and 3’-O-methyl-
epicatechin conjugates (□) after perfusion with: A1 (panel A); a mixture of A1, B2 and A-type 
DP4 (panel B) and epicatechin monomer (panel C). Note that the scale of the Y-axis in panel C is 
different. Error bars represent an average of n ≥ 4 ± SE except for B2 (n= 2). Significant 
increases in time are indicated with *.  
 
Bile 
 
Perfusion with procyanidins 
Similarly as found in plasma, no methylated and/or conjugated dimers were detected in bile 
(MS analysis, see Table 3 for precursor and product ions). Treatment with β-glucuronidase 
introduced many interfering peaks, so quantification of dimers by HPLC-ECD was not 
always possible. No unmodified, methylated or conjugated monomeric epicatechin was 
detected after perfusion with any of the PCs. Perfusion with the dimers B2 and A2 did not 
result (< 10 nM) in the excretion of unmodified B2 or A2 by bile. After perfusion with the 
mixture only unmodified A1 could be quantified. An average concentration of 0.20 (SE 
0.06) and 0.34 (SE 0.06) µM was present after 0-15 and 15-30 min, respectively        
(Figure 4A). However, the presence of unmodified A1 could not be confirmed with LC-
MS analysis. After perfusion with both pure A1 and the mixture, the presence of A1 in bile 
was confirmed with MS analysis, but only after treatment with β-glucuronidase. This might 
indicate that A1 was excreted by bile as its conjugate, although no A1-glucuronide [m/z 
751.0 M-H]- could be identified. As with plasma, perfusion with trimers (DP3) did not 
result in their absorption.  
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Figure 3. MS detection of specific masses in the MRM (negative) mode after separation by 
UHPLC-MS of A) standard of B2, A1 and A2; B) B2 and A1 in plasma after perfusion with a mix 
(B2, A1 and DP4); C) standard of epicatechin (EC), 3’-O-methyl-epicatechin (3OMeEC) and 4’-O-
methyl-epicatechin (4OMeEC); and D) EC, 3OMeEC and 4OMeEC in bile (after deconjugation with 
β-glucuronidase) after perfusion with EC.  
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Figure 4. Bile concentrations of A1 (■), epicatechin conjugates (■) and 3’-O-methyl-epicatechin 
conjugates (□) after perfusion with: a mixture of A1, B2 and A-type DP4 (panel A) and 
epicatechin monomer (panel B). Note that the scale of the Y-axis is different. Error bars 
represent an average of n=5 ±SE. Significant increases in time are indicated with *. 
 
Perfusion with epicatechin 
No unmodified epicatechin was detected in bile. 3’-O-Methyl-epicatechin conjugates were 
the major metabolites present in bile. The concentration increased significantly (P ≤ 0.01) 
from 2.5 (SE 0.7) µM after 0-15 min to a concentration of 12.4 (SE 3.1) µM after 15-30 
min (Figure 4B). The concentration of epicatechin-conjugates was 1.7 (SE 0.4) µM after 
15-30 min. The presence of epicatechin-conjugate and 3’-O-methyl-epicatechin-conjugate, 
determined as epicatechin (m/z 289.1) and 3’-O-methyl-epicatechin (m/z 303.0), 
respectively, after treatment with β-glucuronidase, was confirmed with MS analysis 
(Figure 3D). After 30 min, the molar ratio 3’-O-methyl-epicatechin-conjugate / 
epicatechin-conjugate was 7.3. Also the presence of 4’-O-methyl-epicatechin-conjugate 
(determined as 4’-O-methyl-epicatechin (m/z 303.0)) was established on the basis of MS 
analysis (Figure 3D), but could not be quantified with ECD. 
 
 
Discussion 
 
 
We showed for the first time that procyanidin dimers A1 and A2 can be absorbed from the 
rat small intestine. Additionally, we showed that they were better absorbed than dimer B2. 
The absorption of dimers was 10-20 times less than that of epicatechin (epicatechin 
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conjugates + 3’-O-methyl-epicatechin conjugates). This is a smaller difference than found 
in a human study after the consumption of flavanol-rich cocoa (8), where about 50 times 
less dimer was absorbed than epicatechin. High DP oligomers seemed to enhance the 
absorption of B2, but did not affect the absorption of A1. In contrast to epicatechin, 
conjugation or methylation of procyanidin dimers did not occur. The A-type trimers were 
not absorbed. 
 
Bioavailability of procyanidin dimers 
Our results showed that A1, A2 and B2 were absorbed as unmodified compounds, which is 
in line with the results of Shoji and coworkers (12), who predominantly (90%) detected 
unmodified dimers in rat plasma. Therefore, in contrast to epicatechin (19-21), conjugation 
of procyanidins seemed to be of minor importance. Neither epicatechin nor its metabolites 
were detected in plasma and bile after perfusion with any of the dimers, A-type trimers and 
tetramers. This does not correspond to data obtained by Spencer and coworkers (13). These 
authors detected epicatechin as the main metabolite after ex vivo perfusion of the rat small 
intestine with B2 and B5 (epicatechin-(4-6)-epicatechin).  
 
Procyanidin oligomers affect the absorption of B2 
The presence of tetramers enhanced the absorption of B2, but not that of A1. No A1, B2 or 
trimers were detected after perfusion of tetramers only. The results on B2 are in line with 
the findings of Shoji and coworkers (12) who detected elevated concentrations of B1, B2 
and trimer C1 when low DP oligomers (DP 2-5) were fed in combination with high DP 
oligomers (≥ DP 8). Their hypothesis was that the high DP oligomers bind to mucosal 
proteins facilitating a better absorption of the lower DP oligomers. The influence of high 
DP oligomers on the absorption of low DP oligomers should be examined in more detail as 
high DP oligomers usually coexist with low DP oligomers in foods (1). Therefore, 
bioavailability of some procyanidins might be underestimated in studies performed with 
only low DP oligomers. 
 
Metabolism of dimers is of minor importance 
 
Methylation 
In vitro, the enzyme catechol-O-methyl-transferase, responsible for the methylation of 
different flavonoids in vivo (22), has been demonstrated to be able to methylate PC dimers 
(13). However, in contrast to epicatechin, no methylated and/or conjugated dimers were 
detected in plasma or bile in our in vivo study. The lack of methylated and/or conjugated 
procyanidin standards complicates the analysis of such metabolites. Retention times and 
product ions to optimize MS detection are not known. Therefore, the settings might not 
have been optimal to obtain a sufficiently low detection limit. Small amounts of methylated 
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B-type dimers have been detected after an ex vivo perfusion of the rat small intestine (13). 
Also methylated dimers were detected in plasma with MS analysis after administration of 
1000 mg/kg B1 and B2 to rats (12). In both studies, the methylated dimers were not 
dominating. In contrast, in a rat study performed with specific dimers from wine (23), 
composed of two epicatechin units linked by an ethyl bridge, tetramethylated dimers were 
found as the only metabolites in plasma (24). However, the additional ethyl bridge between 
the monomeric units might have changed the metabolism of these dimers. Our in vivo study 
together with others (12, 13) showed that methylation is of minor importance for the 
absorption of B1, A1 and A2.  
 
Conjugation 
Glucuronidation of phenolic compounds has been described to occur both in the enterocytes 
of the small intestine and the liver (22). For several flavonoids like quercetin (25), genistein 
and apigenin (26), the glucuronides formed in the enterocytes were excreted back into the 
lumen. Levels of excretion of flavonoids ranging between 0-52% of the initial absorbed 
dose have been reported (22). In our study, the perfusion fluid that had passed the 
cannulated intestine did not contain any conjugates for any of the compounds tested. 
Therefore, conjugation and subsequent excretion back into the lumen did not occur for 
epicatechin, procyanidin dimers B2, A1 and A2, and A-type trimers and tetramers. This is 
in line with results obtained for catechin (27). Also in plasma, conjugates of the 
procyanidin dimers A1, A2 and B2 or trimers were absent. 
In bile, A1 was detected (with LC-MS) only after treatment with β-glucuronidase, 
which suggests its conjugation in the liver. However, the presence of glucuronidated A1 in 
bile could not be confirmed with LC-MS. As described above, the lack of appropriate 
standards complicates the analysis of such metabolites. Dimers B2 and A2 were not 
detected in bile, nor their metabolites. Considering that bile contained about 6 times more 
A1 and 14 times more epicatechin metabolites than plasma and that B2 was found in 
plasma after perfusion with the mixture, this suggests that B2 and A2 are excreted by bile to 
a very low extent, if at all. 
 
Absorption and metabolism of epicatechin  
Epicatechin was used as a reference compound because its absorption has been described in 
many animal (19-21) and human studies (28-30). The detection of conjugated epicatechin 
and conjugated 3’-O-methyl-epicatechin (molar ratio: 2.3) as main metabolites is in good 
agreement with that of catechin absorption (molar ratio: 2.8) tested previously in the same 
perfusion system (27). Our results on the metabolism of epicatechin are in line with the 
findings in humans: Epicatechin is completely conjugated, and methylated epicatechin 
occurs (28-30). 
 
Chapter 4 
 
 84 
In conclusion, our results show that dimers A1 and A2 can be absorbed, but their 
absorption is 10-20 fold lower than that of epicatechin. In contrast to epicatechin, these 
dimers are not conjugated or methylated, thus conserving their biological activity inside the 
body. Because bioactivity is mostly altered by conjugation, the conserved activity of the 
free dimers in vivo might partly compensate their lower absorption as compared to 
epicatechin. Furthermore, bioavailability of procyanidins might be underestimated as 
synergy between low and high DP oligomers seems to take place. As procyanidin contents 
of foods are relatively high, procyanidin dimers might contribute to a protective effect of 
polyphenol-rich foods.  
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Abstract 
 
 
Procyanidins (PCs) are highly abundant phenolic compounds in our diet and might be 
responsible for the health effects of chocolate and wine. Due to low absorption of intact 
PCs, microbial metabolism might play an important role. Sofar, only a few studies, with 
crude extracts, rich in PCs but also containing a multitude of other phenolic compounds, 
have been performed to reveal human microbial PC metabolites. Therefore, the origin of 
the metabolites remains questionable. We performed an in vitro fermentation of purified PC 
dimers with human microbiota. The main metabolites identified were 2-(3,4-
dihydroxylphenyl)acetic acid and 5-(3,4-dihydroxyphenyl)-γ-valerolactone. Other 
metabolites detected were: 3-hydroxyphenylacetic acid, 4-hydroxyphenylacetic acid, 3-
hydroxyphenylpropionic acid, phenylvaleric acids, monohydroxylated phenylvalerolactone 
and 1-(3’,4’-dihydroxyphenyl)-3-(2”,4”,6”-trihydroxyphenyl)propan-2-ol. Metabolites that 
could be quantified accounted for at least 12 mole % of the dimers, assuming 1 mole of 
dimers is converted into 2 moles of metabolite. A degradation pathway, which is partly 
different from that of monomeric flavan-3-ols, is proposed.  
 
 
Key words: degradation pathway, human microbial metabolites, hydroxyphenylacetic 
acids, proanthocyanidins, valerolactones 
 
 
 
 
 
 
 
 
 
Abbreviations used: PCs, procyanidins; CV, column volume; ECD, coularray detector; BA, 
benzoic acid; PPA, 3-(phenyl)propionic acid; 3,4-diHPA, 2-(3,4-dihydroxyphenyl)acetic acid; 
3,4-diHPP, 3-(3,4-dihydroxyphenyl)propionic acid; 3-HPP, 3-(3-hydroxyphenyl)propionic acid; 
3-HPA, 2-(3-hydroxyphenyl)acetic acid; 4-HPA, 2-(4-hydroxyphenyl)acetic acid; 3,4-diHPP-2-
ol, 1-(3’,4’-dihydroxyphenyl)-3-(2”,4”,6”-trihydroxyphenyl)propan-2-ol; 3,4-diHPVal, 5-(3,4-
dihydroxyphenyl)-γ-valerolactone; 3,4-diHPV, 5-(3,4-dihydroxylphenyl)valeric acid; HPP-2-ol, 
1-(3’ or 4’-hydroxyphenyl)-3-(2”,4”,6”-trihydroxyphenyl)propan-2-ol; 3 or 4-HPVal, 5-(3 or 4-
hydroxyphenyl)-γ-valerolactone; 3 or 4-HPV,  5-(3 or 4-hydroxyphenyl)valeric acid; PVal, 5-
phenyl-γ-valerolactone; SPE, solid phase extraction. 
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Introduction 
 
 
The intestinal microbiota have been shown to be important for the bioavailability (1, 2) and 
bioactivity (3) of certain phenolic compounds that are present in many daily consumed food 
products, such as fruits, vegetables and nuts (4). Proanthocyanidins (PAs) are one of the 
most abundant phenolic compounds in our diet (5). They potentially are responsible for the 
cardioprotective properties of cocoa products and wine (6, 7). PAs are thought to be poorly 
absorbable. Hence, microbiota of the colon play an important role in their digestion. 
However, knowledge on the fate of PAs in the body is still incomplete. The most common 
subclass of PAs is the procyanidins (PCs), which exclusively consist of (epi)catechin units 
and their galloyl derivatives. The monomeric units of PCs are linked through a C4-C8 or 
C4-C6 bond (B-type), which can coexist with an additional C2-O-C7 bond (A-type). Only 
PC dimers are believed to be absorbed intact (8-10), albeit at much lower efficiency than 
the monomeric units (11). Thus, high amounts of PCs will reach the colon intact as shown 
by Kahle and co-workers (12) 
The monomeric units of PCs, (epi)catechin, are known to be degraded into several 
phenolic acids namely: phenylvaleric acids, phenylpropionic acids, phenylacetic acids, 
benzoic acids and hippuric acids (Figure 1), all mainly hydroxylated at the meta position 
(13-16).  
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Figure 1. Basic structures of microbial metabolites from various species formed out of 
(epi)catechin, which are usually hydroxylated at the positions indicated by R1 and/or R2. 
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Furthermore, 5-(3,4-dihydroxyphenyl)-γ-valerolactone and 5-(3-hydroxyphenyl)-γ-
valerolactone have been identified as metabolites of both epicatechin and catechin in 
various species including man (13, 17-22). 
Ingestion of PC-rich products resulted in increased urinary excretion of most of 
the phenolic acids mentioned above (14-16, 23, 24). Therefore, phenolic acids seem to be 
major metabolites of PCs. However, often PC-rich mixtures were used, which not exclude 
the possibility that the metabolites found actually originates from other phenolic 
compounds that are also present in those mixtures. The microbial metabolic pathways of 
PCs are still not completely characterized. Knowledge on the formation and identity of 
these metabolites is important as they could contribute to the potential health effects of PCs 
in e.g. cocoa and wine.  
A limited number of in vivo and in vitro studies, mostly in rats, have been 
performed to characterize microbial metabolites of PCs (14, 15, 23-26). Studies performed 
with animals can result in substantially different bioconversions compared to humans, as 
has been shown for catechin and epicatechin (19, 27). In vitro fermentations are easier to 
perform than in vivo studies. They have the additional advantage that relatively high 
concentrations of metabolites, not yet affected by absorption and metabolism, are present, 
which facilitates detection. Sofar, only one in vitro fermentation of PC oligomers with an 
average degree of polymerization (DP) of 7 has been performed with microbiota of one 
human subject (28). The use of large PC oligomers might inactivate the microbiota as they 
have pronounced antimicrobial properties (29, 30), likely due to their high interaction with 
proteins (31, 32). Therefore, in the present study, a well-defined and pure PC dimer fraction 
was subjected to an in vitro fermentation with human feces as a source of microbiota. Feces 
of 4 volunteers was pooled, as commonly done by others (27, 33), to adjust for inter-
individual variations. The main objective of this study was to identify human microbial 
metabolites originating from PCs. Based on the metabolites that were detected a possible 
degradation route is proposed. 
 
 
Materials and Methods 
 
 
Materials 
All organic solvents used for HPLC analysis were HPLC grade. Vitaflavan (DRT, Levita 
Chemical International NV, Antwerpen, Belgium), a commercially available grape seed 
extract, was used as PC dimer source. PC standards B1 (epicatechin-(4-8)-catechin), B2 
(epicatechin-(4-8)-epicatechin), B3 (catechin-(4-8)-catechin) and B4 (catechin-(4-8)-
epicatechin) were purchased from Apin Chemicals (Abingdon, UK). Standards of (-)-
epicatechin and (+)-catechin and the phenolic acids 3-(3-hydroxyphenyl)propionic acid (3-
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HPP), 3-(3,4-dihydroxyphenyl)propionic acid (3,4-diHPP), 2-(3-hydroxyphenyl)acetic acid 
(3-HPA), 2-(4-hydroxyphenyl)acetic acid (4-HPA), 2-(3,4-dihydroxyphenyl)acetic acid 
(3,4-diHPA), 3-(phenyl)propionic acid (PPA), and benzoic acid (BA) were purchased from 
Sigma-Alldrich chemie (Steinheim, Germany). 
 
Isolation and characterization of grape seed procyanidins 
 
Removal of gallic acid substituents 
To enable preparative HPLC isolation of PC dimers, gallic acid substituents were 
enzymatically removed as described in Chapter 3. The percentage of galloylation before 
and after tannase treatment was determined by thiolysis. To be able to distinguish between 
the monomeric flavan-3-ols that are formed during thiolysis and the ones already present in 
the extract, the monomeric flavan-3-ols were removed with SPE before thiolysis as 
described by Vidal and coworkers (34). The samples were loaded and washed with H2O (3 
CV), after which the monomeric flavan-3-ols were removed with diethylether (3 CV). The 
PCs were eluted with MeOH (3 CV), evaporated, and dissolved in 2 mL dry MeOH to a 
concentration of approximately 8 mg/mL. Thiolysis was performed as described by Guyot 
and coworkers (35) with some adjustments. In short, PC samples (250 µL) were mixed with 
dry MeOH (500 µL) containing 5% (v/v) benzylmercaptan, and 3.3% (v/v) HCl in dry 
MeOH (250 µL) and incubated at 40 °C for 90 min. After incubation, the samples were 
dried under air, dissolved in 1 mL dry MeOH, and analyzed on HPLC equipped with UV 
and MS detection.  
 
RP-HPLC analysis  
A Thermo Spectra system was used containing a P 4000 pump, an AS 300 autosampler and 
an UV 3000 detector (Thermo Separation products, Fremont, CA, USA). Separation was 
performed on an XterraRP dC18, 4.6 mm ID x 150 mm column with a 3.5 µm particle size 
(Waters). The mobile phase was composed of (A) H2O + 0.1% (v/v) HOAc and (B) ACN + 
0.1% (v/v) HOAc. The elution profile was as follows: 0-10 min, of 15%-25% B; 10-15 min, 
25%-40% B; 15-20 min, isocratic on 40% B; 20-25 min, 40%-95% B; 25-30 min, 95%-
15% B, and reconditioning of the column. The flow rate was 0.7 mL/min and detection was 
performed at 280 nm.  
 
ESI/MS detection 
An LCQ Classic equipped with an ESI source was used and controlled by Xcallibur 
software (Thermo Finnigan, San Jose, CA, USA). The detector was coupled to the HPLC 
system by means of a splitter (Accurate, LC Packings, Amsterdam, The Netherlands), 
which reduced the flow rate 20 times. Measurements were performed in the negative mode 
with an ion spray voltage of 4.5 kV, a capillary voltage of -5.0 V, and a capillary 
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temperature of 270 °C. The scan range was set from m/z 100-2000. The MS/MS function 
was performed in the data dependent mode. The collision energy value was 27%.  
 
Preparative isolation of procyanidin dimers 
Fractionation by DP was performed on a normal phase (NP) column, Inertsil PREP-SIL, 30 
mm ID x 250 mm with a 10 µm particle size (GL Sciences, Tokyo, Japan). A Waters 
system equipped with a 2767 sample manager, a 2525 binary gradient module, a 2996 
photodiode array detector and an UV fraction manager was used. The binary mobile phase 
consisted of (A) hexane and (B) acetone. The elution profile was as follows: 0-30 min, 
40%-60% B; 30-50 min, isocratic at 60% B; 50-70 min, 60%-75% B, followed by a 
washing step at 98% B for 3 min, and reconditioning of the column. The flow rate was 27 
mL/min and PDA spectra from 210-300 nm were recorded. The tannase treated PC fraction 
was dissolved in 10 mL (~70 mg/mL) acetone/hexane/ethanol (7:3:2) and injected. The 
eluate containing the dimers was collected (28.2-38.1 min), evaporated under vacuum and 
lyophilized prior to further analysis. 
 
Recovery of phenolic acids and PC dimers from the fermentation 
buffer 
Seven phenolic acids were used to determine their extraction efficiency from a fecal 
suspension: 3-HPP, 3,4-diHPP, 3-HPA, 4-HPA, 3,4-diHPA, PPA and BA. A 25% (w/v) 
fecal suspension was made as described previously (36) with some alterations. Freshly 
passed feces were immediately suspended in the buffer and homogenized with a stomacher 
(Seward, Worthing, UK) operating for 60 s and sieved (1 mm). Part of it was autoclaved to 
inactivate the microbiota. The active and the inactive suspension (200 µL) were each 
combined with carbonate-phosphate buffer (pH 5.5) (37) containing the phenolic acids (800 
µL) in a Kimax tube (n=3 for both active and inactive suspension), resulting in a 5% (w/v) 
suspension and 200-400 µg/mL phenolic acids. Samples containing the active suspension 
were immediately acidified to a pH below 2 by adding 60 µL HCl (12.1 M) and 5 mL ethyl 
acetate to inactivate the microbiota and prevent conversions. The time between the 
collection of the feces and acidification did not exceed 10 min. Samples were vortexed 
vigorously and centrifuged at 14000 rpm (Eppendorf 5417C, rotor F45-30-11, Hamburg, 
Germany) for 10 min at RT. The ethyl acetate layer was pipetted into another Kimax tube. 
The remaining H2O phase was re-extracted twice with 5 mL ethyl acetate as described 
above. The ethyl acetate phases were individually evaporated with a TurboVap (Zymark, 
Russelsheim, Germany) operated at 50 °C under a stream of nitrogen. The samples were 
subsequently dissolved in 1 mL methanol and diluted 40 times before analysis with HPLC-
UV-ECD as described later. Extraction recoveries are shown in Table 1. The third 
extraction removed only 10% or less of each phenolic acid.  
 
Microbial conversion of procyanidin B-type dimers by human microbiota 
 
 93 
Table 1. Recovery of several phenolic acids after evaporation only, or after extraction from the 
fermentation suspension including subsequent evaporation  
recovery (%) 
compound after evaporation after extraction and subsequent evaporation 
  5% (w/v) active suspension 5% (w/v) inactive suspension 
  1st             2nd            3rd             total 1st              2nd            3rd           total 
3,4-diHPA  92 ± 2 64 ± 9       31 ±14     10 ± 0       105 ±12 58 ±12       28 ± 7       9 ± 1         95 ±16 
4-HPA  92 ± 1 64 ± 8       26 ±  7       7 ± 2         97 ± 2 75 ±10       28 ± 9       6 ± 1       109 ±11 
3-HPA  89 ± 1 60 ± 8       25 ±  5       6 ± 3         91 ± 5 78 ±11       27 ± 8       5 ± 1       110 ±  7 
3,4-diHPP  97 ± 1 60 ± 8       23 ±  7       7 ± 1         90 ± 3 69 ±  9       24 ± 8       6 ± 1         99 ±  9 
3-HPP 105 ± 1 66 ± 9       25 ±  6       6 ± 3         97 ± 4 86 ±12       27 ± 9       5 ± 1       118 ±  9 
PP 120 ± 8 62 ±11        6 ±10        0              68 ± 0 66 ±12         0             0               66 ±12 
BA   71 ± 3 42 ± 9       12 ±  9        2 ± 3        56 ± 3 57 ±12       14 ± 8       0               71 ±11 
a data (average of n=3 ± SD) are based on UV measurements at 270 nm except for the 
hydroxylated acids, which were detected with coularray. Three subsequent extractions were 
performed (1st - 3rd), resulting in a total extraction recovery for each phenolic acid. 
 
To test the stability of the dimers during extraction they were dissolved in carbonate-
phosphate buffer (pH 5.5) (100 µg/mL) without microbiota and extracted twice as 
described above. The total ethyl acetate phase (10 mL) was evaporated and the samples 
were dissolved in 500 µL H2O/ACN/MeOH (86:12:2), acidified with 8 µL H3PO4 (14.8 M) 
and filtered over a 0.22 µm Acrodisc membrane (PALL corporation, MI, USA). Samples 
were analyzed with HPLC-UV-ECD. Extraction recovery of dimers was 15-30%. 
Furthermore, degradation into catechin and epicatechin took place, which together 
accounted for ~0.6 mole % of the originally added dimers. This was observed based on 
injection of standards and MS analysis (described later). No other degradation products 
were detected. Catechin and epicatechin were stable in this system (38). 
 
Fermentation of procyanidin dimers by human microbiota 
 
In vitro fermentation process 
The dimeric fraction was subjected to fermentation with a pool of human microbiota 
obtained from four volunteers who usually ingested a normal diet, presented no digestive 
disease, and had not received antibiotics for at least 3 months as previously described (36). 
Freshly passed feces were immediately taken in an anaerobic chamber, pooled and 
homogenized in carbonate-phosphate buffer (pH 5.5). The mixture of dimers (5 µmol in 
total) was fermented by 1% (w/v) and 5% (w/v) fecal suspensions (10 mL) at 37 °C. 
Samples were taken after 0, 1, 2 and 4 h for the 1% (w/v) suspension and after 0, 1, 2, 4, 6, 
8 and 24 h for the 5% (w/v) suspension. Stability of the dimers to the applied conditions 
was studied by incubating them in the buffer without microbiota or with heat inactivated 
microbiota. Furthermore, fermentations with active fecal suspensions without added dimers 
were conducted as negative controls for each time point. All incubations were performed in 
Chapter 5 
 
 94 
triplicate at all time points mentioned above. At each time point, the content of the 
fermentation bottle was divided over four eppendorfs (2 mL each), frozen rapidly in liquid 
nitrogen and stored at -20 °C.   
 
Short chain fatty acid analysis 
Suppression of SCFA production in the presence of PC dimers could indicate their possible 
inhibitory effects on microbial enzymes involved in SCFA formation. Analysis of SCFA 
was performed with capillary gas chromatography as described previously (39). The sum of 
the amounts of acetic acid, propionic acid, 2-methyl-propionic acid and butyric acid was 
taken and expressed as total SCFA production. 
 
Sample preparation before HPLC analysis 
One eppendorf for each time point was put in an ice bath, slowly thawed, transferred into a 
Kimax tube, acidified and extracted with ethyl acetate twice as described for the analysis of 
the extraction recovery. The total ethyl acetate phase (10 mL) was evaporated under 
nitrogen to a small volume, transferred into HPLC vials and evaporated to dryness. Samples 
were stored at -20 °C. 
 
Analysis of microbial metabolites  
 
HPLC-UV-ECD analysis  
An Hitachi system (Tokyo, Japan) composed of L-2100 pumps and a L-2200 autoinjector 
extended with a Spark Mistral column oven set at 30 °C, an UV and a CoulArray detector 
(ECD) (ESA, Chelmsford, MA, USA) was used. Analysis was performed on an Inertsil 
ODS-3, 4.6 mm ID x 150 mm, 5 µm column (GL Sciences). The mobile phase was 
composed of (A) 10% ACN in sodium phosphate buffer (100 mM, pH 3.35) containing 10 
mg/L SDS and (B) 60% ACN, 10% MeOH in sodium phosphate buffer (30 mM, pH 3.45) 
containing 15 mg/L SDS. The flow rate was 1 mL/min. Detection was performed at 270 nm 
and 50, 450, 600 and 700 mV. The elution profile was as follows: 0-15 min, 20%-57.5% B; 
15-20 min, 57.5%-100% B; 20-30 min, isocratic at 100% B; 30-32 min, 100%- 20% B, and 
reconditioning of the column. Samples were dissolved in 500 µL of H2O/ACN/MeOH 
(86:12:2), acidified with 8 µL H3PO4 (14.8 M) and filtered over a 0.22 µm Acrodisc 
membrane (PALL). For each sample 10 µL was injected.  
Phenolic acid concentrations were calculated based on calibration curves ( 1-20 
µg/mL) and corrected with the average amounts found in the active controls (microbiota 
without dimers) (20-80 nmol, except 4-HPA gave backgrounds of 0.03-0.14 µmol) and 
extraction recoveries (Table 1). Dimer contents were calculated based on calibration curves 
(3-1000 µg/mL) and peak areas of dimer peaks 1, 3 and 4 (Figure 2) at 600 mV and dimer  
Microbial conversion of procyanidin B-type dimers by human microbiota 
 
 95 
 
5 10 15 20 25
0
10
20
30
40
50
Retention time (min)
1
2 4
3
5R
es
po
ns
e 
(µ
A
)
R
es
po
ns
e 
(µ
A
)
 
Figure 2. RP-HPLC profile of the dimer fraction purified by NP-HPLC. The dimers 1 (B1), 2 (B4) 
and 3 (B2 + B3) were identified with standards. Peaks 4 and 5 were also identified as PC dimers 
(m/z 577) but could not be identified further. 
 
peak 2 at 450 mV. Dimer peak 5 could not be monitored because of co-elution with other 
peaks. The amount of dimers detected at t=0 h was expressed as 100%. 
 
MS analysis 
To screen the samples for the presence of phenolic acids and additional metabolites, such as 
valerolactones, HPLC coupled to a LCT Premier quadruple TOF spectrometer equipped 
with an ESI source (Waters/Micromass) was used. An Acquity Ultra Performance HPLC 
system (Waters) was used with the same gradient as used with ECD analysis. The eluents 
were adjusted for MS analysis. Sodium phosphate and SDS were omitted and the pH was 
adjusted with formic acid. After passing the HPLC the flow rate was reduced to 0.2 mL/min 
for MS analysis. The LCT Premier  was operated in the negative mode at a resolution of 
10500 (FHWM), with a source temperature of 120 °C, desolvation temperature of 350 °C, a 
capillary voltage of 2250 V and a sample cone voltage of 50 V. Measurements were 
performed in the W mode. Data were collected in the full scan mode from m/z 100-750. 
A Waters Micromass Quattro Micro 3 system, equipped with an ESI source and 
controlled by Masslynx software was coupled to an HPLC system (Agilent technologies, 
1200 series, Santa-Clara, CA, USA) with the same conditions as used with the LCT 
Premier quadruple TOF spectrometer. Measurements were performed in the negative mode 
with a capillary voltage of 2.0 kV, a capillary temperature of 300 °C and a source 
temperature of 120 °C. The cone voltage and collision energy were optimized for the 
phenolic acids and dimers by infusion experiments of standards (Table 2). Selected 
samples were analyzed for the presence of phenolic acids and dimers in the MRM mode. 
Furthermore, daughter scans were made for the following selected masses, representing 
intermediate structures and valerolactones: 581, 579, 475, 416, 414, 305, 291, 289, 275, 
221, 209, 207, 193, 191, 175 and 125 at a cone voltage of 20 V and a collision energy value 
of 20%.  
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Table 2. The formation of the phenolic acids over time was confirmed by MS/MS analysis of 
specific product ions originating from their parent ions. The collision energy used is indicated by 
Coll. And the Cone voltage applied with Cone. 
phenolic compound parent ion [M-H]- product ion [M-H]- coll. (V) cone (V) 
2-(3,4-dihydroxyphenyl)acetic acid 166.9 122.9 10 20 
    94.7 20 20 
2-(3-hydroxyphenyl)acetic acid 150.9 106.9 10 20 
    64.7 25 20 
2-(4-hydroxyphenyl)acetic acid 150.9 106.9 10 20 
    64.7 25 20 
3-(3-hydroxyphenyl)propionic acid 164.9 121.0 10 25 
  105.9 20 25 
    76.7 10 20 
procyanidin dimer 577.1 289.0 25 35 
  124.9 30 35 
 
 
Statistical analysis 
The Student’s t-Test was used to test: if the amount of dimers significantly reduced in time, 
if SCFA production was altered due to the presence of PC dimers and if there were 
significant differences in phenolic acid recovery after extraction. A probability < 0.05 was 
considered significant. Error bars are depicted as mean ±SD. 
 
 
Results 
 
 
Composition of the procyanidin dimer substrate 
Enzymatic removal of gallic acid substituents improved the resolution upon preparative 
NP-HPLC, especially between the dimers and trimers (data not shown). The percentage of 
galloylation was calculated based on the peak areas of benzylthioethers and monomeric 
flavan-3-ols. Previously published response factors (40) were used to correct the area’s of 
the different peaks because no benzylthioether standards are available. Each response factor 
(RF) was divided by the RF of catechin. For example, 4015870 (RF epicatechin) / 3724170 
(RF catechin) = 1.08. Subsequently, the area found for epicatechin was divided through 
1.08. The degree of polymerization was calculated as; (area monomeric flavan-3-ols 
(terminal units) + area benzylthioethers)/ area monomeric flavan-3-ols (terminal units). The 
proportion of gallic acid decreased from 14% (w/w) to 1% (w/w). After preparative 
purification, the dimer fraction was free of monomeric flavan-3-ols and trimers as their 
masses, m/z 289 [M-H]- and m/z 865 [M-H]-, respectively, were not detected by NP-HPLC-
UV-MS. Three peaks out of 5 could be identified based on RP-HPLC with standards 
namely peak 1 was characterized as B1, peak 2 as B4 and peak 3 consisted of both B2 and 
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B3, based on separation on a different RP column (unpublished results). PC dimer peaks 4 
and 5 (m/z 577 [M-H]-) could not be further identified (Figure 2). Only B-type dimers (m/z 
577 [M-H]-) were detected to be present in the mixture. 
 
Quantitative analysis of microbial metabolites originating from 
procyanidin dimers 
PC dimers were not completely stable over 8 h of incubation in the absence of microbiota 
(buffer control) (Figure 3A). Peaks 1 and 2 were rather stable, but peaks 3 and 4 showed a 
decline of 40-60% compared to t=0 h (not significant, based on concentrations). After 1 h, 
no further decline was detected. Despite extraction recovery of dimers was low, a 
significant decrease in the dimer content in the presence of microbiota was detected for the 
first 4 h (Figure 3B). 
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Figure 3. Recovery of dimers 1 (B1), 2 (B4), 3 (B2/B3) and 4 (unknown) (see Figure 2) from 
the buffer control (Panel A) and the 5% (w/v) active suspension (Panel B) over 8 h of 
incubation. The amount detected at t=0 h was expressed as 100%. The bars represent the 
fermentation time as indicated in the legend. Error bars represent the SD of triplicates and a 
significant decline in comparison to the previous time point was calculated by Student’s t-test 
based on the concentrations (P < 0.05) and indicated by an asterisk. 
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Figure 4. HPLC-ECD detection at 600 mV (Panel A) and 450 mV (Panel B) of the dimer mixture 
fermented with a 5% (w/v) fecal suspension over 8 h. Several phenolic acids and flavonoids 
could be identified with standards and one peak (VI) remained to be identified. Compounds are 
indicated by: I = 3.4-diHPA, II = catechin, III = 4-HPA, IV = epicatechin, V =3-HPA, VI = ? 
and VII = 3-HPP. 
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While the dimers disappeared, 3,4-diHPA, 3-HPA, 3-HPP and 4-HPA appeared 
(Figure 4A), which were identified based on retention time and relative ECD response (at 
450 and 600 mV) of standards. Except for 3,4-diHPA and an unknown peak (VI), which 
were better detected at 450 mV (Figure 4B), the phenolic acids were optimally detected at 
600 mV. The identity of the four phenolic acids was confirmed with HPLC-MS/MS 
analysis (Table 2). The additional unknown product (VI) (Figure 4B) appeared after 1 h of 
fermentation with a maximum response around 4 h. 
The concentrations of the phenolic acids identified all increased during 4 to 6 h of 
fermentation, after which they decreased rapidly (Figure 5). After 6 h, the 4 identified 
phenolic acids accounted for ~1.2 µmol in a ratio of 1:6:12:21 (4-HPA:3-HPA:3-HPP:3,4-
diHPA) originating from 5 µmol PC dimers. BA proved to be absent and the concentration 
of PPA was similar to that found in the active suspension without dimers. Additionally, 
both catechin and epicatechin were detected within the first 2 h of fermentation. However, 
their total amount was similar as detected at all time points of the buffer control, which was 
1.5 - 2 mole % of the dimers added. This excludes the possibility that catechin and 
epicatechin were formed by microbial degradation of dimers during incubation. As 
described earlier, catechin and epicatechin were formed during the extraction in similar 
amounts as found in the samples (total of ~0.06 mole %). No phenolic metabolites were 
detected in fermentations performed with a 1% (w/v) suspension. 
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Figure 5. The formation of 4 phenolic acids over 8 h of fermentation of the dimer mixture with a 
5% (w/v) human fecal suspension. Error bars represent the SD of triplicates.  
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Figure 6. Total SCFA (acetic, propionic, 2-methylpropionic and butyric acid) production  of a 5% 
(w/v) human fecal suspension in the presence or absence (control) of the dimer mixture. 
Significant differences (P ≤ 0.05) are indicated by an asterisk. 
 
SCFA analysis was performed to monitor the activity of the microbiota in the 
presence of dimers. Initially (1-2 h), the presence of dimers inhibited SCFA formation 
significantly in the 5% (w/v) suspension (Figure 6). However, no significant difference in 
maximum amounts of total SCFA produced was found in the presence or absence of 
dimers. In the 1% (w/v) suspension no significant differences in SCFA production were 
found and levels were 6-7 times lower (data not shown) than those in the 5% (w/v) 
suspension.  
 
Identification of microbial metabolite VI as 5-(3,4-dihydroxyphenyl) 
-γ-valerolactone 
Additional analysis with HPLC-qTOF-MS was performed to identify the unknown peak VI. 
Two major peaks appeared in the total ion current (TIC) trace after 6 h at RT=8.3 and 10.0 
min, and some additional ones at RT= 11.4, 12.2 and 15.3, which were absent or small at t= 
0 h (Figure 7A). In addition, these peaks were not detected in the active suspension without 
dimers (data not shown). A shift in retention times was observed with HPLC-qTOF-MS 
(Figure 7A) compared to the HPLC-UV-ECD profiles (Figure 4). Based on the retention 
times and masses analyzed for the standards, the peak at 10.0 min was identified as 3-HPP. 
Based on the relative elution order of the phenolic acids, (epi)catechin and dimers, the peak 
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at t=8.3 min most probably was metabolite VI. The average mass spectrum recorded for 
metabolite VI consisted of three m/z values namely 207, 305 and 415 (Figure 7B). The [M-
H]- 207 pointed to 5-(3,4-dihydroxyphenyl)-γ-valerolactone (3,4-diHPVal), which has a 
mass of 208 Da and has been detected previously as a metabolite of catechin and 
epicatechin (13, 17-20). The elemental composition, calculated by Masslynx software, 
supported this hypothesis. The m/z 415 corresponded to 208 plus 207, which is most likely 
an adduct of 207, and annotated as [2M-H]-. Similar adducts were observed for most of the 
phenolic acid standards, including 3-HPP (Figure 7B). The adduct m/z 305 [M+H3PO4-H]-, 
showed a product ion of m/z 97 when analyzed with MS/MS and arises through the 
interference of phosphate originating from the samples. The MS/MS spectrum of m/z 207 
analyzed with triple Quad MS contained m/z 163 as the main product ion, which is typical 
for 3,4-diHPVal (17, 20). Therefore, metabolite VI was annotated as 3,4-diHPVal and its 
presence was confirmed at all time points except at t=0 h (Figure 8). No 3,4-diHPVal was 
detected in the control samples.  
 
Identification of precursors of 5-(3,4-dihydroxyphenyl)-γ-
valerolactone and other metabolites  
 
Precursors 
3,4-diHPVal has been described to be preceded by the formation of 1-(3’,4’-
dihydroxyphenyl)-3-(2”,4”,6”-trihydroxyphenyl)propan-2-ol (3,4-diHPP-2-ol) (Mw 292) 
by reductive cleavage of the (epi)catechin C-ring (19, 20). HPLC-MS/MS of the samples 
taken at 0 - 8 h of the active suspension, incubated with and without dimers, were analyzed 
for the presence of these metabolites (m/z 291) (Figure 8). The monomeric units 
(epi)catechin (m/z 289 [M-H]-) were confirmed to be present between 0 to 2 h of 
fermentation (also based on RT of standards). As mentioned earlier, this was attributed to 
the extraction procedure. Furthermore, m/z 291 [M-H]- (3,4-diHPP-2-ol) was present after 1 
and 2 h, but absent after 6 h. 
 
Other metabolites 
Analysis with HPLC-qTOF indicated the presence of several metabolites other than 3,4-
diHPVal (Figure 7A). At RT 11.4, 12.2 and 15.3 m/z values of 209, 191 and 193, 
respectively were identified. The elemental composition of these compounds was calculated 
by Masslynx software to represent mono- and dihydroxylated phenylvaleric acids (m/z 209 
and 193) and monohydroxylated phenylvalerolactone (m/z 191). Results of daughter scans 
of these and other selected parent ions are given in Figure 8.  
No masses corresponding to a dimer that underwent reductive cleavage in one or 
both of the C-rings of the monomeric units (m/z 579 and 581 [M-H]-) were detected. Based 
on qTOF data 3,4-diHPVal seemed to be dehydroxylated into 5-(3 or 4-hydroxyphenyl)-γ-
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valerolactone (3 or 4-HPVal, m/z 191 [M-H]-) (Figure 7), which was confirmed by MS/MS 
analysis (Figure 8).No 5-phenyl-γ-valerolactone (PVal) (m/z 175 [M-H]-) was detected. 
Both monohydroxylated phenylvaleric acid (3 or 4-HPV) and dihydroxylated phenylvaleric 
acid (3,4-diHPV) were present after 6 h of fermentation. None of the selected parent ions 
were detected in the active suspension without dimers. Other potential metabolites, 
phloroglucinol (m/z 125), a flavan-3-ol with a phloroglucinol substituent (m/z 414), 3,4-
diHPP-2-ol with a phloroglucinol substituent (m/z 416), a flavan-3-ol with a carboxylated 
phloroglucinol substituent (m/z 475), a monohydroxylated HPP-2-ol (m/z 275) and a mono 
or dimethylated valerolactone (m/z 221 and 235) were not present in any sample. 
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Figure 7. HPLC-qTOF analysis after 0 and 6 h of fermentation of the dimer mixture. The TIC of 
t=0 and t=6 h are compared (A) and spectra of metabolite VI (RT=8.3 min) and 3-HPP (RT=10 
min) are given (B). 
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Figure 8. Several metabolites were detected with HPLC-MS/MS in the negative mode. Daughter 
scans of the parent masses ([M-H]-) of each metabolite were collected. Data of the fermented 
dimer mixture (only B-types) with a 5% (w/v) microbial suspension for 8 h were compared with 
the control samples. Samples that were not analyzed are indicated with -. Yes and no indicates 
the presence or absence of the metabolite.  
 
 
Discussion 
 
 
The four quantified ethyl acetate soluble metabolites, 3,4-diHPA, 3-HPA, 4-HPA, and 3-
HPP, accounted for 1.2 µmol originating from 5 µmol B-type PC dimers       (Figure 5). 
Additional metabolites found were various hydroxylated phenylvaleric acids and 
phenylvalerolactones, and 3,4-diHPP-2-ol. However, these could not be quantified because 
of the lack of standards. The metabolite 3,4-diHPA has not been detected as a human 
metabolite in studies performed with pure catechin (21, 38). Therefore, a direct release of 
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3,4-diHPA from PC dimers is suggested, without preceding conversion of PCs into 
monomers.  
 
Quantification of reaction products 
PC dimers (B-type) were converted into smaller molecules without preference for a specific 
dimer (Figure 3B) as they all decreased within the same time scale. It was estimated that 
the metabolites found after 6 h accounted for at least 12 mole % conversion, assuming that 
1 mole of dimer is converted to 2 moles of metabolites. In vitro fermentation of PA 
oligomers performed by Deprez and coworkers (28) resulted in only 2.7 % ethyl acetate 
soluble products, based on radioactive labeling. This difference might indicate that the 
dimers are easier accessible for microbiota than higher oligomers. A high protein affinity of 
the oligomers might have contributed to low accessibility or antimicrobial effects. 
 
Identified metabolites compared to literature 
The most abundant human metabolite of PC dimers was 3,4-diHPA. In rats the urinary 
excretion of this metabolite also increased after the intake of PC dimer B3 (15). An in vitro 
fermentation of PA oligomers with human microbiota did not result in this metabolite (28). 
Also ingestion of PC rich grape seed tablets did not result in increased urinary excretions of 
3,4-diHPA in humans (24), in contrast to ingestion of PC rich chocolate where 3,4-diHPA 
was observed in urine of healthy human subjects (16). This variation in metabolism could 
have resulted from differences in composition (degree of galloylation and/or degree of 
polymerization) of the oligomers or extracts used. Furthermore, an in vitro fermentation 
with tea extracts rich in monomeric flavan-3-ols resulted in the formation of 3,4-diHPA 
(33). However, quercetin, which is also present in tea (41), is also known to be degraded 
into 3,4-diHPA (36, 42) and therefore it remains unclear where 3,4-diHPA, after 
fermentation of the tea samples, originate from. Studies performed with pure catechin and 
human microbiota (21, 38) did not result in 3,4-diHPA.  
The formation of 3-HPP as a main metabolite is consistent with previous studies 
(23, 28). The high amount of 3-HPA in comparison to 4-HPA suggests that 3,4-diHPA is 
preferably dehydroxylated at the para position. A preference to dehydroxylate the para 
position of several flavonoids has been described previously for human microbiota (36, 38, 
43). Therefore, the monohydroxylated phenylvalerolactone that was detected (Figure 8) is 
suggested to be 3-HPVal, formed out of 3,4-diHPVal, through dehydroxylation at the para 
position. 
 
Tentative degradation pathway  
An important question is whether cleavage of the interflavan bond of dimeric PCs into 
monomeric flavan-3-ols is the first step in their metabolism. The detection of 3,4-diHPP-2-
ol within 2 h suggests that dimers are cleaved into their monomeric units. However, no 
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additional catechin or epicatechin other than that formed during extraction was detected. It 
might be argued that a slow conversion of dimers into flavan-3-ols followed by a rapid 
conversion into 3,4-diHPP-2-ol, phenylvalerolactones and phenolic acids explains that the 
flavan-3-ol intermediates are not detected. Indeed, Aura and coworkers (38) found that 
monomeric flavan-3-ols are rapidly metabolized; 1 µmol monomeric flavan-3-ols was 
completely fermented within 2 h by a 10 mL 5% fecal suspension within the same 
fermentation system. To our knowledge monomeric flavan-3-ols have never been detected 
as microbial metabolites of PCs in humans. Their absence (indicated by us and others) and 
our finding of 3,4-diHPA (not found as a common human metabolite in studies performed 
with pure monomeric flavan-3-ols (21, 38) as the main metabolite does not hint at 
conversion of dimers into monomeric flavan-3-ols as the main degradation route as 
previously suggested (26). An alternative route could be that the interflavan bond is split 
after reductive cleavage of one (Mw 580) or both C-rings (Mw 582) of the dimer resulting 
in the release of 3,4-diHPP-2-ol. However, this route also seems unlikely as m/z 579 and 
581 (Figure 8) were not detected.  
Figure 9 shows a tentative degradation pathway for PC dimers (B-type). The 
formation of both phenolic acids and phenylvalerolactones suggests that cleavage of the C- 
and A-ring occurs at the points indicated in Figure 9. The C-ring cleavage has previously 
been shown to be an important mechanism for human microbial degradation of several 
flavonoids (44). Our data (Figure 8) imply that phenylvalerolactones are slowly degraded 
into phenylvaleric acids, which were only detected after 6 h of fermentation while 3,4-
diHPVal was already present after 2 h. The amount of phenylvaleric acid produced varies 
between species (45). It is not often detected in high amounts as metabolite of monomeric 
flavan-3-ols or PCs, while 3-HPP is often detected as a main metabolite (24, 28). Therefore, 
phenylvaleric acids seem to be rapidly converted into 3-HPP, which was present in high 
amounts. This fits with the results obtained by Meselhy and coworkers (19), who obtained 
phenylvaleric and phenylpropionic acids after fermentation of phenylvalerolactones with 
human microbiota. Previously, rat microbiota were shown to cleave (+)-[ring A - 
14C]catechin through the A-ring to form phenylvalerolactone and CO2. The valerolactone 
was again further metabolized into 3-HPP (22, 46). Detection of phenylvalerolactones after 
fermenting PC dimers shows that human microbiota are also capable to cleave the A-ring. 
 
Human microbiota convert PC dimers into a number of smaller metabolites. Our 
findings suggest a direct degradation of dimers as depicted in Figure 9 instead of cleavage 
into flavan-3-ols first. The health potential of these metabolites should be studied as the 
original PAs are only present in plasma in low amounts. 
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Figure 9. Tentative pathway for human microbial degradation of PC dimers (B-type). The 
preferred route is indicated with         and metabolites derived from the upper and lower unit are 
grouped within rectangles. 
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Some phenolic compounds enhance nitric 
oxide production in endothelial cells in vitro 
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Abstract 
 
 
The blood pressure lowering and vasorelaxing properties of chocolate and wine, might 
relate to the presence of phenolic compounds. One of the mechanisms involved might be 
stimulation of nitric oxide (NO) production by endothelial cells, as NO is a major regulator 
of vasodilatation. This study aimed to develop an in vitro assay based on the hybrid human 
endothelial cell line EA.hy926, to rapidly screen phenolic compounds for their NO 
stimulating potential. The assay was optimized, and a selection of 33 phenolics, viz. 
procyanidins, monomeric flavan-3-ols, flavonols, a flavone, a flavanon, a chalcone, a 
stilbene, and various phenolic acids were tested for their ability to enhance endothelial NO 
production. Of the 33 polyphenols tested, only resveratrol (285% increase in NO 
production), quercetin (110% increase), epicatechingallate (ECg) (85% increase), and  
epigallocatechingallate (EGCg) (60% increase) were significant (P ≤ 0.05) enhancers. 
Several phenolics, e.g. procyanidins, showed a non-significant tendency to elevate the NO 
production. Concentration dependent correlations between enhanced NO production and 
eNOS expression were demonstrated for the three polyphenols tested (resveratrol, ECg and 
EGCg). Thus, an easy screening tool for cellular NO production was developed. Using this 
assay we showed that only a limited number of phenolic compounds might enhance NO 
production with an increased amount of eNOS enzyme as a possible contributing 
mechanism.  
 
 
Key words: nitric oxide, polyphenols, vasodilatation, cardiovascular diseases, EA.hy926 
cells 
 
 
 
 
 
 
 
 
 
Abbreviations used: DP, degree of polymerization; ECg, epicatechingallate; EGC, 
epigallocatechin; EGCg, epigallocatechingallate; eNOS, endothelial nitric oxide synthase; FBS, 
fetal bovine serum; H2O2, hydrogen peroxide; HUVEC, human umbilical vein endothelial cells; 
L-NAME, Nω-nitro-L-arginine methyl ester hydrochloride; NO, nitric oxide; SOD, superoxide 
dismutase  
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Introduction 
 
 
Compromised endothelial function plays an important role in the growing occurrence of 
age- and obesity-related cardiovascular diseases (1). Healthy vasculature regulates blood 
pressure and blood distribution to different tissues via vasodilatation and vasoconstriction. 
Nitric oxide (NO) is one of the main mediators of vasodilatation. In mammalians, 
endothelial NO is produced by the enzyme endothelial nitric oxide synthase (eNOS), which 
converts L-arginine in the presence of O2 and NADPH into L-citruline and NO (2). A 
decreased NO level plays a central role in endothelial dysfunction (1). 
Several studies showed that products rich in phenolics, like red wine and cocoa, 
favorably affect endothelial function (3, 4). Taubert (5) reviewed intervention studies with 
cocoa products, which consistently showed reductions in blood pressure. Furthermore, 
cocoa drinks rich in flavan-3-ols improved the flow-mediated dilation, a measure of 
endothelial function, in human subjects. This coincided with an increase of NO in plasma 
(6). All together, these studies suggest that phenolic compounds could play a beneficial role 
in endothelial function.  
Cocoa and wine contain a multitude of phenolic compounds and it would be 
impossible to test all candidates in intervention studies. Therefore, several in vitro and ex 
vivo systems have been developed to screen the vasoactive potency of compounds. Most 
systems involve isolated arteries and aortas to study vasorelaxing properties (7-11) and 
relaxation of porcine coronary arteries was shown to correlate strongly with NO levels (9). 
The use of fresh tissue to screen many compounds would require a lot of animals. Cultured 
human umbilical vein endothelial cells (HUVEC) could provide a simpler alternative to 
screen for vasoactive compounds. However, HUVECs have to be freshly isolated and lose 
their ability to produce NO already after a limited number of passages (12). Edgell (13) 
developed the hybrid cell line EA.hy926 by fusing HUVEC cells with the permanent cell 
line A549. This hybrid cell line stably produces NO, even after a large number of cell 
divisions, and thus may be used as an efficient screening tool. EA.hy926 cells have been 
used before by Wallerath and coworkers (14) to measure eNOS expression after exposure to 
only a limited number of phenolic compounds without measuring NO production (14) 
except for resveratrol (15). 
Because NO is directly linked to endothelial function we used it as a parameter to 
measure the vasorelaxing potential of polyphenols. Knowledge on the ability of individual 
polyphenols to increase NO production is limited. Therefore, we used EA.hy926 cells to 
screen 33 phenolic compounds for their potential to stimulate NO production. Phenolic 
compounds, known to be present in chocolate and wine, were tested for their vasoactive 
potential including (epi)catechin and proanthocyanidins. Furthermore, microbial 
metabolites of proanthocyanidins and other flavonoids, phenolic acids (16, 17), were tested 
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as the bioavailability of proanthocyanidins is limited. The selection was extended with a 
number of monomeric flavan-3-ols, flavonols, flavones, flavanones and one chalcone.  
 
 
Materials and Methods 
 
 
Materials 
All organic solvents used for HPLC analysis were of HPLC grade. Phenolic compounds 
were obtained as indicated; hippuric acid (Alldrich), 4-hydroxyhippuric acid (Bracher), 2-
hydroxy hippuric acid (kindly provided by P. Kroon, IFR, Norwich), 4-
hydroxyphenylpropionic acid, phenylpropionic acid, 3-hydroxyphenylacetic acid, 3,4-
dihydroxyphenylacetic acid, vanillic acid, p-coumaric acid, caffeic acid, benzoic acid, 
kaempferol (Fluka), 3-hydroxyphenylpropionic acid, 3,4-dihydroxyphenylpropionic acid, 
procyanidin dimers B1 till B4 (Apin chemicals), phloretin (Extrasynthèse). All other 
phenolics were obtained from Sigma. Mixtures composed of procyanidin dimers or 
tetramers were isolated from both peanut skin (kindly provided by Imko-The Nut Company 
BV, Doetinchem, The Netherlands) as well as a commercially available grape seed extract 
(Vitaflavan DRT, Levita Chemical International NV, Belgium, Antwerpen) as described in 
Chapters 2 and 3. Vitaflavan, mainly composed of B-type dimers, trimers and tetramers 
with gallic acid side chains, will be further referred to as B-type DP2-4+ gallic acid (DP = 
degree of polymerization). Chemicals and enzymes used were obtained from Sigma unless 
stated otherwise. Epicatechinglucuronide was prepared as described by Vaidyanathan and 
co-workers (18), subsequently purified with HPLC and freeze dried. 
 
Cell culture 
EA.hy926 cells, kindly provided by Dr. Edgell, were cultured according to their instructions 
(13). In short, cells were grown in DMEM (Gibco) containing 10% Fetal Bovine Serum 
(FBS) (Gibco), 25 mM HEPES and 2% penicilline/streptomycine. Cells were seeded in a 
24-well plate at a density of 1.75 x 10e5 cells/well and incubated at 37 °C and 5% CO2 
(CO2 medical, Hoek-Loos, the Netherlands). After 24 h the cells were confluent and after 
48 h they were used to screen for potential bioactive phenolic compounds.  
The CO2 was purified with a sulfur trap (Valco Instruments Company Inc, 
Switzerland) to remove NO traces before it entered the incubator. Water in the reservoir of 
the incubator was refreshed before every experiment. Without this refreshment, NO 
accumulated from 0 nM to 17000 nM in a couple of weeks.  
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In vitro assay for NO production 
 
Exposure conditions 
Differences between inner and outer wells of 24-well plates can amount to 1000 nM NO 
due to contamination with NO from ambient air. Therefore, only the 8 inner wells were 
used to screen the phenolic compounds. The outer wells contained 1 mL water each to trap 
NO. Phenolic compounds were dissolved in DMSO (100 mM) and diluted in DMEM 
containing 25 mM HEPES, 150 U/mL SOD and 300 U/mL catalase, to a final concentration 
of 0.1% DMSO. Cells were exposed to 300 µL cell culture media, containing the phenolic 
compound (100 µM), for 24 h whereafter supernatant was removed and stored at -80 °C to 
measure the stability of the phenolic compounds. Subsequently, fresh cell culture medium 
(300 µL) containing calcium ionophore A23187 (5 µM) was added to the cells to increase 
the sensitivity of the assay (19) (addition of 5 µM A23187 for 1 h significantly increased 
the NO production 6 fold by cells exposed to 100 µM resveratrol for 24 h). After 1 h of 
incubation with A23187, medium was removed and stored in tightly closed cryovials 
(Simport Plastics Ltd., Beloeil, Canada) at -80 °C until NO measurement. Each exposure 
was tested in triplicate (3 wells) and repeated on at least 3 different days. Thus, each 
exposure generated 3 x 3 = 9 values. In each series, 100 µM resveratrol was taken as a 
positive control (average SD of 34 nM NO between the 3 wells). A control was included 
composed of 0.1% DMSO in DMEM and identically treated as the samples, (average SD of 
18 nM NO between the 3 wells). Measurements were corrected for NO produced by cells 
exposed to only DMEM.  As a negative control, cells were exposed for 24 h to resveratrol 
as described above and subsequently incubated with fresh culture medium containing 
calcium ionophore and the eNOS inhibitor Nω-nitro-L-arginine methyl ester hydrochloride 
(L-NAME) (10 µM). 
 
NOx-measurement 
NOx-analysis was performed as described by Feelisch and coworkers (20) with a few 
alterations. In short, a water-jacketed reaction vessel, kept at 60 ºC, was filled with 20 mL 
freshly prepared Browns solution. Browns solution, stored in the dark on ice until use, was 
made as follows: 45 mM KI and 10 mM I2 in milli-Q water (shake 5 min at 250 rpm) was 
subsequently mixed with glacial acetic acid (1: 121/3) followed by ultrasonic treatment for 5 
min. Samples were injected into the reaction vessel in triplicate (50 µL) through a septum 
that was replaced after each series of measurements. Inside the reaction vessel Browns 
solution reduced NOx (NO2, NO2-, and nitrosated and nitrosylated species) to NO (g). NO 
(g) was transported by helium through a condenser (3 ºC) followed by a 1 M NaOH 
solution, which was kept on ice, to remove traces of acids. Subsequently, the NO (g) passed 
a 0.22 µm filter before it entered a chemiluminiscence detector (CLD 88 et., Eco Physics, 
Duernten, Switzerland). The detection range was set at 0-50 ppb. The whole system was 
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kept at a constant overpressure of 1-1.05 bar throughout the measurements. Browns 
solution was refreshed when peak broadening appeared or large bubbles were generated in 
the reaction vessel. Calibration curves were made with potassium nitrite (0-1000 nM) 
dissolved in a physiologic saline solution (0.9% (w/v) NaCl) (R2> 0.99). 
To prevent NOx-contamination, tubes and equipment that were used were carefully 
screened and exposure of samples to air was minimized. NOx measurements were only 
performed when air NOx concentrations (expressed as NO2) in the Wageningen region were 
below 40 µg/m3 (measured by the Dutch National Institute for Public Health and the 
Environment, (21)) . A plasma sample, which was stored in small batches at -80 °C, was 
used to determine the reproducibility of the NO measurements. This control sample had an 
average NO content of 145 nM (14 measurements of duplicates). The CV was calculated to 
be 6.9% within days (14 duplicates) and 12.4% between days (n=14). Results of a series of 
analysis were rejected when the value obtained in this control sample exceeded ± 2 x 
SDbetween from the average level.  
 
Expression of results 
The mean increase in NO production caused by a compound was calculated as the 
difference between the mean of the sample values of at least 3 exposures (≥ 9 values) and 
the mean of the DMSO blank values measured within the same exposures, and expressed as 
a percentage of the DMSO blank.  
 
HPLC analysis to measure stability of the phenolic compounds 
during exposure conditions  
The cell culture media, which were collected after 24 h, were filtered through a 0.45 µm 
filter and analyzed on HPLC. For the procyanidin fractions a Thermo Spectra system was 
used containing a P 4000 pump, an AS 300 autosampler and an UV 3000 detector (Thermo 
Separation products). Analysis was performed on an XterraRP dC18, 4.6 mm ID x 150 mm, 
3.5 m column (Waters) at room temperature. The mobile phase was composed of (A) 
water + 0.1% (v/v) acetic acid and (B) acetonitrile + 0.1% (v/v) acetic acid. The flow rate 
was 0.7 mL/min and detection was performed at 280 nm. For the fractions isolated from 
peanut skin the elution profile was as follows; the first 5 min isocratic on 10% B; 5-35 min, 
B: linearly 10%-30%; 35-40 min, B: linearly 30%- 90% followed by reconditioning of the 
column. Another elution profile was used to analyze the fractions isolated from grape seeds; 
15 min isocratic on 10% B; 15-35 min, B: linearly 10%-50%; 35-40 min, B: linearly 50%- 
95% followed by reconditioning of the column. For each sample 20 µL was injected.  
Phenolic acids were analyzed on a system composed of L-6200 and L-6000A 
pumps (Hitachi), a 234 autoinjector (Gilson), a Kratos Spectroflow 783 UV detector 
(Kratos Analytical Instruments) and a Spark Mistral column oven set at 30 °C (Separations 
Analytical Instruments B.V). Analysis was performed on an XBridge C18, 3.0 mm ID x 
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250 mm, 5 m column (Waters). The mobile phase was composed of (A) 2% (v/v) 
acetonitrile and (B) 40% (v/v) acetonitrile in sodium phosphate buffer (0.01 M, pH 1.5). 
The flow rate was 0.42 mL/min and detection was performed at 220 nm. The elution profile 
was as follows; 0-20 min, B: linearly 3%-100%; 20-24 min, isocratic on 100% B; 24-25 
min, B: linearly 100%- 3% followed by reconditioning of the column. For each sample 10 
µL was injected.  
Epicatechin, catechin, ECg, epigallocatechin (EGC) and EGCg were analyzed on a 
Hitachi system composed of L-2100 pumps, a L-2200 autoinjector a CoulArray detector 
(ESA, Inc., Chelmsford, MA) and a Spark Mistral column oven set at 30 °C. Analysis was 
performed on an Inertsil ODS-3, 4.6 mm ID x 150 mm, 5 m column (GL Sciences). The 
mobile phase was composed of (A) 10% (v/v) acetonitrile in sodium phosphate buffer (25 
mM, pH 2.4) and (B) 30% (v/v) acetonitrile in sodium phosphate buffer (25 mM, pH 2.4). 
The flow rate was 1 mL/min and detection was performed at -70, -10, 70 and 150 mV. The 
elution profile was as follows; 0-20 min, B: linearly 0%-80%; 20-23 min, B: linearly 80%-
100%; 23-25 min, isocratic on 100% B; 25-26 min, B: linearly 100%- 0% followed by 
reconditioning of the column. For each sample 10 µL was injected. Resveratrol was 
analyzed with the same conditions except detection was performed with UV detection. 
Apigenin, naringenin, quercetin, kaempferol and phloretin were analyzed on the same 
system as described for phenolic acids and an inertsil-ODS3 column as described for the 
flavan-3-ols. An isocratic elution was performed with 31% (v/v) acetonitrile in sodium 
phosphate buffer (25 mM, pH 2.4). Recoveries were calculated based on peak areas 
compared to the original DMSO stocks that were diluted with water instead of medium. 
 
Assessment of eNOS expression by quantitative real time PCR 
analysis 
Total RNA from EA.hy926 cells, exposed 24 h to resveratrol, EGCg or ECg (0 to 200 µM) 
with or without 10 µM L-NAME, was isolated to asses eNOS expression levels by 
quantitative RT-PCR (∆∆ CT method) (22). All exposures were performed in triplicate on 3 
different days and for each condition cells from 4 wells were pooled.  After an exposure of 
24 h, as described above, the medium was removed and the cells were washed with 1 mL 
ice-cold PBS. Subsequently, the cells were incubated for 15 min in 0.5 mL TRIzol 
(Invitrogen), resuspended, pooled and stored at -80 °C. After thawing, RNA was extracted 
with 1.2 mL chloroform and precipitated with 1.2 mL isopropanol according Invitrogen’s 
instruction. RNA quality and quantity was verified on a Bio-Rad Experion and Nanodrop 
spectrophotometer (Nanodrop technologies) and accepted when OD260/280 >1.8.  
For each sample, cDNA was synthesized (iScript cDNA Synthesis kit, Bio-Rad) 
and eNOS expression levels were assessed in triplicate on a MyIQ5 single color real time 
cycler (Bio-Rad) using iQ SYBR-Green Super mix (Bio-Rad) and eNOS specific primers 
(see Table 1). Quantitative RT-PCR data were analyzed with iQ5 optical system software 
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(version 2), normalized to ribosomal protein L32 and -actin reference genes and results 
were accepted when the standard curve (of all analyzed genes), of serial dilutions from 
pooled cDNA samples, showed good efficiencies and linear amplification (R2 >0.99). 
 
Table 1. Primers used for quantitative RT-PCR. 
gene 
symbol sequence ID forward primer (5’-3’) reverse primer (5’-3’) 
product 
length 
(bp) 
eNOS NM_000603   GAGACTTCCGAATCTGGAACAG GCTCGGTGATCTCCACGTT 102 
RP L32 NM_000994.3 GCTGGAAGTGCTGCTGATGTG CGATGGCTTTGCGGTTCTTGG 83 
-actin NM_001101.2 CCACCCCACTTCTCTCTAAGGAG GCATTACATAATTTACACGAAAGCAATG 94 
 
Statistical analysis 
The Cochran’s test (ISO 5725-2, 1994) was used to determine if the highest within-day 
variation that was measured for each phenolic compound on at least 3 different days could 
be considered as an outlier. If the test statistic exceeded the 5% critical value, the 
measurement was excluded from further statistical analyses. The ability of each phenolic to 
significantly enhance NO production or eNOS expression compared to the DMSO controls 
that were measured on the same days was tested by Student’s t-Test. A probability < 0.05 
was considered significant. Error bars are depicted as mean ±SEM of at least 3 exposures. 
To determine if enhanced NO production correlated with eNOS fold changes, the NO 
production was expressed as the concentration of NO detected in exposed cells (0-100 µM 
phenolic compound) divided by the concentration of NO detected in non-exposed cells 
(0.1% DMSO).  
 
 
Results 
 
 
Vasoactive potency of a large set of phenolic compounds 
 
In total 33 phenolic compounds were tested for their ability to stimulate NO production 
(Figure 1). Resveratrol had the largest significant effect (285% increase in NO production), 
followed by quercetin (110% increase), ECg (85% increase), and EGCg (60% increase). A 
number of other phenolic compounds also seemed to enhance NO production, although this 
did not reach statistical significance. As opposed to their galloylated forms, epicatechin and 
catechin did not enhance NO production. Like epicatechin, epicatechin-glucuronide, a 
human metabolite of epicatechin, did not enhance NO production either. Procyanidins 
showed a tendency to increase NO production, which seemed to be related to their degree 
of polymerization. However, a selection of their colonic metabolites, phenolic acids, had no 
effects.  
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Figure 1. Average increase in NO production as a percentage of the DMSO control after 
exposing EA.hy926 cells to 100 μM of flavonoids (A) or phenolic acids (B)  for 24 h. Trans-
resveratrol served as a positive control. Data represent mean ± SEM of 3 or more independent 
exposure experiments. Significant differences were calculated with a Students t-test by 
comparing the NO concentrations (nM) after exposure to a phenolic compound with the NO 
concentrations after exposure to the control (0.1% DMSO) measured on the same days. 
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After exposure to 100 µM resveratrol the addition of L-NAME, a competitive inhibitor of 
eNOS, decreased NO production (Figure 1). Similar results were obtained for epicatechin, 
ECg and EGCg (data not shown). 
 
Dose dependant increase in both NOx production and eNOS 
expression  
Exposure of EA.hy926 cells to resveratrol, EGCg, and ECg resulted in a significant dose 
dependant increase in NO production (Figure 2). For resveratrol and EGCg, production of 
eNOS mRNA was significantly enhanced and paralleled NO production. The increase in 
eNOS mRNA level after exposure to ECg did not reach statistical significance (Figure 2C). 
NO production expressed as the ratio between exposed (0-100 µM, phenolic compound) 
and non-exposed (0.1% DMSO) cells, correlated linearly in a dose-dependent manner with 
the changes in eNOS mRNA expression levels. Addition of L-NAME did not affect eNOS 
expression but only inhibited NO production (Figure 3). Epicatechin (100 µM) did not 
elevate eNOS mRNA levels (data not shown), consistent with its failure to increase NO 
production (Figure 1). 
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Figure 2. Dose-dependant increase in NO production (●) and eNOS expression (x) after 
exposing EA.hy926 cells for 24 h to A) trans-resveratrol, B) EGCg, and C) ECg. Each exposure 
consisted of 3 triplicates repeated on at least 3 different days. Error bars represent ± SEM and 
significant differences are indicated by ○ for NO production and * for eNOS expression (P< 0.05) 
analyzed by Student’s t-Test. 
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Figure 3. The effect on NO production (A) and eNOS expression (B) of exposing L-NAME 
together with trans-resveratrol to EA.hy926 cells for 24 h. Error bars represent ± SEM of n ≥ 14 
for NO measurements and n=3 for expression data. Significant differences compared to the 
exposure without trans-resveratrol was calculated with Student’s t-test (P < 0.05) and indicated 
by an asterisk.  
 
Stability of the phenolic compounds 
The presence of the originally added phenolic compounds (Table 2) in the medium  was 
analyzed after 24 h by HPLC. Addition of HEPES, to stabilize the pH, and the enzymes 
SOD and catalase, to prevent oxidative reactions, improved the stability of compounds like 
3,4-dihydroxyphenylpropionic acid, ECg and EGCg. These additions did not affect NO 
production in the DMSO control sample and were included in the protocol. All phenolic 
acids showed good recoveries (> 80%) with the exception of 3,4-dihydroxyphenylpropionic 
acid (69%) and caffeic acid (56%). Catechin and epicatechin had recoveries of about 50%. 
Epicatechin was partly epimerized (~25%) towards catechin. Catechin did not epimerize. 
EGC, ECg, EGCg, all procyanidins (grape DP2-4, A- and B-type dimers/tetramers and the 
dimers B1 till B4), quercetin and kaempferol showed low recoveries (< 50%). The low 
recoveries obtained for procyanidins might be caused by their complexation with proteins 
and peptides from the medium (23). Therefore, both A- and B-type tetramers were tested in 
medium with and without FBS. Although recoveries of 27-40% were obtained after 24 h of 
exposure in the presence of FBS (Table 2), the stability of both A- and B-type tetramers 
decreased dramatically in the absence of FBS with recoveries of only 5% and 18% 
respectively, already shortly after exposure.  
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Table 2. Recovery of the phenolic compounds after 24 h of incubation with EA.hy926 cells in the 
culture medium. Effects of the addition of HEPES, SOD and catalase were tested (A=without, B= 
with). Measurements are n=1, unless indicated otherwise.  
 
phenolic compound
A B
trans -resveratrol - 79
3,4-dihydroxyphenyl propionic acid 13 69
4-hydroxyphenyl propionic acid 91 92
3-hydroxyphenyl propionic acid 101 116
phenyl propionic acid - -
4-hydroxyhippuric acid 98 95
2-hydroxyhippuric acid 90 87
hippuric acid 103 106
p -coumaric acid 87 84
caffeic acid 31 56
vanillic acid 103 129
gallic acid - -
benzoic acid - -
procyanidin B1 - 22
procyanidin B2 - 30
procyanidin B3 - 15
procyanidin B4 - 9
procyanidin B-type DP2-4 + gallic acid - 46b
procyanidin B-type DP2-4 - 39b
procyanidin B-type DP2 - 36b
procyanidin A-type DP2 - 41b
procyanidin B-type DP4 - 40
procyanidin A-type DP4 - 27b
epigallocatechingallate 0 12a
epigallocatechin 0 -
epicatechingallate 23 43a
catechin - 51
epicatechin 68 48
quercetin - 12b
kaempferol - 41b
apigenin - 52b
naringenin - 66b
phloretin - 32
% recovery 
 
- = not analyzed 
a n=3 
b n=2   
 
 
Discussion  
 
 
The in vitro assay developed offers a simple tool to screen phenolic compounds for their 
ability to increase NO production. Out of 33 phenolic compounds tested at a level of 100 
µM, only resveratrol, quercetin, EGCg and ECg significantly enhanced NO production. 
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Dose dependent correlations between NO stimulation and eNOS upregulation were found 
for all three polyphenols tested, resveratrol, EGCg and ECg, suggesting that stimulation of 
eNOS expression contributes to the increased NO production.  
 
Vasoactive potential within several phenolic classes  
Representatives of different structural classes of phenolics were tested: procyanidins, 
monomeric flavan-3-ols, flavonols, a flavone, a flavanon, a stilbene, a chalcone and 
phenolic acids. Resveratrol, a stilbene, had by far the highest activity, which fits with the 
results of Wallerath who showed a comparable enhancement in both NO production (15) 
and eNOS expression (14, 15) in EA.hy926 cells (1-100 µM). Of the flavonols, only 
quercetin significantly enhanced NO production, whereas kaempferol was inactive. 
Possibly, multiple hydroxyl groups at the B-ring are favorable as suggested by Taubert (9). 
However, our data on the monomeric flavan-3-ols do not support this hypothesis. Like 
catechin and epicatechin, the more hydroxylated EGC did not stimulate NO production, as 
would be expected based on that hypothesis. Conflicting results have been reported for 
epicatechin, which was classified as weak/nonactive in several studies with porcine 
coronary arteries (9, 24) or rat aorta (25, 26). However, in humans epicatechin induced flow 
mediated vasodilatation. ECg and EGCg were the only monomeric flavan-3-ols that 
significantly stimulated NO production in our assay. EGCg has been classified as a potent 
vasoactive compound in various systems such as bovine aortic endothelial cells and rat 
vasculature (27, 28). The galloyl moiety seemed critical for the activity of ECg and EGCg, 
because epicatechin and EGC, lacking this moiety, had no activity. Gallic acid itself was not 
active at all, which is in accordance with other studies performed with EA.hy926 cells (14) 
and arteries (9, 25).  
Effects of isolated proanthocyanidins on NO production have never been studied 
before. Except for dimers, procyanidins with a higher degree of polymerization showed a 
tendency to increase NO production, but no significance was reached. A range of monomers 
up to decamers were tested with rabbit aorta and similarly only tetramers and higher 
oligomers caused relaxation (8). The interflavanic linkage between the flavan-3-ol units (A 
or B-type) seemed to have no effect in our study in contrast to previous observations where 
only A-type dimers and trimers  showed significant relaxation of rabbit aorta rings (8, 29).  
Because procyanidins are very poorly absorbed, the vasodilating properties of their 
colonic metabolites, phenolics acids, are of interest. However, these phenolics did not 
enhance NO production. Wallerath (14) showed that some phenolic acids like benzoic acid, 
vanillic acid, p-coumaric acid and caffeic acid increased eNOS mRNA production. 
However, no data on NO production were presented. The same phenolic acids (up to 2 mM) 
were not able to cause relaxation of rat aortas (25). 
In our study apigenin, naringenin and phloretin, representing a flavone, flavanon 
and a chalcone, respectively, did not enhance the NO production. In porcine arteries, 
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conflicting effects for apigenin  were reported (9, 24). In agreement with our results, 
naringenin (12-100 µM) was not able to enhance NO production and eNOS expression in 
HUVEC cells (30). However, results on porcine arteries are conflicting, because naringenin 
has been classified as a moderate (24) as well as a weak/nonactive (9) vasoactive 
compound. Phloretin has shown moderate relaxation in porcine coronary arteries (30-100 
µM) (24) but to our knowledge nothing is known about its ability to affect NO production. 
 
Correlation between NO production and eNOS expression 
The dose dependent correlations between NO production and eNOS expression as found for 
resveratrol, ECg and EGCg, suggested that NO production was enhanced via a larger 
amount of eNOS enzyme. This was also observed by Wallerath and coworkers (15) 
EA.hy926 cells exposed to up to 100 µM resveratrol, and in addition, the amount of eNOS 
protein increased. 
 
Stability of the phenolic compounds  
Many phenolic compounds are unstable at the pH usually required in the test systems used. 
Until now, stability has not been taken into account. In this study it was shown that several 
phenolic compounds were unstable during the 24 h of incubation. To prevent oxidation of 
phenolic compounds by superoxide and hydrogen peroxide (H2O2) released by 
autoxidation, the enzymes SOD and catalase were added. In addition, H2O2 can either 
increase eNOS activity (31) or decrease NO bioactivity (32). Generation of H2O2 might 
partly explain differences in the vasoactive potency found for several phenolics within 
different test systems. Our data confirm the beneficial effects of SOD/catalase on the 
stability of a number of phenolics. Furthermore, proteins in the medium or on the cell 
surface (33) might interfere during the assay when procyanidins are tested, as was shown 
by Aldini and co-workers (10). Incubations without proteins in the medium could diminish 
procyanidin-protein interactions. However, in the absence of 10% FBS in the medium, 
which represents a less physiological condition, recoveries were even lower suggesting a 
protective effect of the proteins. The influence of such interactions on the bioactivity of 
phenolic compounds in vivo remains to be investigated. 
 
Physiological relevance of the assay 
Physiological concentrations in humans of the phenolics tested are usually well below 10 
µM (34). Even for the strongest enhancer, resveratrol, we could only detect a significant 
effect above 30 µM. However, conditions in vivo are quite different from those in the cell 
culture. The mere fact that NO had to be measured in a relatively large volume of medium 
against a high background, only permitted relatively large changes (~60 nM) in NO to be 
detected. However, Taubert (9) showed that an increase of only 8.5 nM NO already induced 
vasorelaxation ex vivo in porcine coronary arteries. Still, results of our screening assay 
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generally fit with this in vivo assay: quercetin, but not kaempferol, induced NO production 
in vitro as well as vasorelaxation; naringenin, apigenin, catechin, epicatechin, gallic and 
coumaric acid were not able to enhance NO production in vitro, and also failed to increase 
in vivo NO production or relaxation in the porcine arteries (9). In contrast with our study, 
ECg and resveratrol were not active in that study. But, resveratrol (35, 36), EGCg (27, 28) 
and quercetin (24, 37) induced vasorelaxation in various other artery models. Thus, results 
obtained with our in vitro assay correspond with those of the ex vivo artery models.  
Metabolism of phenolic compounds inside the body, resulting in methylation and 
conjugation of phenolic hydroxyl groups with glucuronic acid and sulfate, could also affect 
their activity. We showed that glucuronidation of epicatechin did not change its negative 
effect in this assay. Modulation by glucuronidation, sulfatation and/or methylation on the 
NO production in vitro of phenolics still needs to be studied.  
 
In conclusion, this assay showed to be an easy tool to screen large sets of phenolic 
compounds for their potency to enhance endothelial NO production. Only 4 out of 33 
phenolics, resveratrol, quercetin, ECg, and EGCg, were able to enhance NO production 
significantly. No clear relation between their structure and activity was apparent. 
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The main goal of this thesis was to study the mechanisms that could explain the potential 
health effects of proanthocyanidins (PAs). As a first step, the absorption and 
biotransformation of procyanidins (PCs) were studied. Subsequently, the potential of PCs 
and their microbial metabolites to improve endothelial function were determined by 
assessing their ability to influence NO production, using an endothelial cell line. The use of 
purified PCs for these studies was necessary to produce unambiguous results on their 
bioavailability, biotransformation and bioactivity. Therefore, an efficient isolation 
procedure was developed to obtain both pure A- and B-type PCs. Appropriate analytical 
techniques were set-up for the analysis and characterization of PAs needed for all 
experiments. The main achievements and findings of this thesis are: 
Analytical methods (Chapters 2+3) 
i) A protocol to efficiently purify A- and B-type dimers 
ii) A powerful method to characterize PA molecular diversity, and quantify individual PAs 
Absorption (Chapter 4) 
iii) A-type PC dimers were better absorbed than B-type PC dimers 
iv) Oligomeric PCs enhanced the bioavailability of B-type PC dimers 
Biotransformation (Chapters 4+5) 
v) A-type and B-type PC dimers were exclusively absorbed as unmodified compounds 
vi) 3,4-Dihydroxyphenyl-γ-valerolactone and 3,4-dihydroxyphenylacetic acid were the main 
metabolites of B-type PC dimers upon exposure to human microbiota  
Bioactivity (Chapter 6) 
vii) A- and B-type PC dimers to pentamers had insignificant vasorelaxing properties as measured by 
nitric oxide production of endothelial cells  
viii) Hydroxylated phenylpropionic/phenylacetic acids, the main microbial metabolites of   PCs, had 
no vasorelaxing properties as measured by nitric oxide production of endothelial cells  
 
The biofunctional potential of PAs will be discussed based on the main findings of this 
thesis. 
 
 
Quantification of PAs in our diet 
 
 
Without doubt, PAs are an important part of the total amount of ingested phenolic 
compounds from our diet (1). The methods to quantify PAs in food have improved over 
time, but accurate quantification is still a challenging task. Two main techniques have been 
used for the quantification of PAs: The butanol/HCl assay and NP-HPLC-UV-MS. 
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Quantification by the butanol/HCL assay 
The butanol-HCl assay is a colorimetric assay to quantify the total amount of PAs based on 
the anthocyanidin formation from the extension units of PAs. However, the color formation 
depends on many factors, amongst others the presence of water and metal ions (2, 3). In 
addition, PA characteristics like the type of interflavanic linkage and the monomeric 
composition influence the rate and intensity of color development. Monomeric units 
connected by an A-linkage are relatively resistant to acid-catalyzed cleavage (4, 5) 
compared to B-linkages. Furthermore, the C4-C6 bond is more resistant to cleavage than 
the C4-C8 bond (2). Color formation also depends on the type of anthocyanidins formed, as 
their UV responses differ (2). When the above is taken into account, the type of standard 
that is used can either overestimate or underestimate the amount of PAs and, therefore, 
quantification by the butanol-HCl assay should be approached with caution.  
 
Quantification by NP-HPLC 
Besides the butanol/HCl assay, quantification based on NP-HPLC-UV-MS has been 
performed (1, 6). The advantage of NP-HPLC-UV-MS analysis compared to the 
butanol/HCl assay is that the different oligomeric groups up to a DP of approximately 7, 
depending on the source, can be quantified separately. For quantification purposes, 
oligomeric standards of different degrees of polymerization (DP) have been isolated, often 
from cocoa, by preparative NP-HPLC. These standards are subsequently used to quantify 
PAs in foods and beverages as done by Gu and coworkers (1). This method only enables 
quantification of the total amount of each oligomeric group, e.g. dimers, trimers, etc. 
Besides UV detection, additional MS analysis enables the determination the presence of A- 
and B-type PAs and the different PA subgroups. MS analysis has also been used for 
quantification (6). However, quantification of A- versus B-type PAs on the basis op 
precursor ions might not be very accurate as in our experience optimal MS settings for the 
detection of A- and B-type PAs differ. Therefore, NP-HPLC is not suitable to determine the 
proportion of A- versus B-type within dimers (or larger oligomers).  
 
Quantification by combining NP- and RP-HPLC  
With respect to the difference we observed in the bioavailability of A- and B-type dimers 
(Chapter 4), data on their proportion in food sources, which is currently lacking, would be 
desirable. From the above, it can be concluded that the butanol/HCl assay and NP-HPLC 
are not suitable to separately quantify A- and B-type PCs. Therefore, in this thesis we 
combined NP-HPLC and RP-HPLC to characterize and quantify individual molecular PA 
species in a 20% (v/v) methanol extract of peanut skins (Chapter 2). Pre-purification of 
fractions with different DPs by NP-HPLC followed by the analysis of each fraction on RP-
HPLC enabled us to quantify single oligomers of similar DP. Subsequently, the proportions 
of A- versus B-type PCs could be determined. The peanut skins extract appeared to be 
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mainly composed of A-type PCs (> 95.0% (w/w) of the 20MeOH extract). Furthermore, the 
number and position of the A-linkage in the most abundant molecular species was 
established. Determination of the molar extinction coefficients of individual PA oligomers 
might further improve this method as a quantification technique. 
 
PA composition of food: The influence of processing 
With the improvement of the methods for the quantification and characterization of the PA 
composition in food, the next step would be to determine the factors that can change PA 
composition in foods, e.g. processing. Some processes are known to alter the PA 
composition of food, particularly the ratio between A-type and B-type PAs. For example, 
the fermentation duration of cocoa beans was negatively correlated with the analyzable 
amount of PCs because they were (enzymatically) oxidized (7). Furthermore, the blanching 
of peanuts extensively decreased the PC content, in which A-types were more affected (94-
100 % (w/w) decrease) compared to B-types (53-90% (w/w) decrease) (8). It was 
hypothesized that the decrease in PC content resulted from their high solubility in hot water 
(8) and based on their results A-type PC seem more hot water soluble compared to B-type 
PCs. Another explanation for the difference between A- and B-type PCs might be a higher 
affinity of A-type PCs to bind to denatured (due to the conditions) proteins compared to B-
type PCs. Besides peanut processing, maceration and subsequent cold/hot pressing of 
grapes followed by pasteurization resulted in an increase of PAs in grape juice (9). 
Furthermore, enzymatic treatments might affect PC composition. For example, laccase is an 
enzyme that is used by the food industry for the stabilization of beer, wine and fruit juices 
(10). This enzyme oxidizes phenolic compounds, which will polymerize and subsequently 
the aggregates can be removed by e.g. filtration. This possibly also results in removal of 
PAs. The activity of laccase towards different PA subgroups remains to be established. In 
addition, the use of laccase might change PA composition, because this enzyme has been 
reported to convert B-type dimers into A-type dimers (11). 
 
 
Absorption of PCs 
 
 
Possible mechanisms of absorption 
To date, one of the main questions is: To which extent are PAs absorbed by the human 
body and via which mechanisms? Based on the current knowledge, the bioavailability of 
PAs is relatively low compared to other flavonoids (12) and their mechanism of absorption 
remains unknown.  
The absorption mechanisms that have been reported for phenolic compounds 
involve paracellular and transcellular passive diffusion, and transcellular active transport by 
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specific transporters (Figure 1). Passive transport is mainly related to the hydrophobicity of 
the compounds. Due to the somewhat lipophilic character of many phenolic compounds, 
they can be transported transcellularly via passive diffusion through the lipid bilayer of the 
cell membrane. PAs, which are hydrophilic due to the many hydroxyl groups, might not be 
able to pass the lipid bilayer and, therefore, they might be preferentially absorbed via 
paracellular diffusion. 
 
transcellular route paracellular route
transporters
tight 
junction
apical side
basal side
epithelial cell layer
= lipophilic compound
= hydrophilic compound
= target compounds for transporters
active passive
 
 
Figure 1. Transport mechanisms through the epithelial layer of the small intestine. 
 
Paracellular diffusion is regulated by the tight junctions and is limited by large molecular 
size and poor water solubility of the compounds (13). In Caco-2 cells the pore size of the 
junctions was determined to be 5.2 Å, but this could be extended to ~ 22 Å by the use of 
perturbants that open tight junctions by a Ca2+ independent (palmitoyl-DL-carnitine) or 
Ca2+ dependent (ethyleneglycol-bis-(β-aminoethyl ether)-N,N,N’,N’-tetraacetic acid) 
mechanism (14). 
Table 1 summarizes studies performed with caco-2 cells from which transport 
routes for phenolic compounds have been deduced. For example, the flavonoid hesperitin 
was shown to be transported transcellularly, while its corresponding hydrophilic glycoside 
hesperidin was absorbed paracellularly (15).  
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Table 1. Proposed transport routes for several phenolic compounds1 . 
Transcellular1 Data that pointed to a specific transport route2 Ref. 
naringenin (active)2 transport not affected by TER
5, 
transport affected by a proton gradient (16) 
epicatechingallate (active) 
accumulated in Caco-2 cells,  
transport decreased by adding substrates of the MCT6 
transporter 
(17) 
p/m-coumaric acid  (active) 
transport of a MCT substrate was inhibited, 
transport decreased by adding substrates of the MCT 
transporter, 
compound concentration not limiting 
(18-20) 
hesperetin (active) transport not affected by TER,  transport affected by a proton gradient (15) 
caffeic acid (active) transport decreased by adding substrates of the MCT transporter (18) 
ferulic acid (active) transport decreased by adding substrates of the MCT transporter (21) 
genistein compound concentration not limiting , accumulated in Caco-2 cells (22) 
3-HPP (active)3 
transport of a MCT substrate was inhibited, 
transport decreased by adding substrates of the MCT 
transporter, compound concentration not limiting 
(18, 
20) 
3,4-diHPP4 transport decreased by adding target compounds of the MCT transporter (20) 
Paracellular   
(epi)catechin transport inversely related to TER (23) 
epicatechingallate transport inversely related to TER (23) 
epigallocatechin(gallate) transport inversely related to TER (23) 
hesperidin transport inversely related to TER (15) 
caffeic acid transport inversely related to TER, transport increased linearly with concentration  (18) 
chlorogenic acid transport inversely related to TER,  transport increased linearly with concentration (18) 
gallic acid transport increased linearly with concentration (19) 
3,4-diHPP transport inversely related to TER, transport increased linearly with concentration  
(20, 
24) 
1 based on data obtained from the transport across the cell membrane of Caco-2 cells. 
2 if data indicated that active transport was involved this is indicated between brackets. 
3 3-HPP= 3-hydroxyphenylpropionic acid 
4 3,4-diHPP= 3,4-dihydroxyphenylpropionic acid 
5 TER= transepithelial electrical resistance, also abbreviated as TEER, which is a measure of 
paracellular transport 
6 MCT= monocarboxylic acid transporter  
 
From studies that report transcellular transport of phenolic compounds as the main transport 
route, it is not always clear if transporters are involved and to which extent. However, it can 
be concluded that transcellular transport of phenolic acids, containing a carboxylic acid 
group, involves the monocarboxylic acid transporter (MCT). Interestingly, 
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epicatechingallate, which does not contain a free carboxylic group, also seems to be 
transported by MCT. 
For several phenolic compounds, paracellular diffusion has been reported as 
transport mechanism (Table 1). This does not necessarily mean that the transport 
mechanism reported is the exclusive or the most important absorption mechanism involved. 
From Table 1 it can be concluded that paracellular and transcellular transport can coexist. 
For example, caffeic acid was reported to be mainly absorbed paracellularly, but it is also, 
to a lesser extent, transported transcellularly by the MCT transporter (18).  
Besides studies performed with Caco-2 cells, a number of perfusion experiments 
have been performed with the small intestine of rats. Within these studies, detection of 
methylated and/or glucuronidated metabolites in portal vein plasma or at the apical or basal 
side of the intestine also hints at transcellular transport. Methylation and glucuronidation 
already occurs inside epithelial cells, and detection of these metabolites in the portal vein 
(before liver metabolism can occur) proves that the parent compound has entered the 
epithelial cells. For example, glucuronidated metabolites were detected at the basal side of 
the intestine after perfusion with hesperetin, indicating transcellular transport (25), which is 
in accordance with data obtained with Caco-2 cells (15) (Table 1). Based on data obtained 
by perfusion studies, epicatechin (Chapter 4), quercetin (25, 26), luteolin and kaempferol 
(25) are also transported transcellularly. The absence of methylated and or conjugated 
metabolites in perfusion systems does not necessarily indicate paracellular transport as 
substrate specificity of the enzymes involved should also be considered. One of those 
enzymes is catechol-O-methyl-transferase (COMT), and PC dimers have been reported to 
be substrates for this enzyme (27). Based on our results obtained on the absorption of PC 
dimers (Chapter 4), a possible absorption mechanism will be discussed below. 
 
Absorption of A- and B-type procyanidin dimers 
Prior to our study, only data on the absorption of B-type PCs were available. The results 
presented in Chapter 4 showed that the A-type dimers A1 and A2 were absorbed in the rat 
small intestinal perfusion model. In contrast, the B-type dimer B2 was not absorbed. This 
suggests that A-type dimers are better absorbed than B-type dimers. This observation was 
supported by comparing the absorption of both A- and B-type dimers with that of 
epicatechin. The A-type dimers were 10-17 times less absorbed than epicatechin (on a 
molar basis) (Chapter 4), while B-type dimers were about 50 times (corrected for their 
molar ratios in the cocoa beverage) less absorbed than epicatechin, analyzed in humans, 
upon consumption of a cocoa beverage (28). The concentration of PC B-type dimers, only 
detected twice in human plasma, did not exceed 0.05 µM (28, 29). Our data on the 
absorption of A-type dimers in rats should still be confirmed in human studies. This data 
could be relevant with respect to the intake of e.g. cranberry supplements or other sources 
rich in A-type PCs. 
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A study performed with a Caco-2 cell line supports the hypothesis that PCs are 
transported by paracellular diffusion (30). Absorption of PCs was shown to be inversely 
related to the transepithelial electrical resistance (TER) value, which is a measure of 
paracellular transport (31, 32). The hydrophilic character of PCs and the absence of 
methylated metabolites in our perfusion study (Chapter 4) hints at paracellular transport. 
This was based on the finding that PC dimers are substrates of COMT (27) and therefore 
are expected to be methylated when transported transcellularly. If transported by the 
paracellular route, absorption of PAs is limited by the pore size of the paracellular route. 
The three dimensional structures of PC dimers B1 to B4 have been reported to exist in two 
conformations that are slowly interchanged: Compact and extended (33). The compact form 
dominated (B1: 92%, B3: 95%) when catechin was present as terminal unit. When 
epicatechin instead of catechin was present as terminal unit, the proportion of the extended 
form was higher (B2: 45%, B4: 17%). For B2-3-O-gallate the compact form was 
dominating (≥ 98%). So the gallyol moiety on B2 strongly influences its preferred three 
dimensional structure. Figure 2 shows the compact and extended 3D structure for dimer B2 
(33). 
 
B2 - extended
6.5 Å
7.8 Å
4.2 Å
4.2 Å
4.2 Å
3.6 Å 3.6 Å
B2 - compact
4.2 Å
 
Figure 2. The 3D representation of the compact and extended form of PC dimer B2 (33, with 
permission). The length of the lines is not correlated with the length in angstrom (Å). 
 
The hydrodynamic radii of dimers B1-B4 in D2O have been calculated to be 
between 7.4-8.0 Å (34). Besides the type of solvent, the radius is also depending on the 
preferred confirmation of the dimer, compact or extended, because the largest distance that 
was reported in the extended form of B2 was already 7.8 Å (Figure 2). Based on these data, 
paracellular transport seems to be possible for PA dimers as the pore size of tight junctions 
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was 5.2 Å, which could be maximized to 22 Å (14). It can be hypothesized that A-type 
dimers are more compact than B-type dimers, due to the additional ether bond, which might 
explain their better absorption compared to B-type dimers.  
 
The presence of oligomers enhances the absorption of dimers  
We found that dimer B2 was not absorbed from the rat small intestine when tested as a 
single compound. In contrast, it was clearly absorbed in the presence of tetramers (Chapter 
4). A similar positive effect of high DP oligomers on the absorption of low DP oligomers 
has been reported by Shoji and coworkers (35). The A-type trimers were not absorbed 
(Chapter 4), which supports the hypothesis that only dimers are absorbed. Although the 
hydrodynamic radius of the B-type trimer C2, calculated to be 8.7 Å (34), is not much 
larger than those of dimers, this might have been above the cut-off of the tight junction 
pores in our test system.  
The lack of absorption of high DP oligomers has resulted in an increased interest 
in foods and extracts rich in low DP oligomers. Also, processes that depolymerize high DP 
oligomers have been developed (36, 37), in order to increase the bioavailability of PCs. 
However, based on the finding that high DP oligomers enhance the absorption of low DP 
oligomers, the removal or depolymerization of high DP oligomers could also counteract the 
bioavailability of PAs.  
The mechanisms responsible for the PA dimer bioavailability-enhancing effect of 
higher DP oligomers are unknown. Shoji and coworkers (35) hypothesized that the larger 
oligomers (DP ≥ 8) would preferentially bind to mucosal proteins compared to the small 
oligomers, which would leave the small oligomers available for absorption. Another 
explanation might be that PCs could decrease the free [Ca2+]. Calcium ions play an 
important role in the formation (extracellular Ca2+) and regulation (intracellular Ca2+) of the 
inter-epithelial junctions. These include tight junctions (38, 39), which restrict paracellular 
transport (38, 39). When calcium concentrations decrease, the tight junctions will relax and 
intestinal permeability increases (38, 40). PAs have been shown to be able to affect calcium 
homeostasis within different cell types. For example, pretreatment of platelet cells of 
diabetic patients with an A-type trimer (10 µM) reduced free [Ca2+] (41). In another study 
with T-lymphocyte cells (Jurkat T-cells), epicatechin, PC dimer B2 and PC trimer C1 
prevented K+ stimulated Ca2+ mobilization with IC50 values of 10, 24 and 196 nM, 
respectively, (42). This effect was obtained with physiological relevant concentrations. 
Furthermore, the ability of PCs to decrease Ca2+ mobilization was inversely related to the 
DP. With respect to the PAs in food sources, in which the relative proportion of oligomers 
(DP > 2) is high (1), the concentration of trimers or higher DP oligomers that reach the 
small intestine might still be relevant.  
A possible mechanism involved in the regulation of calcium homeostasis by PAs 
might be their calcium binding properties (43-45). This might result in a decreased [Ca2+], 
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and subsequent opening of the tight junctions, which could result in increased absorption of 
dimers. In order to explain the enhanced absorption of dimers in the presence of oligomers, 
the calcium binding capacity should increase with DP. Flavonoids are known to chelate 
metal ions (46) and three binding sites have been identified: The catechol moiety and 
between the 3-hydroxy or 5-hydroxy and the 4-keto group (47). The catechol moiety on the 
B-ring was shown to be an important feature for metal ion chelation (48). This moiety is 
also present in PAs and increases with DP on the basis of molarities. Additional binding 
sites for calcium might arise from hydroxyl/oxygen groups in different monomeric units, 
which are forced in each other’s proximity, when the molecules adopt their most favorable 
conformation (Figure 3).  
When calcium is indeed bound by the catechol moiety and between the 
monomeric units of PAs as indicated in Figure 3, the calcium binding capacity will not 
only increase on the basis of molarities, but also on the basis of weight. As an example, 1 g 
of dimers or tetramers will bind 2 to 2.5 times more calcium, respectively, than 1 g of 
monomers. The increased calcium binding capacity of oligomers compared to monomers 
will eventually reach a plateau value of ~3. Research in this area would benefit from the 
determination of the Ca2+ binding capacity of PAs as one of the mechanisms that could 
affect calcium availability. Additionally, in vitro studies with e.g. Caco-2 cells could be 
used to monitor free [Ca2+] in the presence of PA oligomers in relation to the absorption of 
dimers.  
 
Procyanidin trimer
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Hypothesized calcium binding sites specific for PAs  
Figure 3. Proposed calcium binding sites within PAs, including the catechol moieties. 
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Microbial metabolism of PAs 
 
 
Due to the limited absorption of PAs, large quantities will reach the colon (49) and are 
exposed to the microbiota. Therefore, microbial metabolites represent an important fraction 
of the ingested PAs, and might (partly) be responsible for the health effects attributed to 
PAs. 
We detected hydroxylated phenylpropionic and phenylacetic acids and 
hydroxylated phenylvalerolactone as the main microbial metabolites derived from B-type 
PC dimers upon incubation with human feces (Chapter 5). Our finding of 3,4-
dihydroxyphenylacetic acid (3,4-diHPA) as a major metabolite was used to suggest a 
tentative degradation pathway for B-type PC dimers (Chapter 5). This metabolite had not 
been detected in studies performed with pure (epi)catechin and human microbiota (50, 51). 
Therefore, it was suggested to originate directly from the B-type dimers without their prior 
cleavage into monomeric units.  
Based on our pathway proposed, it is expected that the fermentation of higher DP 
oligomers will result in increased amounts of 3,4-diHPA correlated to the number of 
extension units (Figure 4). The fate of parts of the PC, the A-rings and part of the C-rings, 
remains unknown. It might be hypothesized that these parts will be converted into 
phloroglucinol and CO2. The CO2 was released after fermentation of [ring A-14C]-catechin 
in guinea pigs and rats (52), and represented 20 % of the ingested dose. Phloroglucinol has 
also been postulated to originate form the A-ring of several flavonoids, like epicatechin, 
quercetin, luteolin and naringenin (53-55), but its detection is difficult. Phloroglucinol 
seems to be quickly converted into butyrate and acetate (56), or it binds to cysteine or other 
compounds in the growth medium (57), which complicates its detection. Our experiments 
can not exclude the possibility that phloroglucinol is a metabolite of PC dimers, despite our 
attempts to detect it with MS analysis.  
A study in which microbial metabolites of low and high DP oligomers are directly 
compared might confirm the proposed pathway for PCs degradation. Data on the microbial 
conversion of A-type PAs are lacking. Possibly, A-type PAs are more resistant to microbial 
degradation, because of the additional ether bond. This additional bond might also affect 
the type of metabolites formed.  
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Figure 4. Expected degradation pathway for PC oligomers based on the proposed pathway given 
in Chapter 5.  
 
PAs and decreased blood pressure: Possible modes of 
action 
 
 
Numerous human intervention studies with PA-rich foods, beverages and supplements 
reported changes in biomarkers, mainly related to a decreased risk for CVD (58). Especially 
studies reporting decreased blood pressure and increased flow mediated dilatation after the 
intake of cocoa, both in healthy (59) and hypertensive (60, 61) human subjects, are 
promising. PAs are considered to be responsible for those beneficial effects, but despite 
extensive research to confirm this, unambiguous proof is still lacking.  
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Nitric oxide (NO), which is produced by eNOS in endothelial cells, is known to be 
a key signaling molecule, regulating vasodilatation. Therefore, we tested the ability of PCs 
and their microbial metabolites to stimulate NO production (Chapter 6) as a possible 
mechanism for the observed decrease in blood pressure after cocoa intake. PCs only 
showed a small insignificant effect, which seems to be positively related to the DP. For the 
microbial metabolites of PCs, no enhanced NO production was detected. Besides phenolic 
acids, valerolactones are also important human microbial metabolites of PCs. 
Valerolactones are structurally different from PCs and other phenolic acids, and thus it 
might be worthwhile testing them with respect to vasorelaxing potential. Valerolactones 
can be synthesized, but the synthesis protocols are quite complex (62, 63). They can also be 
purified after microbial fermentation (64), but this is laborious and requires a large amount 
of starting material. Therefore, efficient methods to generate sufficient quantities of 
valerolactones for bioactivity studies are of great interest.  
Our test system was designed to detect an increase in NO-production, but the NO-
level also depends on the stability of NO itself, which can be degraded by reactive oxygen 
species (ROS). PAs acting as antioxidants (65) might scavenge ROS or target other 
mechanisms involved in ROS production (66, 67), thereby maintaining high NO levels. For 
example, PC dimer B2 was potent in inhibiting NADPH oxidase and scavenging O2-, as 
tested in human umbilical endothelial cells (67), thereby reducing overall ROS production. 
Due to the use of HEPES, SOD and catalase in our test system, the effect of antioxidative 
actions of the test compounds could not be detected.   
 
 
Health potential of PA-rich dietary sources: Which are the 
bioactive compounds? 
 
 
PCs as bioactive compounds 
The low plasma amounts of A- and B-type PC dimers, were not methylated and/or 
conjugated (Chapter 4), which is in contrast to most phenolic compounds (68). Therefore, 
PCs conserve their biological activity, which facilitates the translation of their in vitro 
activity to in vivo situations.  
As mentioned earlier, plasma concentrations of PCs in humans (< 0.05 µM) (28, 
29) are relatively low compared to other phenolic compounds. Flavonols, flavanols and 
isoflavones have been reported to reach concentrations of up to about 5 µM (12) and total 
epicatechin concentrations in human plasma ranged from 0.25-6 µM, after chocolate 
consumption (28, 69-71). However, the conserved structures of PCs in vivo might partly 
compensate their lower absorption. The proportion of unmetabolized versus metabolized 
compounds could be important with respect to their bioactivity. For example epicatechin 
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was completely methylated and conjugated upon absorption upon absorption from the rat 
small intestine (Chapter 4) and some studies reported a decreased bioactivity of 
methylated and glucuronidated epicatechin (72, 73). Also, in humans unmodified 
epicatechin represented only < 10% of the total epicatechin metabolites (71). Therefore, 
plasma concentrations of unmetabolized PC dimers (0.05 µM) are similar to, or only 10 
times lower than, the concentrations of unmetabolized epicatechin (0.03-0.6 µM, 10 % of 
total concentration in humans).  
 
Human microbial metabolites of PCs as bioactive compounds 
Besides PCs themselves, their microbial metabolites might contribute to the beneficial 
health effect of cocoa and wine. Microbial conversions are known to play an important role 
in the absorption of several other phenolic compounds. For example, quercetin-3-rutinoside 
is not absorbed in the small intestine (26), but it is absorbed from the colon after microbial 
removal of the sugar moiety (74). Other examples are high plasma concentrations of 
enterodiol and enterolactone (75), which are microbial products of lignans (76, 77). 
Data on the bioavailability of the PC metabolites, hydroxyphenylpropionic acids, 
hydroxyphenylacetic acids and hydroxyphenylvalerolactones is limited and the extents of 
their absorption in humans remain to be investigated. Phenolic acids are known to be 
extensively excreted in urine (62, 78, 79), and some have been detected in plasma (80) of 
human subjects.  
Concerning the bioactivity of microbial PC metabolites, none of the tested 
metabolites positively influenced NO-production (Chapter 6). A limited number of studies 
determined the bioactivity of the microbial metabolites of PCs. Of these studies only few 
were related to cardiovascular health, including anti-platelet activity of 3,4-diHPA and 4-
HPA (81) and anti-oxidant activity of 3,4-diHPA (82). Up to now, not enough data are 
available to conclude whether microbial metabolites of PCs are (partly) responsible for the 
decreased blood pressure found after cocoa and wine consumption.  
 
PCs as stimulators for the absorption of other health beneficial 
compounds 
In Chapter 4 the stimulation of dimer absorption by oligomers was described. Based on 
this finding, it might be hypothesized that PAs also stimulate the absorption of other 
compounds, targeting in vivo processes involved in maintaining endothelial function. One 
study performed (83) supports the hypothesis that PCs can increase the bioavailability of 
other phenolic compounds. This study showed that the bioavailability of hypericin in rats 
increased with 58% when administered together with PC dimer B2. In addition, an earlier 
study (84) the antidepressant activity of hypericin, an anthraquinone derivative, measured 
in the forced swimming test in rats, also increased when administered together with B2.  
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Summarizing, PC oligomers (DP > 4) enhanced the absorption of dimers 
(Chapter 4, (35), and dimer B2 increased hypericin bioavailability (83). Therefore, PAs 
have the potential to improve the bioavailability of other phenolic compounds, which might 
also include compounds with blood pressure lowering properties.  
 
This thesis increased our knowledge on the absorption, biotransformation and 
bioactivity of A- and B-type PCs. A possible interaction between high and low DP 
oligomers, influencing absorption processes has been discussed, which suggests that until 
now the biofunctional potential of PAs has been underestimated.  
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Intervention studies showed that the intake of proantocyanidins (PAs) is associated with 
beneficial health effects, mainly related to the prevention of cardiovascular diseases. For 
example, several studies showed that a high intake of cocoa and wine, which are rich in 
PAs, decreased blood pressure. PAs are considered to be the bioactive compounds 
responsible for those beneficial health effects. 
PAs are phenolic compounds that are abundant in our diet. Well known PA food 
sources are cocoa, apple, grape seeds, wine, nuts, and cinnamon. PAs are oligomers of 
monomeric flavan-3-ols and belong to the class of flavonoids. The monomeric units can be 
linked to each other by a single C4-C8 or C4-C6 linkage, which is referred to as B-type. 
Besides these single linkages an additional ether bond can be present, C2-O-C7 or C2-O-
C5, which is referred to as A-type. PA is a general name that includes several subgroups. 
With respect to food, three subgroups are relevant: Procyanidins (PCs), prodelphinidins 
(PDs) and propelargonidins (PP). PCs form a homogenous group that exclusively exists of 
(epi)catechin units. The other two subgroups, PDs and PPs, are heterogeneous groups that, 
besides (epi)catechin, exist of (epi)gallocatechin and (epi)afzelechin units, respectively. 
To determine whether PAs are the bioactive compounds responsible for the blood 
lowering effects of cocoa and wine, research on their bioavailability, bioconversion and 
bioactivity is needed. Therefore, the aims of this thesis were: i) to determine the 
bioavailability and metabolism of A-type in comparison to B-type procyanidins, ii) to 
determine the human microbial metabolites of B-type procyanidins, and iii) to determine 
the potential of A- and B-type procyanidins or their microbial metabolites to improve 
vascular function by influencing NO-release of endothelial cells. To achieve these aims 
techniques for the isolation, characterization and quantification of PAs were developed. 
This thesis focused on the bioactive potential of A- and B-type PCs, which were isolated 
from peanut skins and grape seeds, respectively. 
 
Considering the reported health effects of PAs, food supplements enriched in PAs 
are of interest for the food industry. Peanut skins, as a by-product of the peanut butter 
industry, are rich in A-type PAs and might be a potential source for food supplements. To 
determine the biofunctional potential of this source, the PAs present were characterized and 
quantified as described in Chapter 2. The combination of NP and RP-HPLC was used as a 
tool to determine the PA molecular diversity. Fractions (9 in total), containing different 
oligomers, were first isolated with NP-HPLC from a 20% (v/v) aqueous methanol extract 
from peanut skins. Subsequently, each fraction was separated on RP-HPLC and peaks were 
identified with mass spectrometric analysis. Quantification was based on UV responses, 
which were assumed to be similar for the oligomers within each fraction. The extract 
mainly contained A-type PCs (95.0 % (w/w)) and out of a total of 114 peaks, we could 
distinguish 83 different PA molecular species. In the majority of the trimers and tetramers, 
the A-linkage was positioned at the terminal unit, and often more than one A-linkage 
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occurred. This method also enabled determination of the ratio of A- versus B-type dimers 
(19.9 % (w/w) vs 2.4 % (w/w) of the extract). 
In Chapter 3, we describe the efficient isolation of both B-type dimers form grape 
seeds and A-type dimers from peanut skins by combining NP- and RP-HPLC. Previously 
used methods often included multiple chromatographic steps and focused on the isolation 
of one or two specific dimers. We reduced the number of chromatographic steps and 
obtained a yield of 20-400 times more A-type dimers and of about 10 times more B-type 
dimers compared to other methods. Most of the dimers (9 out of 15) were identified with 
NMR spectroscopy and mass spectrometry. For B-type dimers we additionally used a 
combination of thiolysis and available standards. We isolated six dimers from peanut skins. 
The main dimers were A1 (epicatechin-(2-O-7, 4-8)-catechin) and A2 (epicatechin-(2-O-7, 
4-8)-epicatechin). Furthermore, epicatechin-(2-O-7, 4-6)-catechin,  epicatechin-(2-O-7, 4-
8)-entcatechin, which was isolated from peanut skins for the first time, and B7 (epicatechin-
(4-6)-catechin) were identified. One dimer could not be identified. From grape seeds eight 
B-type dimers were isolated of which four were identified as B1 (epicatechin-(4-8)-
catechin), B2 (epicatechin-(4-8)-epicatechin), B3 (catechin-(4-8)-catechin) and B4 
(catechin-(4-8)-epicatechin). The method described delivered enough purified PAs, which 
were used to study their bioavailability, microbial conversion and  blood pressure lowering 
potential. 
 
After obtaining pure A- and B-type dimers and fractions of A-type trimers and 
tetramers, their absorption was tested by an in situ perfusion model of the small intestine of 
rats (Chapter 4). We for the first time reported absorption of A-type PC dimers and 
showed that they were better absorbed than B-type PC dimers. Furthermore, A-type PC 
tetramers stimulated the absorption of B-type PC dimers. In contrast to epicatechin, both A- 
and B-type PC dimers were absorbed unmetabolized. A-type PC trimers were not absorbed. 
Neither epicatechin nor its methylated and/or conjugated metabolites were detected as a 
result of perfusion with any of the PCs. 
Because only a small amount of the PAs is absorbed, a large amount will reach the 
colon where microbial conversions might take place. The microbial metabolites of PAs 
might be (partly) responsible for the beneficial effects of PAs. Thus, identification of these 
PA microbial metabolites is necessary to determine their bioactivity. In Chapter 5 the in 
vitro fermentation of B-type PC dimers with human microbiota is described. Care was 
taken that the PC substrate was free of (epi)catechin, because the presence of (epi)catechin 
would have obscured the origin of the metabolites. The main metabolites identified were 2-
(3,4-dihydroxylphenyl)acetic acid and 5-(3,4-dihydroxyphenyl)-γ-valerolactone. Based on 
the type of metabolites that were detected after different fermentation times, a tentative 
degradation route for B-type dimers has been proposed. In the literature, 2-(3,4-
dihydroxylphenyl)acetic acid has not been reported as a metabolite after fermentation of 
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pure epicatechin. Because we detected it as the main metabolite of B-type PC dimers, this 
suggests its direct release from B-type dimers without prior cleavage of the interflavanic 
bond of the dimer.  
 
The potential vasorelaxing properties of PAs might relate to the stimulation of 
nitric oxide (NO) production by endothelial cells, as NO is a major regulator of 
vasodilatation. A hybrid human endothelial cell line EA.hy926 was optimized to rapidly 
screen phenolic compounds for their NO stimulating potential. Dose-dependent correlations 
between NO stimulation and eNOS upregulation were found for selected phenolic 
compounds, suggesting the stimulation of eNOS expression as a possible mechanism of 
increased NO-production. Most A- and B-type procyanidins showed a non-significant 
tendency to elevate NO production, and microbial metabolites were inactive (Chapter 6). 
Besides phenolic acids, valerolactones were also important human microbial metabolites of 
procyanidins (Chapter 5). Due to a lack of standards we were not able to test 
valerolactones for their vasorelaxing potential. 
 
In the last chapter (Chapter 7), the mechanisms involved in the biofunctional 
potential of PAs are discussed in relation to the results obtained. More particularly, we 
hypothesized that PAs are transported via paracellular diffusion and that the oligomer-
enhanced bioavailability of B-type dimers might involve calcium-mediated mechanisms. 
Furthermore, the progress in PA analysis and the new insights in microbial conversion 
routes of higher DP PA oligomers were elaborated, as well as mechanisms, besides NO 
stimulation, that might be considered as PA targets. 
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Interventie studies hebben laten zien dat de inname van proanthocyanidinen (PA’s) 
geassocieerd kan worden met positieve gezondheidseffecten die hoofdzakelijk gerelateerd 
zijn aan het voorkomen van hart en vaatziekten. Een aantal van die studies liet zien dat een 
hoge inname van cocoa en wijn, beide rijk in PA’s, resulteerde in een verlaagde bloeddruk. 
PA’s worden gezien als de bioactieve componenten die verantwoordelijk zijn voor deze 
positieve gezondheidseffecten. 
 PA’s zijn fenolische componenten die rijkelijk in ons dieet voorkomen. Voedsel 
bronnen die bekend staan PA’s te bevatten zijn cocoa, druivenpitten, wijn, noten en kaneel. 
PA’s zijn oligomeren van monomere flavan-3-olen en behoren tot de klasse van de 
flavonoïden. De monomere bouwstenen kunnen aan elkaar gekoppeld worden door middel 
van een enkelvoudige C4-C8 of C4-C6 binding, wat aangeduid wordt als B-type. Naast 
deze enkelvoudige binding kan er een extra ether binding aanwezig zijn, C2-O-C7 of C2-O-
C5, wat aangeduid wordt als A-type. PA’s is een algemene naam die verschillende 
subgroepen omvat. Met het oog op voeding zijn er drie relevante subgroepen: 
procyanidinen (PC’s), prodelphinidinen (PD’s) en propelargonidinen (PP’s). PC’s vormt 
een homogene groep die exclusief uit (epi)catechine bouwstenen bestaat. De twee andere 
groepen, PD’s en PP’s, zijn heterogene groepen die naast (epi)catechine, bestaan uit 
respectievelijk (epi)gallocatechine en (epi)afzelechine. 
 Om na te kunnen gaan of PA’s bioactieve componenten zijn en verantwoordelijk 
voor de bloeddruk verlagende werking van cocoa en wijn is er onderzoek nodig naar hun 
biobeschikbaarheid, bioconversie en bioactiviteit. Dit resulteerde in de volgende doelen van 
dit proefschrift: i) bepaling van de biobeschikbaarheid en het metabolisme van A-type in 
vergelijking tot B-type PC’s, ii) bepaling van de door menselijke darm microbiota 
gevormde metabolieten uit B-type PC’s en iii) bepaling van de potentie van A- en B-type 
PC’s en hun microbiële metabolieten om de vasculaire functie te verbeteren door de NO-
productie van endotheel cellen te stimuleren. Om deze doelen te bereiken werden er eerst 
technieken ontwikkeld om de PA’s te isoleren, te karakteriseren en te kwantificeren. Dit 
proefschrift richt zich op het bioactieve potentieel van A- en B-type PC’s die opgezuiverd 
werden uit respectievelijk pindavliesjes en druivenpitten.     
 
Op basis van alle gerapporteerde gezondheidseffecten gerelateerd aan PA’s, zijn 
voedingssupplementen die verrijkt zijn in PA’s interessant voor de levensmiddelen 
industrie. Pindavliesjes, een bijproduct van de pindakaas productie, zijn rijk in A-type PC’s 
en daardoor een mogelijke bron voor voedingssupplementen. Om het biofunctionele 
potentieel van deze bron te bepalen werden de aanwezige PA’s gekarakteriseerd en 
gekwantificeerd (Hoofdstuk 2). Er werd een combinatie van NP en RP-HPLC gebruikt om 
de moleculaire diversiteit van PA’s te kunnen bepalen. Eerst werden er 9 fracties, elk 
bestaande uit een verschillende oligomere samenstelling, uit een 20% (v/v) waterig 
methanol extract van pindavliesjes geïsoleerd met behulp van NP-HPLC. Vervolgens werd 
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elke fractie apart met RP-HPLC geanalyseerd en werden de pieken geïdentificeerd met 
behulp van massa spectrometrische detectie. De kwantificering was gebaseerd op UV 
metingen waarin werd aangenomen dat oligomeren binnen één fractie een vergelijkbaar UV 
signaal zouden geven. Het extract bestond voornamelijk uit A-type PC’s (95.0 % (w/w)) en 
van de in totaal 114 geanalyseerde pieken konden we 83 verschillende moleculaire 
structuren onderscheiden. De meerderheid van de trimeren en tetrameren bevatte een A-
binding aan de terminale kant van het oligomeer en vaak waren er meer dan één A-binding 
aanwezig. Deze methode maakte het mogelijk om de proportie A- versus B-type dimeren 
(19.9 % (w/w) vs 2.4 % (w/w) van het extract) te bepalen.   
In Hoofdstuk 3 wordt een methode beschreven om zowel B-type dimeren uit 
druivenpitten en A-type dimeren uit pindavliesjes op een efficiënte manier te zuiveren 
waarbij NP- en RP-HPLC gecombineerd werd. De methoden die voorheen gebruikt werden 
omvatte vaak meerdere chromatografische stappen en waren vaak gericht op het zuiveren 
van één of twee specifieke dimeren. Wij hebben het aantal chromatografische stappen 
verminderd terwijl de opbrengst 20-400 keer toenam voor A-type dimeren en ongeveer 10 
maal voor B-type dimeren in vergelijking met andere methoden. Het merendeel van de 
dimeren (9 van de 15) kon worden geïdentificeerd met NMR spectroscopie en massa 
spectrometrie. Daarnaast werden B-type dimeren ook geïdentificeerd op basis van thiolyse 
en standaarden. Uit pindavliesjes werden zes dimeren geïsoleerd. De voornaamst 
aanwezige dimeren waren A1 (epicatechine-(2-O-7, 4-8)-catechine) en A2 (epicatechine-
(2-O-7, 4-8)-epicatechine). Verder werden ook epicatechine-(2-O-7, 4-6)-catechine, 
epicatechine-(2-O-7, 4-8)-entcatechine, die voor het eerst uit pindaschil geïsoleerd werd, en 
B7 (epicatechine-(4-6)-catechine) geïdentificeerd. Eén dimeer kon niet geïdentificeerd 
worden. Uit druivenpitten werden totaal acht dimeren geïsoleerd waarvan er vier 
geïdentificeerd konden worden als B1 (epicatechine-(4-8)-catechine), B2 (epicatechine-(4-
8)-epicatechine), B3 (catechine-(4-8)-catechine) and B4 (catechine-(4-8)-epicatechine). 
Deze isolatie methode resulteerde in genoeg PA’s om te gebruiken in studies naar hun 
biobeschikbaarheid, microbiële omzetting en bloeddruk verlagend potentieel. 
 
 Nadat er zuivere A- en B-type dimeren plus fracties van A-type trimeren en 
tetrameren verkregen waren, werd hun absorptie getest in een in situ perfusie model met de 
dunne darm van ratten (Hoofdstuk 4). Met dit model konden we de absorptie van A-type 
PC dimeren aantonen wat nog niet bekend was. Bovendien werden A-type PC dimeren 
beter geabsorbeerd dan B-type PC dimeren. Verder werd de absorptie van B-type PC 
dimeren gestimuleerd door de aanwezigheid van A-type PC tetrameren. In tegenstelling tot 
epicatechine werden zowel A- als B-type PC dimeren geabsorbeerd zonder te worden 
gemetaboliseerd. A-type PC trimeren werden niet geabsorbeerd. Epicatechine en zijn 
gemethyleerde en/of geconjugeerde metabolieten werden niet gedetecteerd na perfusie met 
PC’s.  
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 Omdat maar een klein gedeelte van de PA’s geabsorbeerd wordt zal een groot 
gedeelte de dikke darm bereiken waar microbiële omzettingen plaats kunnen vinden. De 
microbiële metabolieten van PA’s zouden (gedeeltelijk) verantwoordelijk kunnen zijn voor 
de voordelige effecten die aan PA’s gerelateerd zijn. Daarom is identificatie van die 
metabolieten nodig om hun bioactiviteit te kunnen testen. Hoofdstuk 5 beschrijft de in 
vitro fermentatie van B-type PC dimeren met humane microbiota. Het PC substraat bevatte 
geen (epi)catechine omdat in aanwezigheid van (epi)catechine de oorsprong van de 
metabolieten onduidelijk zou zijn. De hoofd metabolieten werden geïdentificeerd als 2-
(3,4-dihydroxylphenyl)acetic acid en 5-(3,4-dihydroxyphenyl)-γ-valerolactone. Gebaseerd 
op het type metabolieten die werden gedetecteerd na verschillende tijden van fermentatie, 
werd er een hypothetische afbraak route voor B-type dimeren voorgesteld. In de literatuur 
wordt 2-(3,4-dihydroxylphenyl)acetic acid niet genoemd als metaboliet na fermentatie van 
zuivere epicatechine. Omdat wij het als één van de hoofd metabolieten van B-type dimeren 
hebben gedetecteerd is het aannemelijk dat dit metaboliet direct vrijgemaakt wordt uit B-
type dimeren zonder dat de interflavan binding van het dimeer verbroken wordt.  
 
Het bloeddruk verlagend potentieel van PA’s zou o.a. gerelateerd kunnen zijn aan 
de mogelijke stimulatie van stikstof oxide (NO) productie door endotheel cellen aangezien 
NO een belangrijke regulator is van vaatverwijding. Het gebruik van een hybride humane 
endotheel cellijn (EA.hy926) werd geoptimaliseerd om fenolische componenten snel te 
kunnen screenen voor hun NO stimulerende werking. Voor enkele fenolische componenten 
werden er correlaties gevonden tussen de stimulatie van NO productie en eNOS expressie 
wat gemeten werd met verschillende doses. Dit suggereert dat de stimulering van eNOS 
expressie een mogelijk mechanisme is waardoor de NO productie toeneemt. De meeste A- 
en B-type PC’s lieten een niet significante toename zien in NO productie en de microbiële 
metabolieten waren inactief (Hoofdstuk 6). Naast fenolzuren waren ook valerolactonen 
belangrijke microbiële metabolieten die vanuit PC’s werden gevormd (Hoofdstuk 5). 
Echter, door het gebrek aan standaarden konden we valerolactonen niet testen voor hun 
vaatverwijdend potentieel.  
 In het laatste hoofdstuk (Hoofdstuk 7) worden de mechanismen die betrokken 
kunnen zijn in het biofunctionele potentieel van PA’s in relatie tot de verkregen resultaten 
bediscussieerd. In het bijzonder bespreken we de hypothese dat PA’s via paracellulaire 
diffusie door de darmwand worden getransporteerd. Verder wordt de stimulerende werking 
van de aanwezigheid van tetrameren op de absorptie van B-type dimeren besproken en 
daarbij de mogelijke betrokkenheid van een calciumafhankelijk mechanisme. Ook werd er 
uitgeweid over de vooruitgang in PA analyse, de nieuw verkregen inzichten in de 
microbiële omzetting van grotere oligomeren en de mechanismen (naast stimulering van 
NO productie) die betrokken zijn in vaatverwijding en die door PA’s beïnvloed zouden 
kunnen worden.  
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“Ben je nu een keer uitgestudeerd?” kreeg ik regelmatig te horen. Ik kan nu zeggen dat het 
eindelijk zover is! Natuurlijk heb ik veel geleerd tijdens mijn promotieonderzoek maar ik 
heb het vooral ook ontzettend naar mijn zin gehad. Dit was mede door de vele gezellige en 
meelevende collega’s waar ik altijd terecht kon en daarvoor wil ik jullie natuurlijk allemaal 
hartelijk bedanken. 
Natuurlijk wil ik Jean-Paul, Peter en Harry bedanken voor alle kritieken en 
aanmoedigingen. Jean-Paul bij jou was even binnen lopen altijd een garantie tot minimaal 
één uur discussie en regelmatig vertrok ik met meer vragen dan ik aanvankelijk kwam. Je 
hield me altijd scherp en gaf me het idee tal van mogelijkheden te hebben. Het duurde wat 
langer dan gepland maar uiteindelijk arriveerde ik toch op het RIKILT. Ik was een nitwit op 
het gebied van dier- en cel studies. Peter, je zorgde altijd dat ik gefocust bleef en in mijn 
schrijven meer to the point kwam. Harry, bedankt voor je altijd kritische blik op de 
manuscripten die je onder ogen kreeg. “Wat is nu eigenlijk de boodschap?” was een 
regelmatig terugkerende vraag en dat bleek toch altijd weer moeilijk te verwoorden.  
Ik begon mijn promotie bij levensmiddelenchemie en voegde mij bij de groep van de 
fytonutriënten. Karin dankzij jou kon ik snel aan de slag want veel moeilijkheden had jij al 
overwonnen! Zo kwam ik regelmatig langs omdat de Prep weer eens nukken had. Ik vind 
het super dat je mijn paranimf bent! Aagje, ik denk met een glimlach terug aan de 
momenten dat we samen de HPLC met allerlei gereedschap te lijf gingen. Mark, je kunt 
vast geen pindavliesjes meer zien maar de gezuiverde A-types zijn erg waardevol gebleken! 
Sandra, Nathalie, Mediatrice, Katerina and Nancy I enjoyed working with you and learned 
a lot from it, I hope you had the same experience! Rudy, ik denk met plezier terug aan het 
congres in Salamanca mede dankzij jouw gezelschap.   
Kamergenootjes van 509 bedankt voor de supertijd. Het was het kruispunt waar alles 
samenkwam en waar we allen van vertrokken. Evelien, Koen, Catherina en Neleke, 
ondanks onze zorgen om de neus van de buschauffeur was de AIO –reis naar België, 
Frankrijk en Engeland erg succesvol. Ik had het niet willen missen! 
 
Het tweede deel van mijn promotie was op het RIKILT bij de groep bioactieve stoffen. Een 
roerige tijd mag ik wel zeggen. Dini jij was mijn steun en toeverlaat als ik weer eens in de 
clinch lag met alle snoeren en commando’s van de HPLC’s en de Coularray. In no time had 
je alles aangesloten, leuk dat je mijn paranimf wilt zijn! Erik, bedankt voor je aanwezigheid 
tijdens de dierproef. Jouw rust was welkom tijdens de eerste spannende dagen! Jaap, 
Melissa, Sandra, Annelies, Wendy, Evert, Yvonne, Evelien en Harry bedankt voor alle 
leuke momenten tijdens en buiten het werk om. Ik vond het jammer jullie te zien 
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vertrekken. Yvonne, ik vond het prettig zo nu en dan met een “lotgenoot”over frustraties te 
kunnen praten, succes met het afronden van jouw boekje!  
 
Ad, Anja, Jennifer en Mieke, ook al hadden jullie eigenlijk geen idee wat ik nu eigenlijk 
deed (als chocola maar gezond blijkt te zijn!) bedankt voor jullie interesse en welkome 
afleiding! De skivakanties waren genoeg om er weer fris tegenaan te kunnen gaan. 
Danny, Anita en Peter ik ben blij jullie (schoon)zus te zijn en weet dat jullie er zijn als het 
nodig is. Mam en pap het was best een spannende tijd, mijn eigen plekje, Zenith die de plek 
van haar moeder innam en de stress van de eindsprint van mijn promotie, bedankt voor 
jullie steun en het extra bordje dat altijd klaar stond (staat).  
 
 
Op naar de volgende uitdaging! 
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